#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Differences in atypical resting-state effective connectivity distinguish autism from schizophrenia
#Text=Autism and schizophrenia share overlapping genetic etiology, common changes in brain structure and common cognitive deficits.
1-1	0-11	Differences	_	
1-2	12-14	in	_	
1-3	15-23	atypical	_	
1-4	24-37	resting-state	_	
1-5	38-47	effective	_	
1-6	48-60	connectivity	_	
1-7	61-72	distinguish	_	
1-8	73-79	autism	_	
1-9	80-84	from	_	
1-10	85-98	schizophrenia	_	
1-11	99-105	Autism	http://maven.renci.org/NeuroBridge/neurobridge#AutisticDisorder	
1-12	106-109	and	_	
1-13	110-123	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
1-14	124-129	share	_	
1-15	130-141	overlapping	_	
1-16	142-149	genetic	_	
1-17	150-158	etiology	_	
1-18	158-159	,	_	
1-19	160-166	common	_	
1-20	167-174	changes	_	
1-21	175-177	in	_	
1-22	178-183	brain	_	
1-23	184-193	structure	_	
1-24	194-197	and	_	
1-25	198-204	common	_	
1-26	205-214	cognitive	_	
1-27	215-223	deficits	_	
1-28	223-224	.	_	

#Text=A number of studies using resting state fMRI have shown that machine learning algorithms can distinguish between healthy controls and individuals diagnosed with either autism spectrum disorder or schizophrenia.
2-1	225-226	A	_	
2-2	227-233	number	_	
2-3	234-236	of	_	
2-4	237-244	studies	_	
2-5	245-250	using	_	
2-6	251-258	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
2-7	259-264	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
2-8	265-269	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
2-9	270-274	have	_	
2-10	275-280	shown	_	
2-11	281-285	that	_	
2-12	286-293	machine	_	
2-13	294-302	learning	_	
2-14	303-313	algorithms	_	
2-15	314-317	can	_	
2-16	318-329	distinguish	_	
2-17	330-337	between	_	
2-18	338-345	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
2-19	346-354	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
2-20	355-358	and	_	
2-21	359-370	individuals	_	
2-22	371-380	diagnosed	_	
2-23	381-385	with	_	
2-24	386-392	either	_	
2-25	393-399	autism	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder[3]	
2-26	400-408	spectrum	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder[3]	
2-27	409-417	disorder	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder[3]	
2-28	418-420	or	_	
2-29	421-434	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
2-30	434-435	.	_	

#Text=However, it has not yet been determined whether machine learning algorithms can be used to distinguish between the two disorders.
3-1	436-443	However	_	
3-2	443-444	,	_	
3-3	445-447	it	_	
3-4	448-451	has	_	
3-5	452-455	not	_	
3-6	456-459	yet	_	
3-7	460-464	been	_	
3-8	465-475	determined	_	
3-9	476-483	whether	_	
3-10	484-491	machine	_	
3-11	492-500	learning	_	
3-12	501-511	algorithms	_	
3-13	512-515	can	_	
3-14	516-518	be	_	
3-15	519-523	used	_	
3-16	524-526	to	_	
3-17	527-538	distinguish	_	
3-18	539-546	between	_	
3-19	547-550	the	_	
3-20	551-554	two	_	
3-21	555-564	disorders	_	
3-22	564-565	.	_	

#Text=Using a linear support vector machine, we identify features that are most diagnostic for each disorder and successfully use them to classify an independent cohort of subjects.
4-1	566-571	Using	_	
4-2	572-573	a	_	
4-3	574-580	linear	_	
4-4	581-588	support	_	
4-5	589-595	vector	_	
4-6	596-603	machine	_	
4-7	603-604	,	_	
4-8	605-607	we	_	
4-9	608-616	identify	_	
4-10	617-625	features	_	
4-11	626-630	that	_	
4-12	631-634	are	_	
4-13	635-639	most	_	
4-14	640-650	diagnostic	_	
4-15	651-654	for	_	
4-16	655-659	each	_	
4-17	660-668	disorder	_	
4-18	669-672	and	_	
4-19	673-685	successfully	_	
4-20	686-689	use	_	
4-21	690-694	them	_	
4-22	695-697	to	_	
4-23	698-706	classify	_	
4-24	707-709	an	_	
4-25	710-721	independent	_	
4-26	722-728	cohort	_	
4-27	729-731	of	_	
4-28	732-740	subjects	_	
4-29	740-741	.	_	

#Text=We find both common and divergent connectivity differences largely in the default mode network as well as in salience, and motor networks.
5-1	742-744	We	_	
5-2	745-749	find	_	
5-3	750-754	both	_	
5-4	755-761	common	_	
5-5	762-765	and	_	
5-6	766-775	divergent	_	
5-7	776-788	connectivity	_	
5-8	789-800	differences	_	
5-9	801-808	largely	_	
5-10	809-811	in	_	
5-11	812-815	the	_	
5-12	816-823	default	_	
5-13	824-828	mode	_	
5-14	829-836	network	_	
5-15	837-839	as	_	
5-16	840-844	well	_	
5-17	845-847	as	_	
5-18	848-850	in	_	
5-19	851-859	salience	_	
5-20	859-860	,	_	
5-21	861-864	and	_	
5-22	865-870	motor	_	
5-23	871-879	networks	_	
5-24	879-880	.	_	

#Text=Using divergent connectivity differences, we are able to distinguish autistic subjects from those with schizophrenia.
6-1	881-886	Using	_	
6-2	887-896	divergent	_	
6-3	897-909	connectivity	_	
6-4	910-921	differences	_	
6-5	921-922	,	_	
6-6	923-925	we	_	
6-7	926-929	are	_	
6-8	930-934	able	_	
6-9	935-937	to	_	
6-10	938-949	distinguish	_	
6-11	950-958	autistic	_	
6-12	959-967	subjects	_	
6-13	968-972	from	_	
6-14	973-978	those	_	
6-15	979-983	with	_	
6-16	984-997	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
6-17	997-998	.	_	

#Text=Understanding the common and divergent connectivity changes associated with these disorders may provide a framework for understanding their shared cognitive deficits.
7-1	999-1012	Understanding	_	
7-2	1013-1016	the	_	
7-3	1017-1023	common	_	
7-4	1024-1027	and	_	
7-5	1028-1037	divergent	_	
7-6	1038-1050	connectivity	_	
7-7	1051-1058	changes	_	
7-8	1059-1069	associated	_	
7-9	1070-1074	with	_	
7-10	1075-1080	these	_	
7-11	1081-1090	disorders	_	
7-12	1091-1094	may	_	
7-13	1095-1102	provide	_	
7-14	1103-1104	a	_	
7-15	1105-1114	framework	_	
7-16	1115-1118	for	_	
7-17	1119-1132	understanding	_	
7-18	1133-1138	their	_	
7-19	1139-1145	shared	_	
7-20	1146-1155	cognitive	_	
7-21	1156-1164	deficits	_	
7-22	1164-1165	.	_	

#Text=Highlights
#Text=Common and divergent diagnostic features for autism and schizophrenia are identified.
8-1	1166-1176	Highlights	_	
8-2	1177-1183	Common	_	
8-3	1184-1187	and	_	
8-4	1188-1197	divergent	_	
8-5	1198-1208	diagnostic	_	
8-6	1209-1217	features	_	
8-7	1218-1221	for	_	
8-8	1222-1228	autism	http://maven.renci.org/NeuroBridge/neurobridge#AutisticDisorder	
8-9	1229-1232	and	_	
8-10	1233-1246	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
8-11	1247-1250	are	_	
8-12	1251-1261	identified	_	
8-13	1261-1262	.	_	

#Text=SVM classifiers successfully identify patients from training-naive patient groups.
9-1	1263-1266	SVM	_	
9-2	1267-1278	classifiers	_	
9-3	1279-1291	successfully	_	
9-4	1292-1300	identify	_	
9-5	1301-1309	patients	_	
9-6	1310-1314	from	_	
9-7	1315-1329	training-naive	_	
9-8	1330-1337	patient	_	
9-9	1338-1344	groups	_	
9-10	1344-1345	.	_	

#Text=Diagnostic connectivity changes cluster in the default mode and salience networks.
10-1	1346-1356	Diagnostic	_	
10-2	1357-1369	connectivity	_	
10-3	1370-1377	changes	_	
10-4	1378-1385	cluster	_	
10-5	1386-1388	in	_	
10-6	1389-1392	the	_	
10-7	1393-1400	default	_	
10-8	1401-1405	mode	_	
10-9	1406-1409	and	_	
10-10	1410-1418	salience	_	
10-11	1419-1427	networks	_	
10-12	1427-1428	.	_	

#Text=Shared diagnostic features predict deficits in communication skills in autism.
11-1	1429-1435	Shared	_	
11-2	1436-1446	diagnostic	_	
11-3	1447-1455	features	_	
11-4	1456-1463	predict	_	
11-5	1464-1472	deficits	_	
11-6	1473-1475	in	_	
11-7	1476-1489	communication	_	
11-8	1490-1496	skills	_	
11-9	1497-1499	in	_	
11-10	1500-1506	autism	http://maven.renci.org/NeuroBridge/neurobridge#AutisticDisorder	
11-11	1506-1507	.	_	

#Text=Unique features distinguish autism and schizophrenic patients.
12-1	1508-1514	Unique	_	
12-2	1515-1523	features	_	
12-3	1524-1535	distinguish	_	
12-4	1536-1542	autism	http://maven.renci.org/NeuroBridge/neurobridge#AutisticDisorder	
12-5	1543-1546	and	_	
12-6	1547-1560	schizophrenic	_	
12-7	1561-1569	patients	_	
12-8	1569-1570	.	_	

#Text=Introduction
#Text=Clinical similarities between schizophrenia (SZ) and autism spectrum disorder (ASD) were recognized even in the earliest descriptions of the two disorders.
13-1	1571-1583	Introduction	_	
13-2	1584-1592	Clinical	_	
13-3	1593-1605	similarities	_	
13-4	1606-1613	between	_	
13-5	1614-1627	schizophrenia	_	
13-6	1628-1629	(	_	
13-7	1629-1631	SZ	_	
13-8	1631-1632	)	_	
13-9	1633-1636	and	_	
13-10	1637-1643	autism	_	
13-11	1644-1652	spectrum	_	
13-12	1653-1661	disorder	_	
13-13	1662-1663	(	_	
13-14	1663-1666	ASD	_	
13-15	1666-1667	)	_	
13-16	1668-1672	were	_	
13-17	1673-1683	recognized	_	
13-18	1684-1688	even	_	
13-19	1689-1691	in	_	
13-20	1692-1695	the	_	
13-21	1696-1704	earliest	_	
13-22	1705-1717	descriptions	_	
13-23	1718-1720	of	_	
13-24	1721-1724	the	_	
13-25	1725-1728	two	_	
13-26	1729-1738	disorders	_	
13-27	1738-1739	.	_	

#Text=The first reported cases of autism were initially thought to be a form of infantile SZ.
14-1	1740-1743	The	_	
14-2	1744-1749	first	_	
14-3	1750-1758	reported	_	
14-4	1759-1764	cases	_	
14-5	1765-1767	of	_	
14-6	1768-1774	autism	_	
14-7	1775-1779	were	_	
14-8	1780-1789	initially	_	
14-9	1790-1797	thought	_	
14-10	1798-1800	to	_	
14-11	1801-1803	be	_	
14-12	1804-1805	a	_	
14-13	1806-1810	form	_	
14-14	1811-1813	of	_	
14-15	1814-1823	infantile	_	
14-16	1824-1826	SZ	_	
14-17	1826-1827	.	_	

#Text=In fact, the name Autism, which comes from the Greek word “auto” meaning “self”, was originally used to describe a lack of interest in social interaction in individuals with schizophrenia.
15-1	1828-1830	In	_	
15-2	1831-1835	fact	_	
15-3	1835-1836	,	_	
15-4	1837-1840	the	_	
15-5	1841-1845	name	_	
15-6	1846-1852	Autism	_	
15-7	1852-1853	,	_	
15-8	1854-1859	which	_	
15-9	1860-1865	comes	_	
15-10	1866-1870	from	_	
15-11	1871-1874	the	_	
15-12	1875-1880	Greek	_	
15-13	1881-1885	word	_	
15-14	1886-1887	“	_	
15-15	1887-1891	auto	_	
15-16	1891-1892	”	_	
15-17	1893-1900	meaning	_	
15-18	1901-1902	“	_	
15-19	1902-1906	self	_	
15-20	1906-1907	”	_	
15-21	1907-1908	,	_	
15-22	1909-1912	was	_	
15-23	1913-1923	originally	_	
15-24	1924-1928	used	_	
15-25	1929-1931	to	_	
15-26	1932-1940	describe	_	
15-27	1941-1942	a	_	
15-28	1943-1947	lack	_	
15-29	1948-1950	of	_	
15-30	1951-1959	interest	_	
15-31	1960-1962	in	_	
15-32	1963-1969	social	_	
15-33	1970-1981	interaction	_	
15-34	1982-1984	in	_	
15-35	1985-1996	individuals	_	
15-36	1997-2001	with	_	
15-37	2002-2015	schizophrenia	_	
15-38	2015-2016	.	_	

#Text=Later the term became associated with children who exhibited a similar lack of interest in social interaction and the spectrum of disorders we now call ASD.
16-1	2017-2022	Later	_	
16-2	2023-2026	the	_	
16-3	2027-2031	term	_	
16-4	2032-2038	became	_	
16-5	2039-2049	associated	_	
16-6	2050-2054	with	_	
16-7	2055-2063	children	_	
16-8	2064-2067	who	_	
16-9	2068-2077	exhibited	_	
16-10	2078-2079	a	_	
16-11	2080-2087	similar	_	
16-12	2088-2092	lack	_	
16-13	2093-2095	of	_	
16-14	2096-2104	interest	_	
16-15	2105-2107	in	_	
16-16	2108-2114	social	_	
16-17	2115-2126	interaction	_	
16-18	2127-2130	and	_	
16-19	2131-2134	the	_	
16-20	2135-2143	spectrum	_	
16-21	2144-2146	of	_	
16-22	2147-2156	disorders	_	
16-23	2157-2159	we	_	
16-24	2160-2163	now	_	
16-25	2164-2168	call	_	
16-26	2169-2172	ASD	_	
16-27	2172-2173	.	_	

#Text=The young age of onset of clinical symptoms and lack of psychosis in ASD were later recognized as the main features that separated SZ from ASD.
17-1	2174-2177	The	_	
17-2	2178-2183	young	_	
17-3	2184-2187	age	_	
17-4	2188-2190	of	_	
17-5	2191-2196	onset	_	
17-6	2197-2199	of	_	
17-7	2200-2208	clinical	_	
17-8	2209-2217	symptoms	_	
17-9	2218-2221	and	_	
17-10	2222-2226	lack	_	
17-11	2227-2229	of	_	
17-12	2230-2239	psychosis	_	
17-13	2240-2242	in	_	
17-14	2243-2246	ASD	_	
17-15	2247-2251	were	_	
17-16	2252-2257	later	_	
17-17	2258-2268	recognized	_	
17-18	2269-2271	as	_	
17-19	2272-2275	the	_	
17-20	2276-2280	main	_	
17-21	2281-2289	features	_	
17-22	2290-2294	that	_	
17-23	2295-2304	separated	_	
17-24	2305-2307	SZ	_	
17-25	2308-2312	from	_	
17-26	2313-2316	ASD	_	
17-27	2316-2317	.	_	

#Text=While they are now recognized as distinct disorders, their shared cognitive symptoms include impairments in social interaction and communication, deficits in processing emotion, theory of mind abilities, language skills and learning, and the inability to suppress irrelevant information.
18-1	2318-2323	While	_	
18-2	2324-2328	they	_	
18-3	2329-2332	are	_	
18-4	2333-2336	now	_	
18-5	2337-2347	recognized	_	
18-6	2348-2350	as	_	
18-7	2351-2359	distinct	_	
18-8	2360-2369	disorders	_	
18-9	2369-2370	,	_	
18-10	2371-2376	their	_	
18-11	2377-2383	shared	_	
18-12	2384-2393	cognitive	_	
18-13	2394-2402	symptoms	_	
18-14	2403-2410	include	_	
18-15	2411-2422	impairments	_	
18-16	2423-2425	in	_	
18-17	2426-2432	social	_	
18-18	2433-2444	interaction	_	
18-19	2445-2448	and	_	
18-20	2449-2462	communication	_	
18-21	2462-2463	,	_	
18-22	2464-2472	deficits	_	
18-23	2473-2475	in	_	
18-24	2476-2486	processing	_	
18-25	2487-2494	emotion	_	
18-26	2494-2495	,	_	
18-27	2496-2502	theory	_	
18-28	2503-2505	of	_	
18-29	2506-2510	mind	_	
18-30	2511-2520	abilities	_	
18-31	2520-2521	,	_	
18-32	2522-2530	language	_	
18-33	2531-2537	skills	_	
18-34	2538-2541	and	_	
18-35	2542-2550	learning	_	
18-36	2550-2551	,	_	
18-37	2552-2555	and	_	
18-38	2556-2559	the	_	
18-39	2560-2569	inability	_	
18-40	2570-2572	to	_	
18-41	2573-2581	suppress	_	
18-42	2582-2592	irrelevant	_	
18-43	2593-2604	information	_	
18-44	2604-2605	.	_	

#Text=There are currently no medical tests available for either disorder.
19-1	2606-2611	There	_	
19-2	2612-2615	are	_	
19-3	2616-2625	currently	_	
19-4	2626-2628	no	_	
19-5	2629-2636	medical	_	
19-6	2637-2642	tests	_	
19-7	2643-2652	available	_	
19-8	2653-2656	for	_	
19-9	2657-2663	either	_	
19-10	2664-2672	disorder	_	
19-11	2672-2673	.	_	

#Text=According to the diagnostic guidelines contained in the Diagnostic and Statistical Manual of Mental Disorders (DSM), many patients may qualify as having either condition.
20-1	2674-2683	According	_	
20-2	2684-2686	to	_	
20-3	2687-2690	the	_	
20-4	2691-2701	diagnostic	_	
20-5	2702-2712	guidelines	_	
20-6	2713-2722	contained	_	
20-7	2723-2725	in	_	
20-8	2726-2729	the	_	
20-9	2730-2740	Diagnostic	_	
20-10	2741-2744	and	_	
20-11	2745-2756	Statistical	_	
20-12	2757-2763	Manual	_	
20-13	2764-2766	of	_	
20-14	2767-2773	Mental	_	
20-15	2774-2783	Disorders	_	
20-16	2784-2785	(	_	
20-17	2785-2788	DSM	_	
20-18	2788-2789	)	_	
20-19	2789-2790	,	_	
20-20	2791-2795	many	_	
20-21	2796-2804	patients	_	
20-22	2805-2808	may	_	
20-23	2809-2816	qualify	_	
20-24	2817-2819	as	_	
20-25	2820-2826	having	_	
20-26	2827-2833	either	_	
20-27	2834-2843	condition	_	
20-28	2843-2844	.	_	

#Text=Therefore, there is considerable interest in identifying reliable biomarkers.
21-1	2845-2854	Therefore	_	
21-2	2854-2855	,	_	
21-3	2856-2861	there	_	
21-4	2862-2864	is	_	
21-5	2865-2877	considerable	_	
21-6	2878-2886	interest	_	
21-7	2887-2889	in	_	
21-8	2890-2901	identifying	_	
21-9	2902-2910	reliable	_	
21-10	2911-2921	biomarkers	_	
21-11	2921-2922	.	_	

#Text=Aberrant brain connectivity is strongly implicated in both disorders, as many of the genes implicated in ASD and SZ are involved in developing both long-range projections between brain areas as well as short-range synaptic connections.
22-1	2923-2931	Aberrant	_	
22-2	2932-2937	brain	_	
22-3	2938-2950	connectivity	_	
22-4	2951-2953	is	_	
22-5	2954-2962	strongly	_	
22-6	2963-2973	implicated	_	
22-7	2974-2976	in	_	
22-8	2977-2981	both	_	
22-9	2982-2991	disorders	_	
22-10	2991-2992	,	_	
22-11	2993-2995	as	_	
22-12	2996-3000	many	_	
22-13	3001-3003	of	_	
22-14	3004-3007	the	_	
22-15	3008-3013	genes	_	
22-16	3014-3024	implicated	_	
22-17	3025-3027	in	_	
22-18	3028-3031	ASD	_	
22-19	3032-3035	and	_	
22-20	3036-3038	SZ	_	
22-21	3039-3042	are	_	
22-22	3043-3051	involved	_	
22-23	3052-3054	in	_	
22-24	3055-3065	developing	_	
22-25	3066-3070	both	_	
22-26	3071-3081	long-range	_	
22-27	3082-3093	projections	_	
22-28	3094-3101	between	_	
22-29	3102-3107	brain	_	
22-30	3108-3113	areas	_	
22-31	3114-3116	as	_	
22-32	3117-3121	well	_	
22-33	3122-3124	as	_	
22-34	3125-3136	short-range	_	
22-35	3137-3145	synaptic	_	
22-36	3146-3157	connections	_	
22-37	3157-3158	.	_	

#Text=Comparative studies aimed at understanding the genetic etiological relationship between the two disorders have identified some evidence for overlapping etiology and some evidence for diametric etiology (resulting from reciprocal alterations to common risk factors).
23-1	3159-3170	Comparative	_	
23-2	3171-3178	studies	_	
23-3	3179-3184	aimed	_	
23-4	3185-3187	at	_	
23-5	3188-3201	understanding	_	
23-6	3202-3205	the	_	
23-7	3206-3213	genetic	_	
23-8	3214-3225	etiological	_	
23-9	3226-3238	relationship	_	
23-10	3239-3246	between	_	
23-11	3247-3250	the	_	
23-12	3251-3254	two	_	
23-13	3255-3264	disorders	_	
23-14	3265-3269	have	_	
23-15	3270-3280	identified	_	
23-16	3281-3285	some	_	
23-17	3286-3294	evidence	_	
23-18	3295-3298	for	_	
23-19	3299-3310	overlapping	_	
23-20	3311-3319	etiology	_	
23-21	3320-3323	and	_	
23-22	3324-3328	some	_	
23-23	3329-3337	evidence	_	
23-24	3338-3341	for	_	
23-25	3342-3351	diametric	_	
23-26	3352-3360	etiology	_	
23-27	3361-3362	(	_	
23-28	3362-3371	resulting	_	
23-29	3372-3376	from	_	
23-30	3377-3387	reciprocal	_	
23-31	3388-3399	alterations	_	
23-32	3400-3402	to	_	
23-33	3403-3409	common	_	
23-34	3410-3414	risk	_	
23-35	3415-3422	factors	_	
23-36	3422-3423	)	_	
23-37	3423-3424	.	_	

#Text=While there is strong evidence for genetic risk factors and heritability, overlapping epigenetic mechanisms are now recognized as potentially playing a vital role in pathogenesis (; see for reviews in ASD and schizophrenia respectively).
24-1	3425-3430	While	_	
24-2	3431-3436	there	_	
24-3	3437-3439	is	_	
24-4	3440-3446	strong	_	
24-5	3447-3455	evidence	_	
24-6	3456-3459	for	_	
24-7	3460-3467	genetic	_	
24-8	3468-3472	risk	_	
24-9	3473-3480	factors	_	
24-10	3481-3484	and	_	
24-11	3485-3497	heritability	_	
24-12	3497-3498	,	_	
24-13	3499-3510	overlapping	_	
24-14	3511-3521	epigenetic	_	
24-15	3522-3532	mechanisms	_	
24-16	3533-3536	are	_	
24-17	3537-3540	now	_	
24-18	3541-3551	recognized	_	
24-19	3552-3554	as	_	
24-20	3555-3566	potentially	_	
24-21	3567-3574	playing	_	
24-22	3575-3576	a	_	
24-23	3577-3582	vital	_	
24-24	3583-3587	role	_	
24-25	3588-3590	in	_	
24-26	3591-3603	pathogenesis	_	
24-27	3604-3605	(	_	
24-28	3605-3606	;	_	
24-29	3607-3610	see	_	
24-30	3611-3614	for	_	
24-31	3615-3622	reviews	_	
24-32	3623-3625	in	_	
24-33	3626-3629	ASD	_	
24-34	3630-3633	and	_	
24-35	3634-3647	schizophrenia	_	
24-36	3648-3660	respectively	_	
24-37	3660-3661	)	_	
24-38	3661-3662	.	_	

#Text=The resulting cognitive deficits observed in both disorders are believed to be caused by altered communication between brain areas.
25-1	3663-3666	The	_	
25-2	3667-3676	resulting	_	
25-3	3677-3686	cognitive	_	
25-4	3687-3695	deficits	_	
25-5	3696-3704	observed	_	
25-6	3705-3707	in	_	
25-7	3708-3712	both	_	
25-8	3713-3722	disorders	_	
25-9	3723-3726	are	_	
25-10	3727-3735	believed	_	
25-11	3736-3738	to	_	
25-12	3739-3741	be	_	
25-13	3742-3748	caused	_	
25-14	3749-3751	by	_	
25-15	3752-3759	altered	_	
25-16	3760-3773	communication	_	
25-17	3774-3781	between	_	
25-18	3782-3787	brain	_	
25-19	3788-3793	areas	_	
25-20	3793-3794	.	_	

#Text=However, studies aimed at identifying the regions of altered connectivity have yielded many conflicting results and failed replications.
26-1	3795-3802	However	_	
26-2	3802-3803	,	_	
26-3	3804-3811	studies	_	
26-4	3812-3817	aimed	_	
26-5	3818-3820	at	_	
26-6	3821-3832	identifying	_	
26-7	3833-3836	the	_	
26-8	3837-3844	regions	_	
26-9	3845-3847	of	_	
26-10	3848-3855	altered	_	
26-11	3856-3868	connectivity	_	
26-12	3869-3873	have	_	
26-13	3874-3881	yielded	_	
26-14	3882-3886	many	_	
26-15	3887-3898	conflicting	_	
26-16	3899-3906	results	_	
26-17	3907-3910	and	_	
26-18	3911-3917	failed	_	
26-19	3918-3930	replications	_	
26-20	3930-3931	.	_	

#Text=The large majority of such studies have made use of resting state functional magnetic resonance imaging (fMRI) because of its ease of collection and the ability to make measurements of large-scale functional connectivity across the brain.
27-1	3932-3935	The	_	
27-2	3936-3941	large	_	
27-3	3942-3950	majority	_	
27-4	3951-3953	of	_	
27-5	3954-3958	such	_	
27-6	3959-3966	studies	_	
27-7	3967-3971	have	_	
27-8	3972-3976	made	_	
27-9	3977-3980	use	_	
27-10	3981-3983	of	_	
27-11	3984-3991	resting	_	
27-12	3992-3997	state	_	
27-13	3998-4008	functional	_	
27-14	4009-4017	magnetic	_	
27-15	4018-4027	resonance	_	
27-16	4028-4035	imaging	_	
27-17	4036-4037	(	_	
27-18	4037-4041	fMRI	_	
27-19	4041-4042	)	_	
27-20	4043-4050	because	_	
27-21	4051-4053	of	_	
27-22	4054-4057	its	_	
27-23	4058-4062	ease	_	
27-24	4063-4065	of	_	
27-25	4066-4076	collection	_	
27-26	4077-4080	and	_	
27-27	4081-4084	the	_	
27-28	4085-4092	ability	_	
27-29	4093-4095	to	_	
27-30	4096-4100	make	_	
27-31	4101-4113	measurements	_	
27-32	4114-4116	of	_	
27-33	4117-4128	large-scale	_	
27-34	4129-4139	functional	_	
27-35	4140-4152	connectivity	_	
27-36	4153-4159	across	_	
27-37	4160-4163	the	_	
27-38	4164-4169	brain	_	
27-39	4169-4170	.	_	

#Text=Functional connectivity refers to the temporal correlation between activity in different brain regions often interpreted as an indication of interaction between them.
28-1	4171-4181	Functional	_	
28-2	4182-4194	connectivity	_	
28-3	4195-4201	refers	_	
28-4	4202-4204	to	_	
28-5	4205-4208	the	_	
28-6	4209-4217	temporal	_	
28-7	4218-4229	correlation	_	
28-8	4230-4237	between	_	
28-9	4238-4246	activity	_	
28-10	4247-4249	in	_	
28-11	4250-4259	different	_	
28-12	4260-4265	brain	_	
28-13	4266-4273	regions	_	
28-14	4274-4279	often	_	
28-15	4280-4291	interpreted	_	
28-16	4292-4294	as	_	
28-17	4295-4297	an	_	
28-18	4298-4308	indication	_	
28-19	4309-4311	of	_	
28-20	4312-4323	interaction	_	
28-21	4324-4331	between	_	
28-22	4332-4336	them	_	
28-23	4336-4337	.	_	

#Text=Both disorders are associated with decreases in interhemispheric connectivity (SZ:; ASD:), particularly in sensory regions and alterations in connectivity between frontal and posterior regions in the parietal lobe and occipital cortex (SZ:; ASD:).
29-1	4338-4342	Both	_	
29-2	4343-4352	disorders	_	
29-3	4353-4356	are	_	
29-4	4357-4367	associated	_	
29-5	4368-4372	with	_	
29-6	4373-4382	decreases	_	
29-7	4383-4385	in	_	
29-8	4386-4402	interhemispheric	_	
29-9	4403-4415	connectivity	_	
29-10	4416-4417	(	_	
29-11	4417-4419	SZ	_	
29-12	4419-4420	:	_	
29-13	4420-4421	;	_	
29-14	4422-4425	ASD	_	
29-15	4425-4426	:	_	
29-16	4426-4427	)	_	
29-17	4427-4428	,	_	
29-18	4429-4441	particularly	_	
29-19	4442-4444	in	_	
29-20	4445-4452	sensory	_	
29-21	4453-4460	regions	_	
29-22	4461-4464	and	_	
29-23	4465-4476	alterations	_	
29-24	4477-4479	in	_	
29-25	4480-4492	connectivity	_	
29-26	4493-4500	between	_	
29-27	4501-4508	frontal	_	
29-28	4509-4512	and	_	
29-29	4513-4522	posterior	_	
29-30	4523-4530	regions	_	
29-31	4531-4533	in	_	
29-32	4534-4537	the	_	
29-33	4538-4546	parietal	_	
29-34	4547-4551	lobe	_	
29-35	4552-4555	and	_	
29-36	4556-4565	occipital	_	
29-37	4566-4572	cortex	_	
29-38	4573-4574	(	_	
29-39	4574-4576	SZ	_	
29-40	4576-4577	:	_	
29-41	4577-4578	;	_	
29-42	4579-4582	ASD	_	
29-43	4582-4583	:	_	
29-44	4583-4584	)	_	
29-45	4584-4585	.	_	

#Text=Both have been associated with changes in connectivity within the default mode network (DMN).
30-1	4586-4590	Both	_	
30-2	4591-4595	have	_	
30-3	4596-4600	been	_	
30-4	4601-4611	associated	_	
30-5	4612-4616	with	_	
30-6	4617-4624	changes	_	
30-7	4625-4627	in	_	
30-8	4628-4640	connectivity	_	
30-9	4641-4647	within	_	
30-10	4648-4651	the	_	
30-11	4652-4659	default	_	
30-12	4660-4664	mode	_	
30-13	4665-4672	network	_	
30-14	4673-4674	(	_	
30-15	4674-4677	DMN	_	
30-16	4677-4678	)	_	
30-17	4678-4679	.	_	

#Text=However, in some studies, increases rather than decreases in inter-regional functional connectivity are reported and others fail to find significant regional differences (see for review in ASD and for SZ).
31-1	4680-4687	However	_	
31-2	4687-4688	,	_	
31-3	4689-4691	in	_	
31-4	4692-4696	some	_	
31-5	4697-4704	studies	_	
31-6	4704-4705	,	_	
31-7	4706-4715	increases	_	
31-8	4716-4722	rather	_	
31-9	4723-4727	than	_	
31-10	4728-4737	decreases	_	
31-11	4738-4740	in	_	
31-12	4741-4755	inter-regional	_	
31-13	4756-4766	functional	_	
31-14	4767-4779	connectivity	_	
31-15	4780-4783	are	_	
31-16	4784-4792	reported	_	
31-17	4793-4796	and	_	
31-18	4797-4803	others	_	
31-19	4804-4808	fail	_	
31-20	4809-4811	to	_	
31-21	4812-4816	find	_	
31-22	4817-4828	significant	_	
31-23	4829-4837	regional	_	
31-24	4838-4849	differences	_	
31-25	4850-4851	(	_	
31-26	4851-4854	see	_	
31-27	4855-4858	for	_	
31-28	4859-4865	review	_	
31-29	4866-4868	in	_	
31-30	4869-4872	ASD	_	
31-31	4873-4876	and	_	
31-32	4877-4880	for	_	
31-33	4881-4883	SZ	_	
31-34	4883-4884	)	_	
31-35	4884-4885	.	_	

#Text=Inconsistencies in study outcomes may reflect methodological differences, and/or differences in patient sub-populations (age, sex, IQ, medication, and/or disease severity and duration), but also highlight the variability in these patient populations and the difficulty of characterizing either disorder by changes in connectivity between any one or two regions.
32-1	4886-4901	Inconsistencies	_	
32-2	4902-4904	in	_	
32-3	4905-4910	study	_	
32-4	4911-4919	outcomes	_	
32-5	4920-4923	may	_	
32-6	4924-4931	reflect	_	
32-7	4932-4946	methodological	_	
32-8	4947-4958	differences	_	
32-9	4958-4959	,	_	
32-10	4960-4963	and	_	
32-11	4963-4964	/	_	
32-12	4964-4966	or	_	
32-13	4967-4978	differences	_	
32-14	4979-4981	in	_	
32-15	4982-4989	patient	_	
32-16	4990-5005	sub-populations	_	
32-17	5006-5007	(	_	
32-18	5007-5010	age	_	
32-19	5010-5011	,	_	
32-20	5012-5015	sex	_	
32-21	5015-5016	,	_	
32-22	5017-5019	IQ	_	
32-23	5019-5020	,	_	
32-24	5021-5031	medication	_	
32-25	5031-5032	,	_	
32-26	5033-5036	and	_	
32-27	5036-5037	/	_	
32-28	5037-5039	or	_	
32-29	5040-5047	disease	_	
32-30	5048-5056	severity	_	
32-31	5057-5060	and	_	
32-32	5061-5069	duration	_	
32-33	5069-5070	)	_	
32-34	5070-5071	,	_	
32-35	5072-5075	but	_	
32-36	5076-5080	also	_	
32-37	5081-5090	highlight	_	
32-38	5091-5094	the	_	
32-39	5095-5106	variability	_	
32-40	5107-5109	in	_	
32-41	5110-5115	these	_	
32-42	5116-5123	patient	_	
32-43	5124-5135	populations	_	
32-44	5136-5139	and	_	
32-45	5140-5143	the	_	
32-46	5144-5154	difficulty	_	
32-47	5155-5157	of	_	
32-48	5158-5172	characterizing	_	
32-49	5173-5179	either	_	
32-50	5180-5188	disorder	_	
32-51	5189-5191	by	_	
32-52	5192-5199	changes	_	
32-53	5200-5202	in	_	
32-54	5203-5215	connectivity	_	
32-55	5216-5223	between	_	
32-56	5224-5227	any	_	
32-57	5228-5231	one	_	
32-58	5232-5234	or	_	
32-59	5235-5238	two	_	
32-60	5239-5246	regions	_	
32-61	5246-5247	.	_	

#Text=Where studies of regional changes in connectivity have yielded inconsistent results, studies using whole-brain measures of functional connectivity, in combination with machine learning algorithms, have demonstrated that multivariate patterns of connectivity can successfully distinguish patients from healthy controls.
33-1	5248-5253	Where	_	
33-2	5254-5261	studies	_	
33-3	5262-5264	of	_	
33-4	5265-5273	regional	_	
33-5	5274-5281	changes	_	
33-6	5282-5284	in	_	
33-7	5285-5297	connectivity	_	
33-8	5298-5302	have	_	
33-9	5303-5310	yielded	_	
33-10	5311-5323	inconsistent	_	
33-11	5324-5331	results	_	
33-12	5331-5332	,	_	
33-13	5333-5340	studies	_	
33-14	5341-5346	using	_	
33-15	5347-5358	whole-brain	_	
33-16	5359-5367	measures	_	
33-17	5368-5370	of	_	
33-18	5371-5381	functional	_	
33-19	5382-5394	connectivity	_	
33-20	5394-5395	,	_	
33-21	5396-5398	in	_	
33-22	5399-5410	combination	_	
33-23	5411-5415	with	_	
33-24	5416-5423	machine	_	
33-25	5424-5432	learning	_	
33-26	5433-5443	algorithms	_	
33-27	5443-5444	,	_	
33-28	5445-5449	have	_	
33-29	5450-5462	demonstrated	_	
33-30	5463-5467	that	_	
33-31	5468-5480	multivariate	_	
33-32	5481-5489	patterns	_	
33-33	5490-5492	of	_	
33-34	5493-5505	connectivity	_	
33-35	5506-5509	can	_	
33-36	5510-5522	successfully	_	
33-37	5523-5534	distinguish	_	
33-38	5535-5543	patients	_	
33-39	5544-5548	from	_	
33-40	5549-5556	healthy	_	
33-41	5557-5565	controls	_	
33-42	5565-5566	.	_	

#Text=Using a multivariate classification approach, a recent study aimed at identifying biomarkers specifically for ASD found that application of their ASD model to other disorders was moderately successful in identifying SZ patients from healthy controls, but not those with attention-deficit hyperactivity disorder (ADHD) or major depressive disorder.
34-1	5567-5572	Using	_	
34-2	5573-5574	a	_	
34-3	5575-5587	multivariate	_	
34-4	5588-5602	classification	_	
34-5	5603-5611	approach	_	
34-6	5611-5612	,	_	
34-7	5613-5614	a	_	
34-8	5615-5621	recent	_	
34-9	5622-5627	study	_	
34-10	5628-5633	aimed	_	
34-11	5634-5636	at	_	
34-12	5637-5648	identifying	_	
34-13	5649-5659	biomarkers	_	
34-14	5660-5672	specifically	_	
34-15	5673-5676	for	_	
34-16	5677-5680	ASD	_	
34-17	5681-5686	found	_	
34-18	5687-5691	that	_	
34-19	5692-5703	application	_	
34-20	5704-5706	of	_	
34-21	5707-5712	their	_	
34-22	5713-5716	ASD	_	
34-23	5717-5722	model	_	
34-24	5723-5725	to	_	
34-25	5726-5731	other	_	
34-26	5732-5741	disorders	_	
34-27	5742-5745	was	_	
34-28	5746-5756	moderately	_	
34-29	5757-5767	successful	_	
34-30	5768-5770	in	_	
34-31	5771-5782	identifying	_	
34-32	5783-5785	SZ	_	
34-33	5786-5794	patients	_	
34-34	5795-5799	from	_	
34-35	5800-5807	healthy	_	
34-36	5808-5816	controls	_	
34-37	5816-5817	,	_	
34-38	5818-5821	but	_	
34-39	5822-5825	not	_	
34-40	5826-5831	those	_	
34-41	5832-5836	with	_	
34-42	5837-5854	attention-deficit	_	
34-43	5855-5868	hyperactivity	_	
34-44	5869-5877	disorder	_	
34-45	5878-5879	(	_	
34-46	5879-5883	ADHD	_	
34-47	5883-5884	)	_	
34-48	5885-5887	or	_	
34-49	5888-5893	major	_	
34-50	5894-5904	depressive	_	
34-51	5905-5913	disorder	_	
34-52	5913-5914	.	_	

#Text=This suggests that common cognitive deficits in the two disorders may be accompanied by common changes in connectivity.
35-1	5915-5919	This	_	
35-2	5920-5928	suggests	_	
35-3	5929-5933	that	_	
35-4	5934-5940	common	_	
35-5	5941-5950	cognitive	_	
35-6	5951-5959	deficits	_	
35-7	5960-5962	in	_	
35-8	5963-5966	the	_	
35-9	5967-5970	two	_	
35-10	5971-5980	disorders	_	
35-11	5981-5984	may	_	
35-12	5985-5987	be	_	
35-13	5988-5999	accompanied	_	
35-14	6000-6002	by	_	
35-15	6003-6009	common	_	
35-16	6010-6017	changes	_	
35-17	6018-6020	in	_	
35-18	6021-6033	connectivity	_	
35-19	6033-6034	.	_	

#Text=Studies designed to make direct comparisons between ASD and SZ may identify divergent features that make the two disorders unique, which can aid in the development of customized interventions.
36-1	6035-6042	Studies	_	
36-2	6043-6051	designed	_	
36-3	6052-6054	to	_	
36-4	6055-6059	make	_	
36-5	6060-6066	direct	_	
36-6	6067-6078	comparisons	_	
36-7	6079-6086	between	_	
36-8	6087-6090	ASD	_	
36-9	6091-6094	and	_	
36-10	6095-6097	SZ	_	
36-11	6098-6101	may	_	
36-12	6102-6110	identify	_	
36-13	6111-6120	divergent	_	
36-14	6121-6129	features	_	
36-15	6130-6134	that	_	
36-16	6135-6139	make	_	
36-17	6140-6143	the	_	
36-18	6144-6147	two	_	
36-19	6148-6157	disorders	_	
36-20	6158-6164	unique	_	
36-21	6164-6165	,	_	
36-22	6166-6171	which	_	
36-23	6172-6175	can	_	
36-24	6176-6179	aid	_	
36-25	6180-6182	in	_	
36-26	6183-6186	the	_	
36-27	6187-6198	development	_	
36-28	6199-6201	of	_	
36-29	6202-6212	customized	_	
36-30	6213-6226	interventions	_	
36-31	6226-6227	.	_	

#Text=However, to our knowledge no previous studies have directly compared patterns of connectivity changes in ASD from those in SZ.
37-1	6228-6235	However	_	
37-2	6235-6236	,	_	
37-3	6237-6239	to	_	
37-4	6240-6243	our	_	
37-5	6244-6253	knowledge	_	
37-6	6254-6256	no	_	
37-7	6257-6265	previous	_	
37-8	6266-6273	studies	_	
37-9	6274-6278	have	_	
37-10	6279-6287	directly	_	
37-11	6288-6296	compared	_	
37-12	6297-6305	patterns	_	
37-13	6306-6308	of	_	
37-14	6309-6321	connectivity	_	
37-15	6322-6329	changes	_	
37-16	6330-6332	in	_	
37-17	6333-6336	ASD	_	
37-18	6337-6341	from	_	
37-19	6342-6347	those	_	
37-20	6348-6350	in	_	
37-21	6351-6353	SZ	_	
37-22	6353-6354	.	_	

#Text=Furthermore, it is unknown whether machine learning algorithms can be used to differentiate between the two disorders.
38-1	6355-6366	Furthermore	_	
38-2	6366-6367	,	_	
38-3	6368-6370	it	_	
38-4	6371-6373	is	_	
38-5	6374-6381	unknown	_	
38-6	6382-6389	whether	_	
38-7	6390-6397	machine	_	
38-8	6398-6406	learning	_	
38-9	6407-6417	algorithms	_	
38-10	6418-6421	can	_	
38-11	6422-6424	be	_	
38-12	6425-6429	used	_	
38-13	6430-6432	to	_	
38-14	6433-6446	differentiate	_	
38-15	6447-6454	between	_	
38-16	6455-6458	the	_	
38-17	6459-6462	two	_	
38-18	6463-6472	disorders	_	
38-19	6472-6473	.	_	

#Text=In this study, we apply graph theoretical techniques to resting state brain activity in autistic and schizophrenic patient populations, building whole-brain models of effectivity connectivity between brain regions over time.
39-1	6474-6476	In	_	
39-2	6477-6481	this	_	
39-3	6482-6487	study	_	
39-4	6487-6488	,	_	
39-5	6489-6491	we	_	
39-6	6492-6497	apply	_	
39-7	6498-6503	graph	_	
39-8	6504-6515	theoretical	_	
39-9	6516-6526	techniques	_	
39-10	6527-6529	to	_	
39-11	6530-6537	resting	_	
39-12	6538-6543	state	_	
39-13	6544-6549	brain	_	
39-14	6550-6558	activity	_	
39-15	6559-6561	in	_	
39-16	6562-6570	autistic	_	
39-17	6571-6574	and	_	
39-18	6575-6588	schizophrenic	_	
39-19	6589-6596	patient	_	
39-20	6597-6608	populations	_	
39-21	6608-6609	,	_	
39-22	6610-6618	building	_	
39-23	6619-6630	whole-brain	_	
39-24	6631-6637	models	_	
39-25	6638-6640	of	_	
39-26	6641-6652	effectivity	_	
39-27	6653-6665	connectivity	_	
39-28	6666-6673	between	_	
39-29	6674-6679	brain	_	
39-30	6680-6687	regions	_	
39-31	6688-6692	over	_	
39-32	6693-6697	time	_	
39-33	6697-6698	.	_	

#Text=Then, using supervised machine learning in combination with a feature selection algorithm, we identify features that are most diagnostic for each.
40-1	6699-6703	Then	_	
40-2	6703-6704	,	_	
40-3	6705-6710	using	_	
40-4	6711-6721	supervised	_	
40-5	6722-6729	machine	_	
40-6	6730-6738	learning	_	
40-7	6739-6741	in	_	
40-8	6742-6753	combination	_	
40-9	6754-6758	with	_	
40-10	6759-6760	a	_	
40-11	6761-6768	feature	_	
40-12	6769-6778	selection	_	
40-13	6779-6788	algorithm	_	
40-14	6788-6789	,	_	
40-15	6790-6792	we	_	
40-16	6793-6801	identify	_	
40-17	6802-6810	features	_	
40-18	6811-6815	that	_	
40-19	6816-6819	are	_	
40-20	6820-6824	most	_	
40-21	6825-6835	diagnostic	_	
40-22	6836-6839	for	_	
40-23	6840-6844	each	_	
40-24	6844-6845	.	_	

#Text=We cross-validate the resulting machine learning models on independent training-naive data sets to determine if they generalize outside the training data sets.
41-1	6846-6848	We	_	
41-2	6849-6863	cross-validate	_	
41-3	6864-6867	the	_	
41-4	6868-6877	resulting	_	
41-5	6878-6885	machine	_	
41-6	6886-6894	learning	_	
41-7	6895-6901	models	_	
41-8	6902-6904	on	_	
41-9	6905-6916	independent	_	
41-10	6917-6931	training-naive	_	
41-11	6932-6936	data	_	
41-12	6937-6941	sets	_	
41-13	6942-6944	to	_	
41-14	6945-6954	determine	_	
41-15	6955-6957	if	_	
41-16	6958-6962	they	_	
41-17	6963-6973	generalize	_	
41-18	6974-6981	outside	_	
41-19	6982-6985	the	_	
41-20	6986-6994	training	_	
41-21	6995-6999	data	_	
41-22	7000-7004	sets	_	
41-23	7004-7005	.	_	

#Text=Finally, we identify changes in effective connectivity that are common to both ASD and SZ and show that their divergent features can be used to successfully classify autistic subjects from those diagnosed with schizophrenia.
42-1	7006-7013	Finally	_	
42-2	7013-7014	,	_	
42-3	7015-7017	we	_	
42-4	7018-7026	identify	_	
42-5	7027-7034	changes	_	
42-6	7035-7037	in	_	
42-7	7038-7047	effective	_	
42-8	7048-7060	connectivity	_	
42-9	7061-7065	that	_	
42-10	7066-7069	are	_	
42-11	7070-7076	common	_	
42-12	7077-7079	to	_	
42-13	7080-7084	both	_	
42-14	7085-7088	ASD	_	
42-15	7089-7092	and	_	
42-16	7093-7095	SZ	_	
42-17	7096-7099	and	_	
42-18	7100-7104	show	_	
42-19	7105-7109	that	_	
42-20	7110-7115	their	_	
42-21	7116-7125	divergent	_	
42-22	7126-7134	features	_	
42-23	7135-7138	can	_	
42-24	7139-7141	be	_	
42-25	7142-7146	used	_	
42-26	7147-7149	to	_	
42-27	7150-7162	successfully	_	
42-28	7163-7171	classify	_	
42-29	7172-7180	autistic	_	
42-30	7181-7189	subjects	_	
42-31	7190-7194	from	_	
42-32	7195-7200	those	_	
42-33	7201-7210	diagnosed	_	
42-34	7211-7215	with	_	
42-35	7216-7229	schizophrenia	_	
42-36	7229-7230	.	_	

#Text=Materials and methods
#Text=Data
#Text=Resting state data for subjects with SZ was archived by the Center for Biomedical Research Excellence (COBRE) and obtained from http://fcon_1000.projects.nitrc.org/indi/retro/cobre.html.
43-1	7231-7240	Materials	http://www.case.edu/ProvCaRe/provcare#StudyMethod[4]	
43-2	7241-7244	and	http://www.case.edu/ProvCaRe/provcare#StudyMethod[4]	
43-3	7245-7252	methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod[4]	
43-4	7253-7257	Data	_	
43-5	7258-7265	Resting	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[6]	
43-6	7266-7271	state	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[6]	
43-7	7272-7276	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-8	7277-7280	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-9	7281-7289	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-10	7290-7294	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-11	7295-7297	SZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[7]	
43-12	7298-7301	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-13	7302-7310	archived	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-14	7311-7313	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-15	7314-7317	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-16	7318-7324	Center	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-17	7325-7328	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-18	7329-7339	Biomedical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-19	7340-7348	Research	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-20	7349-7359	Excellence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-21	7360-7361	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-22	7361-7366	COBRE	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-23	7366-7367	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-24	7368-7371	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-25	7372-7380	obtained	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-26	7381-7385	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-27	7386-7390	http	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-28	7390-7391	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-29	7391-7392	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-30	7392-7393	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-31	7393-7397	fcon	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-32	7397-7398	_	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-33	7398-7402	1000	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-34	7402-7403	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-35	7403-7421	projects.nitrc.org	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-36	7421-7422	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-37	7422-7426	indi	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-38	7426-7427	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-39	7427-7432	retro	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-40	7432-7433	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-41	7433-7443	cobre.html	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	
43-42	7443-7444	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[5]	

#Text=The data set included 146 subjects ranging in age between 18 and 65 (72 SZ mean age = 38.17; SD = 13.89; 58 males and 74 controls mean age = 35.82; SD = 11.58; 51 males).
44-1	7445-7448	The	_	
44-2	7449-7453	data	_	
44-3	7454-7457	set	_	
44-4	7458-7466	included	_	
44-5	7467-7470	146	_	
44-6	7471-7479	subjects	_	
44-7	7480-7487	ranging	_	
44-8	7488-7490	in	_	
44-9	7491-7494	age	_	
44-10	7495-7502	between	_	
44-11	7503-7505	18	_	
44-12	7506-7509	and	_	
44-13	7510-7512	65	_	
44-14	7513-7514	(	_	
44-15	7514-7516	72	_	
44-16	7517-7519	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
44-17	7520-7524	mean	_	
44-18	7525-7528	age	_	
44-19	7528-7529	 	_	
44-20	7529-7530	=	_	
44-21	7530-7531	 	_	
44-22	7531-7536	38.17	_	
44-23	7536-7537	;	_	
44-24	7538-7540	SD	_	
44-25	7540-7541	 	_	
44-26	7541-7542	=	_	
44-27	7542-7543	 	_	
44-28	7543-7548	13.89	_	
44-29	7548-7549	;	_	
44-30	7550-7552	58	_	
44-31	7553-7558	males	_	
44-32	7559-7562	and	_	
44-33	7563-7565	74	_	
44-34	7566-7574	controls	_	
44-35	7575-7579	mean	_	
44-36	7580-7583	age	_	
44-37	7583-7584	 	_	
44-38	7584-7585	=	_	
44-39	7585-7586	 	_	
44-40	7586-7591	35.82	_	
44-41	7591-7592	;	_	
44-42	7593-7595	SD	_	
44-43	7595-7596	 	_	
44-44	7596-7597	=	_	
44-45	7597-7598	 	_	
44-46	7598-7603	11.58	_	
44-47	7603-7604	;	_	
44-48	7605-7607	51	_	
44-49	7608-7613	males	_	
44-50	7613-7614	)	_	
44-51	7614-7615	.	_	

#Text=This data set was used to train a support vector machine (SVM) classifier.
45-1	7616-7620	This	_	
45-2	7621-7625	data	_	
45-3	7626-7629	set	_	
45-4	7630-7633	was	_	
45-5	7634-7638	used	_	
45-6	7639-7641	to	_	
45-7	7642-7647	train	_	
45-8	7648-7649	a	_	
45-9	7650-7657	support	_	
45-10	7658-7664	vector	_	
45-11	7665-7672	machine	_	
45-12	7673-7674	(	_	
45-13	7674-7677	SVM	_	
45-14	7677-7678	)	_	
45-15	7679-7689	classifier	_	
45-16	7689-7690	.	_	

#Text=A separate data set was used as a testing cross validation set.
46-1	7691-7692	A	_	
46-2	7693-7701	separate	_	
46-3	7702-7706	data	_	
46-4	7707-7710	set	_	
46-5	7711-7714	was	_	
46-6	7715-7719	used	_	
46-7	7720-7722	as	_	
46-8	7723-7724	a	_	
46-9	7725-7732	testing	_	
46-10	7733-7738	cross	_	
46-11	7739-7749	validation	_	
46-12	7750-7753	set	_	
46-13	7753-7754	.	_	

#Text=The classifier was never trained on the testing cross validation data sets.
47-1	7755-7758	The	_	
47-2	7759-7769	classifier	_	
47-3	7770-7773	was	_	
47-4	7774-7779	never	_	
47-5	7780-7787	trained	_	
47-6	7788-7790	on	_	
47-7	7791-7794	the	_	
47-8	7795-7802	testing	_	
47-9	7803-7808	cross	_	
47-10	7809-7819	validation	_	
47-11	7820-7824	data	_	
47-12	7825-7829	sets	_	
47-13	7829-7830	.	_	

#Text=Testing data was collected at the Rutgers University Brain Imaging Center as part of another study (not yet published).
48-1	7831-7838	Testing	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
48-2	7839-7843	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
48-3	7844-7847	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
48-4	7848-7857	collected	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
48-5	7858-7860	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
48-6	7861-7864	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
48-7	7865-7872	Rutgers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
48-8	7873-7883	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
48-9	7884-7889	Brain	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
48-10	7890-7897	Imaging	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
48-11	7898-7904	Center	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
48-12	7905-7907	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
48-13	7908-7912	part	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
48-14	7913-7915	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
48-15	7916-7923	another	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
48-16	7924-7929	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
48-17	7930-7931	(	_	
48-18	7931-7934	not	_	
48-19	7935-7938	yet	_	
48-20	7939-7948	published	_	
48-21	7948-7949	)	_	
48-22	7949-7950	.	_	

#Text=It included 10 subjects ranging in age from 19 to 54 years old (5 SZ mean age = 42.6; SD = 11.59; 2 males and 5 controls mean age = 20; SD = 1.22; 2 males) with two resting state scans each.
49-1	7951-7953	It	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-2	7954-7962	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-3	7963-7965	10	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-4	7966-7974	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-5	7975-7982	ranging	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-6	7983-7985	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-7	7986-7989	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-8	7990-7994	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-9	7995-7997	19	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-10	7998-8000	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-11	8001-8003	54	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-12	8003-8004	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-13	8004-8009	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-14	8010-8013	old	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-15	8014-8015	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-16	8015-8016	5	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-17	8017-8019	SZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[10]	
49-18	8020-8024	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-19	8025-8028	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-20	8028-8029	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-21	8029-8030	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-22	8030-8031	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-23	8031-8035	42.6	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-24	8035-8036	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-25	8037-8039	SD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-26	8039-8040	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-27	8040-8041	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-28	8041-8042	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-29	8042-8047	11.59	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-30	8047-8048	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-31	8049-8050	2	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-32	8051-8056	males	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-33	8057-8060	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-34	8061-8062	5	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-35	8063-8071	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-36	8072-8076	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-37	8077-8080	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-38	8080-8081	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-39	8081-8082	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-40	8082-8083	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-41	8083-8085	20	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-42	8085-8086	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-43	8087-8089	SD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-44	8089-8090	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-45	8090-8091	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-46	8091-8092	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-47	8092-8096	1.22	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-48	8096-8097	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-49	8098-8099	2	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-50	8100-8105	males	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-51	8105-8106	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-52	8107-8111	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-53	8112-8115	two	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-54	8116-8123	resting	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]|http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[11]	
49-55	8124-8129	state	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]|http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[11]	
49-56	8130-8135	scans	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-57	8136-8140	each	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
49-58	8140-8141	.	_	

#Text=Resting state data for autistic spectrum disorder subjects was archived by the Autism Brian Imaging Exchange (ABIDE) and obtained from http://fcon_1000.projects.nitrc.org/indi/abide.
50-1	8142-8149	Resting	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]|http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[13]	
50-2	8150-8155	state	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]|http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[13]	
50-3	8156-8160	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-4	8161-8164	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-5	8165-8173	autistic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]|http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder[14]	
50-6	8174-8182	spectrum	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]|http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder[14]	
50-7	8183-8191	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]|http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder[14]	
50-8	8192-8200	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-9	8201-8204	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-10	8205-8213	archived	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-11	8214-8216	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-12	8217-8220	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-13	8221-8227	Autism	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-14	8228-8233	Brian	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-15	8234-8241	Imaging	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-16	8242-8250	Exchange	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-17	8251-8252	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-18	8252-8257	ABIDE	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-19	8257-8258	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-20	8259-8262	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-21	8263-8271	obtained	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-22	8272-8276	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-23	8277-8281	http	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-24	8281-8282	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-25	8282-8283	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-26	8283-8284	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-27	8284-8288	fcon	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-28	8288-8289	_	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-29	8289-8293	1000	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-30	8293-8294	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-31	8294-8312	projects.nitrc.org	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-32	8312-8313	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-33	8313-8317	indi	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-34	8317-8318	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-35	8318-8323	abide	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
50-36	8323-8324	.	_	

#Text=We used the ABIDE I University of Utah School of Medicine (USM) data set.
51-1	8325-8327	We	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-2	8328-8332	used	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-3	8333-8336	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-4	8337-8342	ABIDE	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-5	8343-8344	I	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-6	8345-8355	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-7	8356-8358	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-8	8359-8363	Utah	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-9	8364-8370	School	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-10	8371-8373	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-11	8374-8382	Medicine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-12	8383-8384	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-13	8384-8387	USM	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-14	8387-8388	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-15	8389-8393	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-16	8394-8397	set	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
51-17	8397-8398	.	_	

#Text=It consisted of 101 subjects between the ages of 8 and 50 (58 ASD 11–50 years old; mean = 22.65; SD = 7.73 and 43 controls 8–39 years old; mean = 21.36; SD = 7.64).
52-1	8399-8401	It	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-2	8402-8411	consisted	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-3	8412-8414	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-4	8415-8418	101	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-5	8419-8427	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-6	8428-8435	between	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-7	8436-8439	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-8	8440-8444	ages	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-9	8445-8447	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-10	8448-8449	8	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-11	8450-8453	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-12	8454-8456	50	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-13	8457-8458	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-14	8458-8460	58	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-15	8461-8464	ASD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]|http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder[17]	
52-16	8465-8467	11	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-17	8467-8468	–	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-18	8468-8470	50	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-19	8470-8471	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-20	8471-8476	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-21	8477-8480	old	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-22	8480-8481	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-23	8482-8486	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-24	8486-8487	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-25	8487-8488	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-26	8488-8489	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-27	8489-8494	22.65	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-28	8494-8495	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-29	8496-8498	SD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-30	8498-8499	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-31	8499-8500	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-32	8500-8501	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-33	8501-8505	7.73	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-34	8506-8509	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-35	8510-8512	43	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-36	8513-8521	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-37	8522-8523	8	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-38	8523-8524	–	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-39	8524-8526	39	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-40	8526-8527	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-41	8527-8532	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-42	8533-8536	old	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-43	8536-8537	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-44	8538-8542	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-45	8542-8543	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-46	8543-8544	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-47	8544-8545	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-48	8545-8550	21.36	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-49	8550-8551	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-50	8552-8554	SD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-51	8554-8555	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-52	8555-8556	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-53	8556-8557	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-54	8557-8561	7.64	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-55	8561-8562	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
52-56	8562-8563	.	_	

#Text=As the COBRE data set did not include any individuals below 18 years of age, we excluded subjects below the age of 18 resulting in 37 patients (mean age = 26.34, SD = 7.37, 37 males) and 27 controls (mean age = 25.42, SD = 6.28, 27 males).
53-1	8564-8566	As	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-2	8567-8570	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-3	8571-8576	COBRE	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-4	8577-8581	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-5	8582-8585	set	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-6	8586-8589	did	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-7	8590-8593	not	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-8	8594-8601	include	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-9	8602-8605	any	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-10	8606-8617	individuals	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-11	8618-8623	below	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-12	8624-8626	18	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-13	8626-8627	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-14	8627-8632	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-15	8633-8635	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-16	8636-8639	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-17	8639-8640	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-18	8641-8643	we	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-19	8644-8652	excluded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-20	8653-8661	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-21	8662-8667	below	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-22	8668-8671	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-23	8672-8675	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-24	8676-8678	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-25	8679-8681	18	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-26	8682-8691	resulting	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-27	8692-8694	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-28	8695-8697	37	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-29	8698-8706	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-30	8707-8708	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-31	8708-8712	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-32	8713-8716	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-33	8716-8717	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-34	8717-8718	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-35	8718-8719	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-36	8719-8724	26.34	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-37	8724-8725	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-38	8726-8728	SD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-39	8728-8729	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-40	8729-8730	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-41	8730-8731	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-42	8731-8735	7.37	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-43	8735-8736	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-44	8737-8739	37	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-45	8740-8745	males	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-46	8745-8746	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-47	8747-8750	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-48	8751-8753	27	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-49	8754-8762	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-50	8763-8764	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-51	8764-8768	mean	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-52	8769-8772	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-53	8772-8773	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-54	8773-8774	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-55	8774-8775	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-56	8775-8780	25.42	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-57	8780-8781	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-58	8782-8784	SD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-59	8784-8785	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-60	8785-8786	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-61	8786-8787	 	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-62	8787-8791	6.28	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-63	8791-8792	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-64	8793-8795	27	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-65	8796-8801	males	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-66	8801-8802	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	
53-67	8802-8803	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[18]	

#Text=Testing cross validation was performed on the ABIDE II Barrow Neurological Institute (BNI) data set.
54-1	8804-8811	Testing	_	
54-2	8812-8817	cross	_	
54-3	8818-8828	validation	_	
54-4	8829-8832	was	_	
54-5	8833-8842	performed	_	
54-6	8843-8845	on	_	
54-7	8846-8849	the	_	
54-8	8850-8855	ABIDE	_	
54-9	8856-8858	II	_	
54-10	8859-8865	Barrow	_	
54-11	8866-8878	Neurological	_	
54-12	8879-8888	Institute	_	
54-13	8889-8890	(	_	
54-14	8890-8893	BNI	_	
54-15	8893-8894	)	_	
54-16	8895-8899	data	_	
54-17	8900-8903	set	_	
54-18	8903-8904	.	_	

#Text=It consisted of 58 subjects between the ages of 18 and 64 (29 controls 18–64; mean age = 39.59, SD = 15.09 and 29 patients 18–62; mean age = 37.44; SD = 16.09).
55-1	8905-8907	It	_	
55-2	8908-8917	consisted	_	
55-3	8918-8920	of	_	
55-4	8921-8923	58	_	
55-5	8924-8932	subjects	_	
55-6	8933-8940	between	_	
55-7	8941-8944	the	_	
55-8	8945-8949	ages	_	
55-9	8950-8952	of	_	
55-10	8953-8955	18	_	
55-11	8956-8959	and	_	
55-12	8960-8962	64	_	
55-13	8963-8964	(	_	
55-14	8964-8966	29	_	
55-15	8967-8975	controls	_	
55-16	8976-8978	18	_	
55-17	8978-8979	–	_	
55-18	8979-8981	64	_	
55-19	8981-8982	;	_	
55-20	8983-8987	mean	_	
55-21	8988-8991	age	_	
55-22	8991-8992	 	_	
55-23	8992-8993	=	_	
55-24	8993-8994	 	_	
55-25	8994-8999	39.59	_	
55-26	8999-9000	,	_	
55-27	9001-9003	SD	_	
55-28	9003-9004	 	_	
55-29	9004-9005	=	_	
55-30	9005-9006	 	_	
55-31	9006-9011	15.09	_	
55-32	9012-9015	and	_	
55-33	9016-9018	29	_	
55-34	9019-9027	patients	_	
55-35	9028-9030	18	_	
55-36	9030-9031	–	_	
55-37	9031-9033	62	_	
55-38	9033-9034	;	_	
55-39	9035-9039	mean	_	
55-40	9040-9043	age	_	
55-41	9043-9044	 	_	
55-42	9044-9045	=	_	
55-43	9045-9046	 	_	
55-44	9046-9051	37.44	_	
55-45	9051-9052	;	_	
55-46	9053-9055	SD	_	
55-47	9055-9056	 	_	
55-48	9056-9057	=	_	
55-49	9057-9058	 	_	
55-50	9058-9063	16.09	_	
55-51	9063-9064	)	_	
55-52	9064-9065	.	_	

#Text=After removing four 18 year old subjects, our sample consisted of 27 controls (mean age = 39.58; SD = 15.09; 27 males) and 27 patients (mean age = 37.6; SD = 16.09; 27 males).
56-1	9066-9071	After	_	
56-2	9072-9080	removing	_	
56-3	9081-9085	four	_	
56-4	9086-9088	18	_	
56-5	9088-9089	 	_	
56-6	9089-9093	year	_	
56-7	9094-9097	old	_	
56-8	9098-9106	subjects	_	
56-9	9106-9107	,	_	
56-10	9108-9111	our	_	
56-11	9112-9118	sample	_	
56-12	9119-9128	consisted	_	
56-13	9129-9131	of	_	
56-14	9132-9134	27	_	
56-15	9135-9143	controls	_	
56-16	9144-9145	(	_	
56-17	9145-9149	mean	_	
56-18	9150-9153	age	_	
56-19	9153-9154	 	_	
56-20	9154-9155	=	_	
56-21	9155-9156	 	_	
56-22	9156-9161	39.58	_	
56-23	9161-9162	;	_	
56-24	9163-9165	SD	_	
56-25	9165-9166	 	_	
56-26	9166-9167	=	_	
56-27	9167-9168	 	_	
56-28	9168-9173	15.09	_	
56-29	9173-9174	;	_	
56-30	9175-9177	27	_	
56-31	9178-9183	males	_	
56-32	9183-9184	)	_	
56-33	9185-9188	and	_	
56-34	9189-9191	27	_	
56-35	9192-9200	patients	_	
56-36	9201-9202	(	_	
56-37	9202-9206	mean	_	
56-38	9207-9210	age	_	
56-39	9210-9211	 	_	
56-40	9211-9212	=	_	
56-41	9212-9213	 	_	
56-42	9213-9217	37.6	_	
56-43	9217-9218	;	_	
56-44	9219-9221	SD	_	
56-45	9221-9222	 	_	
56-46	9222-9223	=	_	
56-47	9223-9224	 	_	
56-48	9224-9229	16.09	_	
56-49	9229-9230	;	_	
56-50	9231-9233	27	_	
56-51	9234-9239	males	_	
56-52	9239-9240	)	_	
56-53	9240-9241	.	_	

#Text=All data was collected in compliance with their relevant institutional review boards.
57-1	9242-9245	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
57-2	9246-9250	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
57-3	9251-9254	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
57-4	9255-9264	collected	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
57-5	9265-9267	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
57-6	9268-9278	compliance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
57-7	9279-9283	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
57-8	9284-9289	their	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
57-9	9290-9298	relevant	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
57-10	9299-9312	institutional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
57-11	9313-9319	review	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
57-12	9320-9326	boards	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]	
57-13	9326-9327	.	_	

#Text=To identify common and disparate features and to use SVM to distinguish between SZ and ASD, we created a hybrid control group made up of subjects from each of the SZ and ASD control sets.
58-1	9328-9330	To	_	
58-2	9331-9339	identify	_	
58-3	9340-9346	common	_	
58-4	9347-9350	and	_	
58-5	9351-9360	disparate	_	
58-6	9361-9369	features	_	
58-7	9370-9373	and	_	
58-8	9374-9376	to	_	
58-9	9377-9380	use	_	
58-10	9381-9384	SVM	_	
58-11	9385-9387	to	_	
58-12	9388-9399	distinguish	_	
58-13	9400-9407	between	_	
58-14	9408-9410	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
58-15	9411-9414	and	_	
58-16	9415-9418	ASD	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder	
58-17	9418-9419	,	_	
58-18	9420-9422	we	_	
58-19	9423-9430	created	_	
58-20	9431-9432	a	_	
58-21	9433-9439	hybrid	_	
58-22	9440-9447	control	_	
58-23	9448-9453	group	_	
58-24	9454-9458	made	_	
58-25	9459-9461	up	_	
58-26	9462-9464	of	_	
58-27	9465-9473	subjects	_	
58-28	9474-9478	from	_	
58-29	9479-9483	each	_	
58-30	9484-9486	of	_	
58-31	9487-9490	the	_	
58-32	9491-9493	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
58-33	9494-9497	and	_	
58-34	9498-9501	ASD	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder	
58-35	9502-9509	control	_	
58-36	9510-9514	sets	_	
58-37	9514-9515	.	_	

#Text=The hybrid control group was constructed by combining the 27 ASD control subjects from the ASD training set with 27 randomly selected subjects from the control group of the SZ training data set.
59-1	9516-9519	The	_	
59-2	9520-9526	hybrid	_	
59-3	9527-9534	control	_	
59-4	9535-9540	group	_	
59-5	9541-9544	was	_	
59-6	9545-9556	constructed	_	
59-7	9557-9559	by	_	
59-8	9560-9569	combining	_	
59-9	9570-9573	the	_	
59-10	9574-9576	27	_	
59-11	9577-9580	ASD	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder	
59-12	9581-9588	control	_	
59-13	9589-9597	subjects	_	
59-14	9598-9602	from	_	
59-15	9603-9606	the	_	
59-16	9607-9610	ASD	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder	
59-17	9611-9619	training	_	
59-18	9620-9623	set	_	
59-19	9624-9628	with	_	
59-20	9629-9631	27	_	
59-21	9632-9640	randomly	_	
59-22	9641-9649	selected	_	
59-23	9650-9658	subjects	_	
59-24	9659-9663	from	_	
59-25	9664-9667	the	_	
59-26	9668-9675	control	_	
59-27	9676-9681	group	_	
59-28	9682-9684	of	_	
59-29	9685-9688	the	_	
59-30	9689-9691	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
59-31	9692-9700	training	_	
59-32	9701-9705	data	_	
59-33	9706-9709	set	_	
59-34	9709-9710	.	_	

#Text=The RFE procedure was then applied to identify features that distinguish SZ patients from the hybrid control group and ASD patients from the hybrid control group.
60-1	9711-9714	The	_	
60-2	9715-9718	RFE	_	
60-3	9719-9728	procedure	_	
60-4	9729-9732	was	_	
60-5	9733-9737	then	_	
60-6	9738-9745	applied	_	
60-7	9746-9748	to	_	
60-8	9749-9757	identify	_	
60-9	9758-9766	features	_	
60-10	9767-9771	that	_	
60-11	9772-9783	distinguish	_	
60-12	9784-9786	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
60-13	9787-9795	patients	_	
60-14	9796-9800	from	_	
60-15	9801-9804	the	_	
60-16	9805-9811	hybrid	_	
60-17	9812-9819	control	_	
60-18	9820-9825	group	_	
60-19	9826-9829	and	_	
60-20	9830-9833	ASD	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder	
60-21	9834-9842	patients	_	
60-22	9843-9847	from	_	
60-23	9848-9851	the	_	
60-24	9852-9858	hybrid	_	
60-25	9859-9866	control	_	
60-26	9867-9872	group	_	
60-27	9872-9873	.	_	

#Text=The ASD and SZ feature sets were then compared to identify common and disparate features of the two disorders.
61-1	9874-9877	The	_	
61-2	9878-9881	ASD	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder	
61-3	9882-9885	and	_	
61-4	9886-9888	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
61-5	9889-9896	feature	_	
61-6	9897-9901	sets	_	
61-7	9902-9906	were	_	
61-8	9907-9911	then	_	
61-9	9912-9920	compared	_	
61-10	9921-9923	to	_	
61-11	9924-9932	identify	_	
61-12	9933-9939	common	_	
61-13	9940-9943	and	_	
61-14	9944-9953	disparate	_	
61-15	9954-9962	features	_	
61-16	9963-9965	of	_	
61-17	9966-9969	the	_	
61-18	9970-9973	two	_	
61-19	9974-9983	disorders	_	
61-20	9983-9984	.	_	

#Text=Preprocessing
#Text=Preprocessing steps were carried out using FSL (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSL) and included brain extraction using FSL's BET, motion correction using FSL's MCFLIRT, and linear registration to the Montreal Neurological Institute (MNI152) 2mm standard using FSL's FLIRT.
62-1	9985-9998	Preprocessing	_	
62-2	9999-10012	Preprocessing	_	
62-3	10013-10018	steps	_	
62-4	10019-10023	were	_	
62-5	10024-10031	carried	_	
62-6	10032-10035	out	_	
62-7	10036-10041	using	_	
62-8	10042-10045	FSL	_	
62-9	10046-10047	(	_	
62-10	10047-10051	http	_	
62-11	10051-10052	:	_	
62-12	10052-10053	/	_	
62-13	10053-10054	/	_	
62-14	10054-10072	fsl.fmrib.ox.ac.uk	_	
62-15	10072-10073	/	_	
62-16	10073-10076	fsl	_	
62-17	10076-10077	/	_	
62-18	10077-10084	fslwiki	_	
62-19	10084-10085	/	_	
62-20	10085-10088	FSL	_	
62-21	10088-10089	)	_	
62-22	10090-10093	and	_	
62-23	10094-10102	included	_	
62-24	10103-10108	brain	_	
62-25	10109-10119	extraction	_	
62-26	10120-10125	using	_	
62-27	10126-10131	FSL's	_	
62-28	10132-10135	BET	_	
62-29	10135-10136	,	_	
62-30	10137-10143	motion	_	
62-31	10144-10154	correction	_	
62-32	10155-10160	using	_	
62-33	10161-10166	FSL's	_	
62-34	10167-10174	MCFLIRT	_	
62-35	10174-10175	,	_	
62-36	10176-10179	and	_	
62-37	10180-10186	linear	_	
62-38	10187-10199	registration	_	
62-39	10200-10202	to	_	
62-40	10203-10206	the	_	
62-41	10207-10215	Montreal	_	
62-42	10216-10228	Neurological	_	
62-43	10229-10238	Institute	_	
62-44	10239-10240	(	_	
62-45	10240-10246	MNI152	_	
62-46	10246-10247	)	_	
62-47	10248-10251	2mm	_	
62-48	10252-10260	standard	_	
62-49	10261-10266	using	_	
62-50	10267-10272	FSL's	_	
62-51	10273-10278	FLIRT	_	
62-52	10278-10279	.	_	

#Text=Frame displacement parameters were regressed out of each data set to control for motion.
63-1	10280-10285	Frame	_	
63-2	10286-10298	displacement	_	
63-3	10299-10309	parameters	_	
63-4	10310-10314	were	_	
63-5	10315-10324	regressed	_	
63-6	10325-10328	out	_	
63-7	10329-10331	of	_	
63-8	10332-10336	each	_	
63-9	10337-10341	data	_	
63-10	10342-10345	set	_	
63-11	10346-10348	to	_	
63-12	10349-10356	control	_	
63-13	10357-10360	for	_	
63-14	10361-10367	motion	_	
63-15	10367-10368	.	_	

#Text=ROI selection
#Text=We chose to use a set of 283 regions of interest (ROIs) spanning both cortical and subcortical areas.
64-1	10369-10372	ROI	_	
64-2	10373-10382	selection	_	
64-3	10383-10385	We	_	
64-4	10386-10391	chose	_	
64-5	10392-10394	to	_	
64-6	10395-10398	use	_	
64-7	10399-10400	a	_	
64-8	10401-10404	set	_	
64-9	10405-10407	of	_	
64-10	10408-10411	283	_	
64-11	10412-10419	regions	_	
64-12	10420-10422	of	_	
64-13	10423-10431	interest	_	
64-14	10432-10433	(	_	
64-15	10433-10437	ROIs	_	
64-16	10437-10438	)	_	
64-17	10439-10447	spanning	_	
64-18	10448-10452	both	_	
64-19	10453-10461	cortical	_	
64-20	10462-10465	and	_	
64-21	10466-10477	subcortical	_	
64-22	10478-10483	areas	_	
64-23	10483-10484	.	_	

#Text=These ROIs are an extended version of a previously generated parcellation based on meta-analysis over a range of tasks that resulted in 264 ROIs of putative functional relevance.
65-1	10485-10490	These	_	
65-2	10491-10495	ROIs	_	
65-3	10496-10499	are	_	
65-4	10500-10502	an	_	
65-5	10503-10511	extended	_	
65-6	10512-10519	version	_	
65-7	10520-10522	of	_	
65-8	10523-10524	a	_	
65-9	10525-10535	previously	_	
65-10	10536-10545	generated	_	
65-11	10546-10558	parcellation	_	
65-12	10559-10564	based	_	
65-13	10565-10567	on	_	
65-14	10568-10581	meta-analysis	_	
65-15	10582-10586	over	_	
65-16	10587-10588	a	_	
65-17	10589-10594	range	_	
65-18	10595-10597	of	_	
65-19	10598-10603	tasks	_	
65-20	10604-10608	that	_	
65-21	10609-10617	resulted	_	
65-22	10618-10620	in	_	
65-23	10621-10624	264	_	
65-24	10625-10629	ROIs	_	
65-25	10630-10632	of	_	
65-26	10633-10641	putative	_	
65-27	10642-10652	functional	_	
65-28	10653-10662	relevance	_	
65-29	10662-10663	.	_	

#Text=Each ROI is a 5 mm sphere around a voxel of peak significant activity during performance of tasks such as button-pressing, reading, and memory retrieval.
66-1	10664-10668	Each	_	
66-2	10669-10672	ROI	_	
66-3	10673-10675	is	_	
66-4	10676-10677	a	_	
66-5	10678-10679	5	_	
66-6	10679-10680	 	_	
66-7	10680-10682	mm	_	
66-8	10683-10689	sphere	_	
66-9	10690-10696	around	_	
66-10	10697-10698	a	_	
66-11	10699-10704	voxel	_	
66-12	10705-10707	of	_	
66-13	10708-10712	peak	_	
66-14	10713-10724	significant	_	
66-15	10725-10733	activity	_	
66-16	10734-10740	during	_	
66-17	10741-10752	performance	_	
66-18	10753-10755	of	_	
66-19	10756-10761	tasks	_	
66-20	10762-10766	such	_	
66-21	10767-10769	as	_	
66-22	10770-10785	button-pressing	_	
66-23	10785-10786	,	_	
66-24	10787-10794	reading	_	
66-25	10794-10795	,	_	
66-26	10796-10799	and	_	
66-27	10800-10806	memory	_	
66-28	10807-10816	retrieval	_	
66-29	10816-10817	.	_	

#Text=Bilateral regions in the brainstem, basal forebrain, hippocampus, amygdala, and putamen make up the additional 19 ROIs.
67-1	10818-10827	Bilateral	_	
67-2	10828-10835	regions	_	
67-3	10836-10838	in	_	
67-4	10839-10842	the	_	
67-5	10843-10852	brainstem	_	
67-6	10852-10853	,	_	
67-7	10854-10859	basal	_	
67-8	10860-10869	forebrain	_	
67-9	10869-10870	,	_	
67-10	10871-10882	hippocampus	_	
67-11	10882-10883	,	_	
67-12	10884-10892	amygdala	_	
67-13	10892-10893	,	_	
67-14	10894-10897	and	_	
67-15	10898-10905	putamen	_	
67-16	10906-10910	make	_	
67-17	10911-10913	up	_	
67-18	10914-10917	the	_	
67-19	10918-10928	additional	_	
67-20	10929-10931	19	_	
67-21	10932-10936	ROIs	_	
67-22	10936-10937	.	_	

#Text=For each subject, average time series were extracted for each ROI over the 5 mm spheres.
68-1	10938-10941	For	_	
68-2	10942-10946	each	_	
68-3	10947-10954	subject	_	
68-4	10954-10955	,	_	
68-5	10956-10963	average	_	
68-6	10964-10968	time	_	
68-7	10969-10975	series	_	
68-8	10976-10980	were	_	
68-9	10981-10990	extracted	_	
68-10	10991-10994	for	_	
68-11	10995-10999	each	_	
68-12	11000-11003	ROI	_	
68-13	11004-11008	over	_	
68-14	11009-11012	the	_	
68-15	11013-11014	5	_	
68-16	11014-11015	 	_	
68-17	11015-11017	mm	_	
68-18	11018-11025	spheres	_	
68-19	11025-11026	.	_	

#Text=Data sets were matched for number of time points to the COBRE SZ data set by randomly selecting a start point that resulted in 120 consecutive scans.
69-1	11027-11031	Data	_	
69-2	11032-11036	sets	_	
69-3	11037-11041	were	_	
69-4	11042-11049	matched	_	
69-5	11050-11053	for	_	
69-6	11054-11060	number	_	
69-7	11061-11063	of	_	
69-8	11064-11068	time	_	
69-9	11069-11075	points	_	
69-10	11076-11078	to	_	
69-11	11079-11082	the	_	
69-12	11083-11088	COBRE	_	
69-13	11089-11091	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
69-14	11092-11096	data	_	
69-15	11097-11100	set	_	
69-16	11101-11103	by	_	
69-17	11104-11112	randomly	_	
69-18	11113-11122	selecting	_	
69-19	11123-11124	a	_	
69-20	11125-11130	start	_	
69-21	11131-11136	point	_	
69-22	11137-11141	that	_	
69-23	11142-11150	resulted	_	
69-24	11151-11153	in	_	
69-25	11154-11157	120	_	
69-26	11158-11169	consecutive	_	
69-27	11170-11175	scans	_	
69-28	11175-11176	.	_	

#Text=Connectivity matrix graph model generation
#Text=There are a number of approaches to define functional relationships between brain areas.
70-1	11177-11189	Connectivity	_	
70-2	11190-11196	matrix	_	
70-3	11197-11202	graph	_	
70-4	11203-11208	model	_	
70-5	11209-11219	generation	_	
70-6	11220-11225	There	_	
70-7	11226-11229	are	_	
70-8	11230-11231	a	_	
70-9	11232-11238	number	_	
70-10	11239-11241	of	_	
70-11	11242-11252	approaches	_	
70-12	11253-11255	to	_	
70-13	11256-11262	define	_	
70-14	11263-11273	functional	_	
70-15	11274-11287	relationships	_	
70-16	11288-11295	between	_	
70-17	11296-11301	brain	_	
70-18	11302-11307	areas	_	
70-19	11307-11308	.	_	

#Text=One common approach is functional connectivity, which refers to temporal correlations signal intensity across brain regions.
71-1	11309-11312	One	_	
71-2	11313-11319	common	_	
71-3	11320-11328	approach	_	
71-4	11329-11331	is	_	
71-5	11332-11342	functional	_	
71-6	11343-11355	connectivity	_	
71-7	11355-11356	,	_	
71-8	11357-11362	which	_	
71-9	11363-11369	refers	_	
71-10	11370-11372	to	_	
71-11	11373-11381	temporal	_	
71-12	11382-11394	correlations	_	
71-13	11395-11401	signal	_	
71-14	11402-11411	intensity	_	
71-15	11412-11418	across	_	
71-16	11419-11424	brain	_	
71-17	11425-11432	regions	_	
71-18	11432-11433	.	_	

#Text=In this study, we utilize a Bayesian approach to determine effective connectivity between brain areas.
72-1	11434-11436	In	_	
72-2	11437-11441	this	_	
72-3	11442-11447	study	_	
72-4	11447-11448	,	_	
72-5	11449-11451	we	_	
72-6	11452-11459	utilize	_	
72-7	11460-11461	a	_	
72-8	11462-11470	Bayesian	_	
72-9	11471-11479	approach	_	
72-10	11480-11482	to	_	
72-11	11483-11492	determine	_	
72-12	11493-11502	effective	_	
72-13	11503-11515	connectivity	_	
72-14	11516-11523	between	_	
72-15	11524-11529	brain	_	
72-16	11530-11535	areas	_	
72-17	11535-11536	.	_	

#Text=Effective connectivity is a measure of the influence brain regions exert over each other over time.
73-1	11537-11546	Effective	_	
73-2	11547-11559	connectivity	_	
73-3	11560-11562	is	_	
73-4	11563-11564	a	_	
73-5	11565-11572	measure	_	
73-6	11573-11575	of	_	
73-7	11576-11579	the	_	
73-8	11580-11589	influence	_	
73-9	11590-11595	brain	_	
73-10	11596-11603	regions	_	
73-11	11604-11609	exert	_	
73-12	11610-11614	over	_	
73-13	11615-11619	each	_	
73-14	11620-11625	other	_	
73-15	11626-11630	over	_	
73-16	11631-11635	time	_	
73-17	11635-11636	.	_	

#Text=Using Bayes Nets to determine effective connectivity offers some advantage over functional connectivity measures in that they are less sensitive to motion artifacts.
74-1	11637-11642	Using	_	
74-2	11643-11648	Bayes	_	
74-3	11649-11653	Nets	_	
74-4	11654-11656	to	_	
74-5	11657-11666	determine	_	
74-6	11667-11676	effective	_	
74-7	11677-11689	connectivity	_	
74-8	11690-11696	offers	_	
74-9	11697-11701	some	_	
74-10	11702-11711	advantage	_	
74-11	11712-11716	over	_	
74-12	11717-11727	functional	_	
74-13	11728-11740	connectivity	_	
74-14	11741-11749	measures	_	
74-15	11750-11752	in	_	
74-16	11753-11757	that	_	
74-17	11758-11762	they	_	
74-18	11763-11766	are	_	
74-19	11767-11771	less	_	
74-20	11772-11781	sensitive	_	
74-21	11782-11784	to	_	
74-22	11785-11791	motion	_	
74-23	11792-11801	artifacts	_	
74-24	11801-11802	.	_	

#Text=Whereas motion results in artificially altered correlation coefficients across the brain, the probabilistic determination of connections between variables in Bayesian models make them less susceptible to spurious connections resulting from motion artifacts.
75-1	11803-11810	Whereas	_	
75-2	11811-11817	motion	_	
75-3	11818-11825	results	_	
75-4	11826-11828	in	_	
75-5	11829-11841	artificially	_	
75-6	11842-11849	altered	_	
75-7	11850-11861	correlation	_	
75-8	11862-11874	coefficients	_	
75-9	11875-11881	across	_	
75-10	11882-11885	the	_	
75-11	11886-11891	brain	_	
75-12	11891-11892	,	_	
75-13	11893-11896	the	_	
75-14	11897-11910	probabilistic	_	
75-15	11911-11924	determination	_	
75-16	11925-11927	of	_	
75-17	11928-11939	connections	_	
75-18	11940-11947	between	_	
75-19	11948-11957	variables	_	
75-20	11958-11960	in	_	
75-21	11961-11969	Bayesian	_	
75-22	11970-11976	models	_	
75-23	11977-11981	make	_	
75-24	11982-11986	them	_	
75-25	11987-11991	less	_	
75-26	11992-12003	susceptible	_	
75-27	12004-12006	to	_	
75-28	12007-12015	spurious	_	
75-29	12016-12027	connections	_	
75-30	12028-12037	resulting	_	
75-31	12038-12042	from	_	
75-32	12043-12049	motion	_	
75-33	12050-12059	artifacts	_	
75-34	12059-12060	.	_	

#Text=In this study, Bayesian network models were generated for each subject to represent the effective connectivity between ROIs.
76-1	12061-12063	In	_	
76-2	12064-12068	this	_	
76-3	12069-12074	study	_	
76-4	12074-12075	,	_	
76-5	12076-12084	Bayesian	_	
76-6	12085-12092	network	_	
76-7	12093-12099	models	_	
76-8	12100-12104	were	_	
76-9	12105-12114	generated	_	
76-10	12115-12118	for	_	
76-11	12119-12123	each	_	
76-12	12124-12131	subject	_	
76-13	12132-12134	to	_	
76-14	12135-12144	represent	_	
76-15	12145-12148	the	_	
76-16	12149-12158	effective	_	
76-17	12159-12171	connectivity	_	
76-18	12172-12179	between	_	
76-19	12180-12184	ROIs	_	
76-20	12184-12185	.	_	

#Text=Bayesian network models are graphical models where variables (ROIs) are depicted as the nodes of the network and directed edges as the interactions between nodes.
77-1	12186-12194	Bayesian	_	
77-2	12195-12202	network	_	
77-3	12203-12209	models	_	
77-4	12210-12213	are	_	
77-5	12214-12223	graphical	_	
77-6	12224-12230	models	_	
77-7	12231-12236	where	_	
77-8	12237-12246	variables	_	
77-9	12247-12248	(	_	
77-10	12248-12252	ROIs	_	
77-11	12252-12253	)	_	
77-12	12254-12257	are	_	
77-13	12258-12266	depicted	_	
77-14	12267-12269	as	_	
77-15	12270-12273	the	_	
77-16	12274-12279	nodes	_	
77-17	12280-12282	of	_	
77-18	12283-12286	the	_	
77-19	12287-12294	network	_	
77-20	12295-12298	and	_	
77-21	12299-12307	directed	_	
77-22	12308-12313	edges	_	
77-23	12314-12316	as	_	
77-24	12317-12320	the	_	
77-25	12321-12333	interactions	_	
77-26	12334-12341	between	_	
77-27	12342-12347	nodes	_	
77-28	12347-12348	.	_	

#Text=Connections between ROIs represent probabilistic dependencies among variables quantified by their conditional probability distributions.
78-1	12349-12360	Connections	_	
78-2	12361-12368	between	_	
78-3	12369-12373	ROIs	_	
78-4	12374-12383	represent	_	
78-5	12384-12397	probabilistic	_	
78-6	12398-12410	dependencies	_	
78-7	12411-12416	among	_	
78-8	12417-12426	variables	_	
78-9	12427-12437	quantified	_	
78-10	12438-12440	by	_	
78-11	12441-12446	their	_	
78-12	12447-12458	conditional	_	
78-13	12459-12470	probability	_	
78-14	12471-12484	distributions	_	
78-15	12484-12485	.	_	

#Text=The network structure expresses the joint probability distribution over all variables.
79-1	12486-12489	The	_	
79-2	12490-12497	network	_	
79-3	12498-12507	structure	_	
79-4	12508-12517	expresses	_	
79-5	12518-12521	the	_	
79-6	12522-12527	joint	_	
79-7	12528-12539	probability	_	
79-8	12540-12552	distribution	_	
79-9	12553-12557	over	_	
79-10	12558-12561	all	_	
79-11	12562-12571	variables	_	
79-12	12571-12572	.	_	

#Text=The structure of a Bayesian network model representing the interactions between each of the ROIs over the scan duration is learned from the ROI time series data using a score-based hill-climbing greedy search algorithm as implemented in the R bnlearn package (https://cran.r-project.org/web/packages/bnlearn/index.html).
80-1	12573-12576	The	_	
80-2	12577-12586	structure	_	
80-3	12587-12589	of	_	
80-4	12590-12591	a	_	
80-5	12592-12600	Bayesian	_	
80-6	12601-12608	network	_	
80-7	12609-12614	model	_	
80-8	12615-12627	representing	_	
80-9	12628-12631	the	_	
80-10	12632-12644	interactions	_	
80-11	12645-12652	between	_	
80-12	12653-12657	each	_	
80-13	12658-12660	of	_	
80-14	12661-12664	the	_	
80-15	12665-12669	ROIs	_	
80-16	12670-12674	over	_	
80-17	12675-12678	the	_	
80-18	12679-12683	scan	_	
80-19	12684-12692	duration	_	
80-20	12693-12695	is	_	
80-21	12696-12703	learned	_	
80-22	12704-12708	from	_	
80-23	12709-12712	the	_	
80-24	12713-12716	ROI	_	
80-25	12717-12721	time	_	
80-26	12722-12728	series	_	
80-27	12729-12733	data	_	
80-28	12734-12739	using	_	
80-29	12740-12741	a	_	
80-30	12742-12753	score-based	_	
80-31	12754-12767	hill-climbing	_	
80-32	12768-12774	greedy	_	
80-33	12775-12781	search	_	
80-34	12782-12791	algorithm	_	
80-35	12792-12794	as	_	
80-36	12795-12806	implemented	_	
80-37	12807-12809	in	_	
80-38	12810-12813	the	_	
80-39	12814-12815	R	_	
80-40	12816-12823	bnlearn	_	
80-41	12824-12831	package	_	
80-42	12832-12833	(	_	
80-43	12833-12838	https	_	
80-44	12838-12839	:	_	
80-45	12839-12840	/	_	
80-46	12840-12841	/	_	
80-47	12841-12859	cran.r-project.org	_	
80-48	12859-12860	/	_	
80-49	12860-12863	web	_	
80-50	12863-12864	/	_	
80-51	12864-12872	packages	_	
80-52	12872-12873	/	_	
80-53	12873-12880	bnlearn	_	
80-54	12880-12881	/	_	
80-55	12881-12891	index.html	_	
80-56	12891-12892	)	_	
80-57	12892-12893	.	_	

#Text=Such algorithms have been benchmarked for use in fMRI data and have demonstrated excellent accuracy and stability over known network structures.
81-1	12894-12898	Such	_	
81-2	12899-12909	algorithms	_	
81-3	12910-12914	have	_	
81-4	12915-12919	been	_	
81-5	12920-12931	benchmarked	_	
81-6	12932-12935	for	_	
81-7	12936-12939	use	_	
81-8	12940-12942	in	_	
81-9	12943-12947	fMRI	_	
81-10	12948-12952	data	_	
81-11	12953-12956	and	_	
81-12	12957-12961	have	_	
81-13	12962-12974	demonstrated	_	
81-14	12975-12984	excellent	_	
81-15	12985-12993	accuracy	_	
81-16	12994-12997	and	_	
81-17	12998-13007	stability	_	
81-18	13008-13012	over	_	
81-19	13013-13018	known	_	
81-20	13019-13026	network	_	
81-21	13027-13037	structures	_	
81-22	13037-13038	.	_	

#Text=Bayesian information criterion (BIC) scores measure the goodness of fit of the network structure based on the log-likelihood of the data given the network structure, while simultaneously penalizing the number of parameters in the model
82-1	13039-13047	Bayesian	_	
82-2	13048-13059	information	_	
82-3	13060-13069	criterion	_	
82-4	13070-13071	(	_	
82-5	13071-13074	BIC	_	
82-6	13074-13075	)	_	
82-7	13076-13082	scores	_	
82-8	13083-13090	measure	_	
82-9	13091-13094	the	_	
82-10	13095-13103	goodness	_	
82-11	13104-13106	of	_	
82-12	13107-13110	fit	_	
82-13	13111-13113	of	_	
82-14	13114-13117	the	_	
82-15	13118-13125	network	_	
82-16	13126-13135	structure	_	
82-17	13136-13141	based	_	
82-18	13142-13144	on	_	
82-19	13145-13148	the	_	
82-20	13149-13163	log-likelihood	_	
82-21	13164-13166	of	_	
82-22	13167-13170	the	_	
82-23	13171-13175	data	_	
82-24	13176-13181	given	_	
82-25	13182-13185	the	_	
82-26	13186-13193	network	_	
82-27	13194-13203	structure	_	
82-28	13203-13204	,	_	
82-29	13205-13210	while	_	
82-30	13211-13225	simultaneously	_	
82-31	13226-13236	penalizing	_	
82-32	13237-13240	the	_	
82-33	13241-13247	number	_	
82-34	13248-13250	of	_	
82-35	13251-13261	parameters	_	
82-36	13262-13264	in	_	
82-37	13265-13268	the	_	
82-38	13269-13274	model	_	

#Text=.
83-1	13274-13275	.	_	

#Text= = maximized likelihood function of the model M over the observed data x, and parameter values θ
#Text=n = number of data points
#Text=k = number of parameters to be estimated.
84-1	13276-13277	 	_	
84-2	13277-13278	=	_	
84-3	13278-13279	 	_	
84-4	13279-13288	maximized	_	
84-5	13289-13299	likelihood	_	
84-6	13300-13308	function	_	
84-7	13309-13311	of	_	
84-8	13312-13315	the	_	
84-9	13316-13321	model	_	
84-10	13322-13323	M	_	
84-11	13324-13328	over	_	
84-12	13329-13332	the	_	
84-13	13333-13341	observed	_	
84-14	13342-13346	data	_	
84-15	13347-13348	x	_	
84-16	13348-13349	,	_	
84-17	13350-13353	and	_	
84-18	13354-13363	parameter	_	
84-19	13364-13370	values	_	
84-20	13371-13372	θ	_	
84-21	13373-13374	n	_	
84-22	13374-13375	 	_	
84-23	13375-13376	=	_	
84-24	13376-13377	 	_	
84-25	13377-13383	number	_	
84-26	13384-13386	of	_	
84-27	13387-13391	data	_	
84-28	13392-13398	points	_	
84-29	13399-13400	k	_	
84-30	13400-13401	 	_	
84-31	13401-13402	=	_	
84-32	13402-13403	 	_	
84-33	13403-13409	number	_	
84-34	13410-13412	of	_	
84-35	13413-13423	parameters	_	
84-36	13424-13426	to	_	
84-37	13427-13429	be	_	
84-38	13430-13439	estimated	_	
84-39	13439-13440	.	_	

#Text=As the number of parameters k in the model increases the BIC score also increases; lower BIC scores are considered better models.
85-1	13441-13443	As	_	
85-2	13444-13447	the	_	
85-3	13448-13454	number	_	
85-4	13455-13457	of	_	
85-5	13458-13468	parameters	_	
85-6	13469-13470	k	_	
85-7	13471-13473	in	_	
85-8	13474-13477	the	_	
85-9	13478-13483	model	_	
85-10	13484-13493	increases	_	
85-11	13494-13497	the	_	
85-12	13498-13501	BIC	_	
85-13	13502-13507	score	_	
85-14	13508-13512	also	_	
85-15	13513-13522	increases	_	
85-16	13522-13523	;	_	
85-17	13524-13529	lower	_	
85-18	13530-13533	BIC	_	
85-19	13534-13540	scores	_	
85-20	13541-13544	are	_	
85-21	13545-13555	considered	_	
85-22	13556-13562	better	_	
85-23	13563-13569	models	_	
85-24	13569-13570	.	_	

#Text=In this way, the number of parameters in the model is constrained.
86-1	13571-13573	In	_	
86-2	13574-13578	this	_	
86-3	13579-13582	way	_	
86-4	13582-13583	,	_	
86-5	13584-13587	the	_	
86-6	13588-13594	number	_	
86-7	13595-13597	of	_	
86-8	13598-13608	parameters	_	
86-9	13609-13611	in	_	
86-10	13612-13615	the	_	
86-11	13616-13621	model	_	
86-12	13622-13624	is	_	
86-13	13625-13636	constrained	_	
86-14	13636-13637	.	_	

#Text=Edges are added to the model individually and a new BIC score is calculated to determine whether the additional variable improves the fit.
87-1	13638-13643	Edges	_	
87-2	13644-13647	are	_	
87-3	13648-13653	added	_	
87-4	13654-13656	to	_	
87-5	13657-13660	the	_	
87-6	13661-13666	model	_	
87-7	13667-13679	individually	_	
87-8	13680-13683	and	_	
87-9	13684-13685	a	_	
87-10	13686-13689	new	_	
87-11	13690-13693	BIC	_	
87-12	13694-13699	score	_	
87-13	13700-13702	is	_	
87-14	13703-13713	calculated	_	
87-15	13714-13716	to	_	
87-16	13717-13726	determine	_	
87-17	13727-13734	whether	_	
87-18	13735-13738	the	_	
87-19	13739-13749	additional	_	
87-20	13750-13758	variable	_	
87-21	13759-13767	improves	_	
87-22	13768-13771	the	_	
87-23	13772-13775	fit	_	
87-24	13775-13776	.	_	

#Text=The search procedure concludes when the fit is not further improved (the BIC score is not reduced) by inclusion of new edge parameters.
88-1	13777-13780	The	_	
88-2	13781-13787	search	_	
88-3	13788-13797	procedure	_	
88-4	13798-13807	concludes	_	
88-5	13808-13812	when	_	
88-6	13813-13816	the	_	
88-7	13817-13820	fit	_	
88-8	13821-13823	is	_	
88-9	13824-13827	not	_	
88-10	13828-13835	further	_	
88-11	13836-13844	improved	_	
88-12	13845-13846	(	_	
88-13	13846-13849	the	_	
88-14	13850-13853	BIC	_	
88-15	13854-13859	score	_	
88-16	13860-13862	is	_	
88-17	13863-13866	not	_	
88-18	13867-13874	reduced	_	
88-19	13874-13875	)	_	
88-20	13876-13878	by	_	
88-21	13879-13888	inclusion	_	
88-22	13889-13891	of	_	
88-23	13892-13895	new	_	
88-24	13896-13900	edge	_	
88-25	13901-13911	parameters	_	
88-26	13911-13912	.	_	

#Text=The number of ROIs in our feature set was 283, resulting in 80,089 (283 × 283) possible edges or features.
89-1	13913-13916	The	_	
89-2	13917-13923	number	_	
89-3	13924-13926	of	_	
89-4	13927-13931	ROIs	_	
89-5	13932-13934	in	_	
89-6	13935-13938	our	_	
89-7	13939-13946	feature	_	
89-8	13947-13950	set	_	
89-9	13951-13954	was	_	
89-10	13955-13958	283	_	
89-11	13958-13959	,	_	
89-12	13960-13969	resulting	_	
89-13	13970-13972	in	_	
89-14	13973-13979	80,089	_	
89-15	13980-13981	(	_	
89-16	13981-13984	283	_	
89-17	13984-13985	 	_	
89-18	13985-13986	×	_	
89-19	13986-13987	 	_	
89-20	13987-13990	283	_	
89-21	13990-13991	)	_	
89-22	13992-14000	possible	_	
89-23	14001-14006	edges	_	
89-24	14007-14009	or	_	
89-25	14010-14018	features	_	
89-26	14018-14019	.	_	

#Text=Therefore this is the feature space that is searched during the learning procedure.
90-1	14020-14029	Therefore	_	
90-2	14030-14034	this	_	
90-3	14035-14037	is	_	
90-4	14038-14041	the	_	
90-5	14042-14049	feature	_	
90-6	14050-14055	space	_	
90-7	14056-14060	that	_	
90-8	14061-14063	is	_	
90-9	14064-14072	searched	_	
90-10	14073-14079	during	_	
90-11	14080-14083	the	_	
90-12	14084-14092	learning	_	
90-13	14093-14102	procedure	_	
90-14	14102-14103	.	_	

#Text=Once the graph structure is found, edge weights are determined as linear regression coefficients, resulting in a weighted connectivity matrix for each subject.
91-1	14104-14108	Once	_	
91-2	14109-14112	the	_	
91-3	14113-14118	graph	_	
91-4	14119-14128	structure	_	
91-5	14129-14131	is	_	
91-6	14132-14137	found	_	
91-7	14137-14138	,	_	
91-8	14139-14143	edge	_	
91-9	14144-14151	weights	_	
91-10	14152-14155	are	_	
91-11	14156-14166	determined	_	
91-12	14167-14169	as	_	
91-13	14170-14176	linear	_	
91-14	14177-14187	regression	_	
91-15	14188-14200	coefficients	_	
91-16	14200-14201	,	_	
91-17	14202-14211	resulting	_	
91-18	14212-14214	in	_	
91-19	14215-14216	a	_	
91-20	14217-14225	weighted	_	
91-21	14226-14238	connectivity	_	
91-22	14239-14245	matrix	_	
91-23	14246-14249	for	_	
91-24	14250-14254	each	_	
91-25	14255-14262	subject	_	
91-26	14262-14263	.	_	

#Text=These weights were then normalized by subject by z-scoring over the non-zero model edge weights in order to preserve the relationships between variables and to facilitate comparison across subjects and data centers.
92-1	14264-14269	These	_	
92-2	14270-14277	weights	_	
92-3	14278-14282	were	_	
92-4	14283-14287	then	_	
92-5	14288-14298	normalized	_	
92-6	14299-14301	by	_	
92-7	14302-14309	subject	_	
92-8	14310-14312	by	_	
92-9	14313-14322	z-scoring	_	
92-10	14323-14327	over	_	
92-11	14328-14331	the	_	
92-12	14332-14340	non-zero	_	
92-13	14341-14346	model	_	
92-14	14347-14351	edge	_	
92-15	14352-14359	weights	_	
92-16	14360-14362	in	_	
92-17	14363-14368	order	_	
92-18	14369-14371	to	_	
92-19	14372-14380	preserve	_	
92-20	14381-14384	the	_	
92-21	14385-14398	relationships	_	
92-22	14399-14406	between	_	
92-23	14407-14416	variables	_	
92-24	14417-14420	and	_	
92-25	14421-14423	to	_	
92-26	14424-14434	facilitate	_	
92-27	14435-14445	comparison	_	
92-28	14446-14452	across	_	
92-29	14453-14461	subjects	_	
92-30	14462-14465	and	_	
92-31	14466-14470	data	_	
92-32	14471-14478	centers	_	
92-33	14478-14479	.	_	

#Text=Identifying relevant discriminatory features
#Text=A linear support vector machine (SVM) was used to classify between schizophrenic patients and controls based on each subject's weighted connectivity matrix.
93-1	14480-14491	Identifying	_	
93-2	14492-14500	relevant	_	
93-3	14501-14515	discriminatory	_	
93-4	14516-14524	features	_	
93-5	14525-14526	A	_	
93-6	14527-14533	linear	_	
93-7	14534-14541	support	_	
93-8	14542-14548	vector	_	
93-9	14549-14556	machine	_	
93-10	14557-14558	(	_	
93-11	14558-14561	SVM	_	
93-12	14561-14562	)	_	
93-13	14563-14566	was	_	
93-14	14567-14571	used	_	
93-15	14572-14574	to	_	
93-16	14575-14583	classify	_	
93-17	14584-14591	between	_	
93-18	14592-14605	schizophrenic	_	
93-19	14606-14614	patients	_	
93-20	14615-14618	and	_	
93-21	14619-14627	controls	_	
93-22	14628-14633	based	_	
93-23	14634-14636	on	_	
93-24	14637-14641	each	_	
93-25	14642-14651	subject's	_	
93-26	14652-14660	weighted	_	
93-27	14661-14673	connectivity	_	
93-28	14674-14680	matrix	_	
93-29	14680-14681	.	_	

#Text=An SVM is a supervised multivariate classification method that treats each of the features, or edges, as a point in a high dimensional space.
94-1	14682-14684	An	_	
94-2	14685-14688	SVM	_	
94-3	14689-14691	is	_	
94-4	14692-14693	a	_	
94-5	14694-14704	supervised	_	
94-6	14705-14717	multivariate	_	
94-7	14718-14732	classification	_	
94-8	14733-14739	method	_	
94-9	14740-14744	that	_	
94-10	14745-14751	treats	_	
94-11	14752-14756	each	_	
94-12	14757-14759	of	_	
94-13	14760-14763	the	_	
94-14	14764-14772	features	_	
94-15	14772-14773	,	_	
94-16	14774-14776	or	_	
94-17	14777-14782	edges	_	
94-18	14782-14783	,	_	
94-19	14784-14786	as	_	
94-20	14787-14788	a	_	
94-21	14789-14794	point	_	
94-22	14795-14797	in	_	
94-23	14798-14799	a	_	
94-24	14800-14804	high	_	
94-25	14805-14816	dimensional	_	
94-26	14817-14822	space	_	
94-27	14822-14823	.	_	

#Text=Training of an SVM results in a set of support vectors (points in multidimensional feature-space) that represent the boundary between classes.
95-1	14824-14832	Training	_	
95-2	14833-14835	of	_	
95-3	14836-14838	an	_	
95-4	14839-14842	SVM	_	
95-5	14843-14850	results	_	
95-6	14851-14853	in	_	
95-7	14854-14855	a	_	
95-8	14856-14859	set	_	
95-9	14860-14862	of	_	
95-10	14863-14870	support	_	
95-11	14871-14878	vectors	_	
95-12	14879-14880	(	_	
95-13	14880-14886	points	_	
95-14	14887-14889	in	_	
95-15	14890-14906	multidimensional	_	
95-16	14907-14920	feature-space	_	
95-17	14920-14921	)	_	
95-18	14922-14926	that	_	
95-19	14927-14936	represent	_	
95-20	14937-14940	the	_	
95-21	14941-14949	boundary	_	
95-22	14950-14957	between	_	
95-23	14958-14965	classes	_	
95-24	14965-14966	.	_	

#Text=Because the support vectors are at the boundary between classes, they are not useful in determining features that are most indicative of each class.
96-1	14967-14974	Because	_	
96-2	14975-14978	the	_	
96-3	14979-14986	support	_	
96-4	14987-14994	vectors	_	
96-5	14995-14998	are	_	
96-6	14999-15001	at	_	
96-7	15002-15005	the	_	
96-8	15006-15014	boundary	_	
96-9	15015-15022	between	_	
96-10	15023-15030	classes	_	
96-11	15030-15031	,	_	
96-12	15032-15036	they	_	
96-13	15037-15040	are	_	
96-14	15041-15044	not	_	
96-15	15045-15051	useful	_	
96-16	15052-15054	in	_	
96-17	15055-15066	determining	_	
96-18	15067-15075	features	_	
96-19	15076-15080	that	_	
96-20	15081-15084	are	_	
96-21	15085-15089	most	_	
96-22	15090-15100	indicative	_	
96-23	15101-15103	of	_	
96-24	15104-15108	each	_	
96-25	15109-15114	class	_	
96-26	15114-15115	.	_	

#Text=We identify the most indicative features using recursive feature elimination (RFE).
97-1	15116-15118	We	_	
97-2	15119-15127	identify	_	
97-3	15128-15131	the	_	
97-4	15132-15136	most	_	
97-5	15137-15147	indicative	_	
97-6	15148-15156	features	_	
97-7	15157-15162	using	_	
97-8	15163-15172	recursive	_	
97-9	15173-15180	feature	_	
97-10	15181-15192	elimination	_	
97-11	15193-15194	(	_	
97-12	15194-15197	RFE	_	
97-13	15197-15198	)	_	
97-14	15198-15199	.	_	

#Text=The basic principle of RFE is to initially include all edges in the model and to gradually exclude edges, that do not contribute in discriminating between the two classes.
98-1	15200-15203	The	_	
98-2	15204-15209	basic	_	
98-3	15210-15219	principle	_	
98-4	15220-15222	of	_	
98-5	15223-15226	RFE	_	
98-6	15227-15229	is	_	
98-7	15230-15232	to	_	
98-8	15233-15242	initially	_	
98-9	15243-15250	include	_	
98-10	15251-15254	all	_	
98-11	15255-15260	edges	_	
98-12	15261-15263	in	_	
98-13	15264-15267	the	_	
98-14	15268-15273	model	_	
98-15	15274-15277	and	_	
98-16	15278-15280	to	_	
98-17	15281-15290	gradually	_	
98-18	15291-15298	exclude	_	
98-19	15299-15304	edges	_	
98-20	15304-15305	,	_	
98-21	15306-15310	that	_	
98-22	15311-15313	do	_	
98-23	15314-15317	not	_	
98-24	15318-15328	contribute	_	
98-25	15329-15331	in	_	
98-26	15332-15346	discriminating	_	
98-27	15347-15354	between	_	
98-28	15355-15358	the	_	
98-29	15359-15362	two	_	
98-30	15363-15370	classes	_	
98-31	15370-15371	.	_	

#Text=This approach iteratively trains and tests the SVM, discarding the least important features at each iteration until a core set of features remain, having the highest discriminative power.
99-1	15372-15376	This	_	
99-2	15377-15385	approach	_	
99-3	15386-15397	iteratively	_	
99-4	15398-15404	trains	_	
99-5	15405-15408	and	_	
99-6	15409-15414	tests	_	
99-7	15415-15418	the	_	
99-8	15419-15422	SVM	_	
99-9	15422-15423	,	_	
99-10	15424-15434	discarding	_	
99-11	15435-15438	the	_	
99-12	15439-15444	least	_	
99-13	15445-15454	important	_	
99-14	15455-15463	features	_	
99-15	15464-15466	at	_	
99-16	15467-15471	each	_	
99-17	15472-15481	iteration	_	
99-18	15482-15487	until	_	
99-19	15488-15489	a	_	
99-20	15490-15494	core	_	
99-21	15495-15498	set	_	
99-22	15499-15501	of	_	
99-23	15502-15510	features	_	
99-24	15511-15517	remain	_	
99-25	15517-15518	,	_	
99-26	15519-15525	having	_	
99-27	15526-15529	the	_	
99-28	15530-15537	highest	_	
99-29	15538-15552	discriminative	_	
99-30	15553-15558	power	_	
99-31	15558-15559	.	_	

#Text=At each iteration, data from the training set is randomly sub-divided into training and testing sets consisting of 10% of the total number of subjects.
100-1	15560-15562	At	_	
100-2	15563-15567	each	_	
100-3	15568-15577	iteration	_	
100-4	15577-15578	,	_	
100-5	15579-15583	data	_	
100-6	15584-15588	from	_	
100-7	15589-15592	the	_	
100-8	15593-15601	training	_	
100-9	15602-15605	set	_	
100-10	15606-15608	is	_	
100-11	15609-15617	randomly	_	
100-12	15618-15629	sub-divided	_	
100-13	15630-15634	into	_	
100-14	15635-15643	training	_	
100-15	15644-15647	and	_	
100-16	15648-15655	testing	_	
100-17	15656-15660	sets	_	
100-18	15661-15671	consisting	_	
100-19	15672-15674	of	_	
100-20	15675-15678	10%	_	
100-21	15679-15681	of	_	
100-22	15682-15685	the	_	
100-23	15686-15691	total	_	
100-24	15692-15698	number	_	
100-25	15699-15701	of	_	
100-26	15702-15710	subjects	_	
100-27	15710-15711	.	_	

#Text=After training, the least significant 10% of features are removed from the feature set.
101-1	15712-15717	After	_	
101-2	15718-15726	training	_	
101-3	15726-15727	,	_	
101-4	15728-15731	the	_	
101-5	15732-15737	least	_	
101-6	15738-15749	significant	_	
101-7	15750-15753	10%	_	
101-8	15754-15756	of	_	
101-9	15757-15765	features	_	
101-10	15766-15769	are	_	
101-11	15770-15777	removed	_	
101-12	15778-15782	from	_	
101-13	15783-15786	the	_	
101-14	15787-15794	feature	_	
101-15	15795-15798	set	_	
101-16	15798-15799	.	_	

#Text=Feature significance is based on the support vector model coefficients.
102-1	15800-15807	Feature	_	
102-2	15808-15820	significance	_	
102-3	15821-15823	is	_	
102-4	15824-15829	based	_	
102-5	15830-15832	on	_	
102-6	15833-15836	the	_	
102-7	15837-15844	support	_	
102-8	15845-15851	vector	_	
102-9	15852-15857	model	_	
102-10	15858-15870	coefficients	_	
102-11	15870-15871	.	_	

#Text=Classification accuracy on the held out 10% of subjects is recorded at each iteration.
103-1	15872-15886	Classification	_	
103-2	15887-15895	accuracy	_	
103-3	15896-15898	on	_	
103-4	15899-15902	the	_	
103-5	15903-15907	held	_	
103-6	15908-15911	out	_	
103-7	15912-15915	10%	_	
103-8	15916-15918	of	_	
103-9	15919-15927	subjects	_	
103-10	15928-15930	is	_	
103-11	15931-15939	recorded	_	
103-12	15940-15942	at	_	
103-13	15943-15947	each	_	
103-14	15948-15957	iteration	_	
103-15	15957-15958	.	_	

#Text=A bootstrap procedure was implemented that repeats the RFE process 100 times.
104-1	15959-15960	A	_	
104-2	15961-15970	bootstrap	_	
104-3	15971-15980	procedure	_	
104-4	15981-15984	was	_	
104-5	15985-15996	implemented	_	
104-6	15997-16001	that	_	
104-7	16002-16009	repeats	_	
104-8	16010-16013	the	_	
104-9	16014-16017	RFE	_	
104-10	16018-16025	process	_	
104-11	16026-16029	100	_	
104-12	16030-16035	times	_	
104-13	16035-16036	.	_	

#Text=Accuracies are averaged over the 100 bootstrap samples.
105-1	16037-16047	Accuracies	_	
105-2	16048-16051	are	_	
105-3	16052-16060	averaged	_	
105-4	16061-16065	over	_	
105-5	16066-16069	the	_	
105-6	16070-16073	100	_	
105-7	16074-16083	bootstrap	_	
105-8	16084-16091	samples	_	
105-9	16091-16092	.	_	

#Text=The number of features to include in the final model was determined by choosing the number that yielded the highest classification accuracy on average over the 100 bootstrap samples.
106-1	16093-16096	The	_	
106-2	16097-16103	number	_	
106-3	16104-16106	of	_	
106-4	16107-16115	features	_	
106-5	16116-16118	to	_	
106-6	16119-16126	include	_	
106-7	16127-16129	in	_	
106-8	16130-16133	the	_	
106-9	16134-16139	final	_	
106-10	16140-16145	model	_	
106-11	16146-16149	was	_	
106-12	16150-16160	determined	_	
106-13	16161-16163	by	_	
106-14	16164-16172	choosing	_	
106-15	16173-16176	the	_	
106-16	16177-16183	number	_	
106-17	16184-16188	that	_	
106-18	16189-16196	yielded	_	
106-19	16197-16200	the	_	
106-20	16201-16208	highest	_	
106-21	16209-16223	classification	_	
106-22	16224-16232	accuracy	_	
106-23	16233-16235	on	_	
106-24	16236-16243	average	_	
106-25	16244-16248	over	_	
106-26	16249-16252	the	_	
106-27	16253-16256	100	_	
106-28	16257-16266	bootstrap	_	
106-29	16267-16274	samples	_	
106-30	16274-16275	.	_	

#Text=Edge features were sorted according to the frequency (1–100) of their inclusion in the top feature set yielding highest accuracy.
107-1	16276-16280	Edge	_	
107-2	16281-16289	features	_	
107-3	16290-16294	were	_	
107-4	16295-16301	sorted	_	
107-5	16302-16311	according	_	
107-6	16312-16314	to	_	
107-7	16315-16318	the	_	
107-8	16319-16328	frequency	_	
107-9	16329-16330	(	_	
107-10	16330-16331	1	_	
107-11	16331-16332	–	_	
107-12	16332-16335	100	_	
107-13	16335-16336	)	_	
107-14	16337-16339	of	_	
107-15	16340-16345	their	_	
107-16	16346-16355	inclusion	_	
107-17	16356-16358	in	_	
107-18	16359-16362	the	_	
107-19	16363-16366	top	_	
107-20	16367-16374	feature	_	
107-21	16375-16378	set	_	
107-22	16379-16387	yielding	_	
107-23	16388-16395	highest	_	
107-24	16396-16404	accuracy	_	
107-25	16404-16405	.	_	

#Text=The RFE process was done separately and identically for both the SZ and ASD data sets, resulting in a separate set of distinguishing features for each patient population from that of healthy controls.
108-1	16406-16409	The	_	
108-2	16410-16413	RFE	_	
108-3	16414-16421	process	_	
108-4	16422-16425	was	_	
108-5	16426-16430	done	_	
108-6	16431-16441	separately	_	
108-7	16442-16445	and	_	
108-8	16446-16457	identically	_	
108-9	16458-16461	for	_	
108-10	16462-16466	both	_	
108-11	16467-16470	the	_	
108-12	16471-16473	SZ	_	
108-13	16474-16477	and	_	
108-14	16478-16481	ASD	_	
108-15	16482-16486	data	_	
108-16	16487-16491	sets	_	
108-17	16491-16492	,	_	
108-18	16493-16502	resulting	_	
108-19	16503-16505	in	_	
108-20	16506-16507	a	_	
108-21	16508-16516	separate	_	
108-22	16517-16520	set	_	
108-23	16521-16523	of	_	
108-24	16524-16538	distinguishing	_	
108-25	16539-16547	features	_	
108-26	16548-16551	for	_	
108-27	16552-16556	each	_	
108-28	16557-16564	patient	_	
108-29	16565-16575	population	_	
108-30	16576-16580	from	_	
108-31	16581-16585	that	_	
108-32	16586-16588	of	_	
108-33	16589-16596	healthy	_	
108-34	16597-16605	controls	_	
108-35	16605-16606	.	_	

#Text=A separate SVM model for SZ and ASD was then created using these features.
109-1	16607-16608	A	_	
109-2	16609-16617	separate	_	
109-3	16618-16621	SVM	_	
109-4	16622-16627	model	_	
109-5	16628-16631	for	_	
109-6	16632-16634	SZ	_	
109-7	16635-16638	and	_	
109-8	16639-16642	ASD	_	
109-9	16643-16646	was	_	
109-10	16647-16651	then	_	
109-11	16652-16659	created	_	
109-12	16660-16665	using	_	
109-13	16666-16671	these	_	
109-14	16672-16680	features	_	
109-15	16680-16681	.	_	

#Text=Cross validation on independent data
#Text=Independent data sets, from a new cohort of subjects that were collected at different sites were used as testing cross validation sets.
110-1	16682-16687	Cross	_	
110-2	16688-16698	validation	_	
110-3	16699-16701	on	_	
110-4	16702-16713	independent	_	
110-5	16714-16718	data	_	
110-6	16719-16730	Independent	_	
110-7	16731-16735	data	_	
110-8	16736-16740	sets	_	
110-9	16740-16741	,	_	
110-10	16742-16746	from	_	
110-11	16747-16748	a	_	
110-12	16749-16752	new	_	
110-13	16753-16759	cohort	_	
110-14	16760-16762	of	_	
110-15	16763-16771	subjects	_	
110-16	16772-16776	that	_	
110-17	16777-16781	were	_	
110-18	16782-16791	collected	_	
110-19	16792-16794	at	_	
110-20	16795-16804	different	_	
110-21	16805-16810	sites	_	
110-22	16811-16815	were	_	
110-23	16816-16820	used	_	
110-24	16821-16823	as	_	
110-25	16824-16831	testing	_	
110-26	16832-16837	cross	_	
110-27	16838-16848	validation	_	
110-28	16849-16853	sets	_	
110-29	16853-16854	.	_	

#Text=The SVM models generated from the features identified through the RFE procedure, were used to predict group membership of the testing cross validation data sets.
111-1	16855-16858	The	_	
111-2	16859-16862	SVM	_	
111-3	16863-16869	models	_	
111-4	16870-16879	generated	_	
111-5	16880-16884	from	_	
111-6	16885-16888	the	_	
111-7	16889-16897	features	_	
111-8	16898-16908	identified	_	
111-9	16909-16916	through	_	
111-10	16917-16920	the	_	
111-11	16921-16924	RFE	_	
111-12	16925-16934	procedure	_	
111-13	16934-16935	,	_	
111-14	16936-16940	were	_	
111-15	16941-16945	used	_	
111-16	16946-16948	to	_	
111-17	16949-16956	predict	_	
111-18	16957-16962	group	_	
111-19	16963-16973	membership	_	
111-20	16974-16976	of	_	
111-21	16977-16980	the	_	
111-22	16981-16988	testing	_	
111-23	16989-16994	cross	_	
111-24	16995-17005	validation	_	
111-25	17006-17010	data	_	
111-26	17011-17015	sets	_	
111-27	17015-17016	.	_	

#Text=Each of the new data sets underwent identical preprocessing procedures as the original training cohorts.
112-1	17017-17021	Each	_	
112-2	17022-17024	of	_	
112-3	17025-17028	the	_	
112-4	17029-17032	new	_	
112-5	17033-17037	data	_	
112-6	17038-17042	sets	_	
112-7	17043-17052	underwent	_	
112-8	17053-17062	identical	_	
112-9	17063-17076	preprocessing	_	
112-10	17077-17087	procedures	_	
112-11	17088-17090	as	_	
112-12	17091-17094	the	_	
112-13	17095-17103	original	_	
112-14	17104-17112	training	_	
112-15	17113-17120	cohorts	_	
112-16	17120-17121	.	_	

#Text=Their weighted edge matrices were used to determine how well our SVM models generalize.
113-1	17122-17127	Their	_	
113-2	17128-17136	weighted	_	
113-3	17137-17141	edge	_	
113-4	17142-17150	matrices	_	
113-5	17151-17155	were	_	
113-6	17156-17160	used	_	
113-7	17161-17163	to	_	
113-8	17164-17173	determine	_	
113-9	17174-17177	how	_	
113-10	17178-17182	well	_	
113-11	17183-17186	our	_	
113-12	17187-17190	SVM	_	
113-13	17191-17197	models	_	
113-14	17198-17208	generalize	_	
113-15	17208-17209	.	_	

#Text=We predicted the group membership (ASD vs control, SZ vs control) on these new subjects using the SVM models that were trained on the initial training cohort of subjects.
114-1	17210-17212	We	_	
114-2	17213-17222	predicted	_	
114-3	17223-17226	the	_	
114-4	17227-17232	group	_	
114-5	17233-17243	membership	_	
114-6	17244-17245	(	_	
114-7	17245-17248	ASD	_	
114-8	17249-17251	vs	_	
114-9	17252-17259	control	_	
114-10	17259-17260	,	_	
114-11	17261-17263	SZ	_	
114-12	17264-17266	vs	_	
114-13	17267-17274	control	_	
114-14	17274-17275	)	_	
114-15	17276-17278	on	_	
114-16	17279-17284	these	_	
114-17	17285-17288	new	_	
114-18	17289-17297	subjects	_	
114-19	17298-17303	using	_	
114-20	17304-17307	the	_	
114-21	17308-17311	SVM	_	
114-22	17312-17318	models	_	
114-23	17319-17323	that	_	
114-24	17324-17328	were	_	
114-25	17329-17336	trained	_	
114-26	17337-17339	on	_	
114-27	17340-17343	the	_	
114-28	17344-17351	initial	_	
114-29	17352-17360	training	_	
114-30	17361-17367	cohort	_	
114-31	17368-17370	of	_	
114-32	17371-17379	subjects	_	
114-33	17379-17380	.	_	

#Text=Cross-validation in this way, allows us to see how well our models generalize outside of the patient population on which it was trained and also ensures that classification accuracy is not driven by differences in age, scanning site or other potential cohort or procedural differences in subject groups.
115-1	17381-17397	Cross-validation	_	
115-2	17398-17400	in	_	
115-3	17401-17405	this	_	
115-4	17406-17409	way	_	
115-5	17409-17410	,	_	
115-6	17411-17417	allows	_	
115-7	17418-17420	us	_	
115-8	17421-17423	to	_	
115-9	17424-17427	see	_	
115-10	17428-17431	how	_	
115-11	17432-17436	well	_	
115-12	17437-17440	our	_	
115-13	17441-17447	models	_	
115-14	17448-17458	generalize	_	
115-15	17459-17466	outside	_	
115-16	17467-17469	of	_	
115-17	17470-17473	the	_	
115-18	17474-17481	patient	_	
115-19	17482-17492	population	_	
115-20	17493-17495	on	_	
115-21	17496-17501	which	_	
115-22	17502-17504	it	_	
115-23	17505-17508	was	_	
115-24	17509-17516	trained	_	
115-25	17517-17520	and	_	
115-26	17521-17525	also	_	
115-27	17526-17533	ensures	_	
115-28	17534-17538	that	_	
115-29	17539-17553	classification	_	
115-30	17554-17562	accuracy	_	
115-31	17563-17565	is	_	
115-32	17566-17569	not	_	
115-33	17570-17576	driven	_	
115-34	17577-17579	by	_	
115-35	17580-17591	differences	_	
115-36	17592-17594	in	_	
115-37	17595-17598	age	_	
115-38	17598-17599	,	_	
115-39	17600-17608	scanning	_	
115-40	17609-17613	site	_	
115-41	17614-17616	or	_	
115-42	17617-17622	other	_	
115-43	17623-17632	potential	_	
115-44	17633-17639	cohort	_	
115-45	17640-17642	or	_	
115-46	17643-17653	procedural	_	
115-47	17654-17665	differences	_	
115-48	17666-17668	in	_	
115-49	17669-17676	subject	_	
115-50	17677-17683	groups	_	
115-51	17683-17684	.	_	

#Text=Identifying common and disparate features of autism and schizophrenia
#Text=To identify common and disparate features of ASD and SZ we formed a control group from a mixture of equal numbers of subjects from the control groups of the ASD and SZ data sets.
116-1	17685-17696	Identifying	_	
116-2	17697-17703	common	_	
116-3	17704-17707	and	_	
116-4	17708-17717	disparate	_	
116-5	17718-17726	features	_	
116-6	17727-17729	of	_	
116-7	17730-17736	autism	_	
116-8	17737-17740	and	_	
116-9	17741-17754	schizophrenia	_	
116-10	17755-17757	To	_	
116-11	17758-17766	identify	_	
116-12	17767-17773	common	_	
116-13	17774-17777	and	_	
116-14	17778-17787	disparate	_	
116-15	17788-17796	features	_	
116-16	17797-17799	of	_	
116-17	17800-17803	ASD	_	
116-18	17804-17807	and	_	
116-19	17808-17810	SZ	_	
116-20	17811-17813	we	_	
116-21	17814-17820	formed	_	
116-22	17821-17822	a	_	
116-23	17823-17830	control	_	
116-24	17831-17836	group	_	
116-25	17837-17841	from	_	
116-26	17842-17843	a	_	
116-27	17844-17851	mixture	_	
116-28	17852-17854	of	_	
116-29	17855-17860	equal	_	
116-30	17861-17868	numbers	_	
116-31	17869-17871	of	_	
116-32	17872-17880	subjects	_	
116-33	17881-17885	from	_	
116-34	17886-17889	the	_	
116-35	17890-17897	control	_	
116-36	17898-17904	groups	_	
116-37	17905-17907	of	_	
116-38	17908-17911	the	_	
116-39	17912-17915	ASD	_	
116-40	17916-17919	and	_	
116-41	17920-17922	SZ	_	
116-42	17923-17927	data	_	
116-43	17928-17932	sets	_	
116-44	17932-17933	.	_	

#Text=Using this control group during training avoids identifying features that could potentially distinguish the two data sets (SZ and ASD training sets) for reasons having nothing to do with the different patient population features.
117-1	17934-17939	Using	_	
117-2	17940-17944	this	_	
117-3	17945-17952	control	_	
117-4	17953-17958	group	_	
117-5	17959-17965	during	_	
117-6	17966-17974	training	_	
117-7	17975-17981	avoids	_	
117-8	17982-17993	identifying	_	
117-9	17994-18002	features	_	
117-10	18003-18007	that	_	
117-11	18008-18013	could	_	
117-12	18014-18025	potentially	_	
117-13	18026-18037	distinguish	_	
117-14	18038-18041	the	_	
117-15	18042-18045	two	_	
117-16	18046-18050	data	_	
117-17	18051-18055	sets	_	
117-18	18056-18057	(	_	
117-19	18057-18059	SZ	_	
117-20	18060-18063	and	_	
117-21	18064-18067	ASD	_	
117-22	18068-18076	training	_	
117-23	18077-18081	sets	_	
117-24	18081-18082	)	_	
117-25	18083-18086	for	_	
117-26	18087-18094	reasons	_	
117-27	18095-18101	having	_	
117-28	18102-18109	nothing	_	
117-29	18110-18112	to	_	
117-30	18113-18115	do	_	
117-31	18116-18120	with	_	
117-32	18121-18124	the	_	
117-33	18125-18134	different	_	
117-34	18135-18142	patient	_	
117-35	18143-18153	population	_	
117-36	18154-18162	features	_	
117-37	18162-18163	.	_	

#Text=That is, the hybrid control group is also drawn from samples across scanners.
118-1	18164-18168	That	_	
118-2	18169-18171	is	_	
118-3	18171-18172	,	_	
118-4	18173-18176	the	_	
118-5	18177-18183	hybrid	_	
118-6	18184-18191	control	_	
118-7	18192-18197	group	_	
118-8	18198-18200	is	_	
118-9	18201-18205	also	_	
118-10	18206-18211	drawn	_	
118-11	18212-18216	from	_	
118-12	18217-18224	samples	_	
118-13	18225-18231	across	_	
118-14	18232-18240	scanners	_	
118-15	18240-18241	.	_	

#Text=Therefore, the classification cannot be made solely on differences that may be present in data samples due to collection at different scanner sites.
119-1	18242-18251	Therefore	_	
119-2	18251-18252	,	_	
119-3	18253-18256	the	_	
119-4	18257-18271	classification	_	
119-5	18272-18278	cannot	_	
119-6	18279-18281	be	_	
119-7	18282-18286	made	_	
119-8	18287-18293	solely	_	
119-9	18294-18296	on	_	
119-10	18297-18308	differences	_	
119-11	18309-18313	that	_	
119-12	18314-18317	may	_	
119-13	18318-18320	be	_	
119-14	18321-18328	present	_	
119-15	18329-18331	in	_	
119-16	18332-18336	data	_	
119-17	18337-18344	samples	_	
119-18	18345-18348	due	_	
119-19	18349-18351	to	_	
119-20	18352-18362	collection	_	
119-21	18363-18365	at	_	
119-22	18366-18375	different	_	
119-23	18376-18383	scanner	_	
119-24	18384-18389	sites	_	
119-25	18389-18390	.	_	

#Text=RFE was performed separately for ASD and SZ against this common control group.
120-1	18391-18394	RFE	_	
120-2	18395-18398	was	_	
120-3	18399-18408	performed	_	
120-4	18409-18419	separately	_	
120-5	18420-18423	for	_	
120-6	18424-18427	ASD	_	
120-7	18428-18431	and	_	
120-8	18432-18434	SZ	_	
120-9	18435-18442	against	_	
120-10	18443-18447	this	_	
120-11	18448-18454	common	_	
120-12	18455-18462	control	_	
120-13	18463-18468	group	_	
120-14	18468-18469	.	_	

#Text=Identified features were separated into common and divergent feature sets.
121-1	18470-18480	Identified	_	
121-2	18481-18489	features	_	
121-3	18490-18494	were	_	
121-4	18495-18504	separated	_	
121-5	18505-18509	into	_	
121-6	18510-18516	common	_	
121-7	18517-18520	and	_	
121-8	18521-18530	divergent	_	
121-9	18531-18538	feature	_	
121-10	18539-18543	sets	_	
121-11	18543-18544	.	_	

#Text=Common features were those identified by both the SZ and ASD RFE procedures against the common control; divergent features were the remaining SZ and ASD features combined.
122-1	18545-18551	Common	_	
122-2	18552-18560	features	_	
122-3	18561-18565	were	_	
122-4	18566-18571	those	_	
122-5	18572-18582	identified	_	
122-6	18583-18585	by	_	
122-7	18586-18590	both	_	
122-8	18591-18594	the	_	
122-9	18595-18597	SZ	_	
122-10	18598-18601	and	_	
122-11	18602-18605	ASD	_	
122-12	18606-18609	RFE	_	
122-13	18610-18620	procedures	_	
122-14	18621-18628	against	_	
122-15	18629-18632	the	_	
122-16	18633-18639	common	_	
122-17	18640-18647	control	_	
122-18	18647-18648	;	_	
122-19	18649-18658	divergent	_	
122-20	18659-18667	features	_	
122-21	18668-18672	were	_	
122-22	18673-18676	the	_	
122-23	18677-18686	remaining	_	
122-24	18687-18689	SZ	_	
122-25	18690-18693	and	_	
122-26	18694-18697	ASD	_	
122-27	18698-18706	features	_	
122-28	18707-18715	combined	_	
122-29	18715-18716	.	_	

#Text=Features were then divided into non-overlapping functional networks for the purpose of visualization using network definitions from a previously defined functional brain atlas.
123-1	18717-18725	Features	_	
123-2	18726-18730	were	_	
123-3	18731-18735	then	_	
123-4	18736-18743	divided	_	
123-5	18744-18748	into	_	
123-6	18749-18764	non-overlapping	_	
123-7	18765-18775	functional	_	
123-8	18776-18784	networks	_	
123-9	18785-18788	for	_	
123-10	18789-18792	the	_	
123-11	18793-18800	purpose	_	
123-12	18801-18803	of	_	
123-13	18804-18817	visualization	_	
123-14	18818-18823	using	_	
123-15	18824-18831	network	_	
123-16	18832-18843	definitions	_	
123-17	18844-18848	from	_	
123-18	18849-18850	a	_	
123-19	18851-18861	previously	_	
123-20	18862-18869	defined	_	
123-21	18870-18880	functional	_	
123-22	18881-18886	brain	_	
123-23	18887-18892	atlas	_	
123-24	18892-18893	.	_	

#Text=ROIs were defined as belonging to a given network if they were spatially overlapping with the atlas network mask.
124-1	18894-18898	ROIs	_	
124-2	18899-18903	were	_	
124-3	18904-18911	defined	_	
124-4	18912-18914	as	_	
124-5	18915-18924	belonging	_	
124-6	18925-18927	to	_	
124-7	18928-18929	a	_	
124-8	18930-18935	given	_	
124-9	18936-18943	network	_	
124-10	18944-18946	if	_	
124-11	18947-18951	they	_	
124-12	18952-18956	were	_	
124-13	18957-18966	spatially	_	
124-14	18967-18978	overlapping	_	
124-15	18979-18983	with	_	
124-16	18984-18987	the	_	
124-17	18988-18993	atlas	_	
124-18	18994-19001	network	_	
124-19	19002-19006	mask	_	
124-20	19006-19007	.	_	

#Text=Results
#Text=Discriminative connectivity features
#Text=RFE was performed separately on the ABIDE USM and the COBRE SZ training data sets and resulted in: 1) a set of features or edges that were most diagnostic in distinguishing ASD/SZ subjects from healthy controls.
125-1	19008-19015	Results	_	
125-2	19016-19030	Discriminative	_	
125-3	19031-19043	connectivity	_	
125-4	19044-19052	features	_	
125-5	19053-19056	RFE	_	
125-6	19057-19060	was	_	
125-7	19061-19070	performed	_	
125-8	19071-19081	separately	_	
125-9	19082-19084	on	_	
125-10	19085-19088	the	_	
125-11	19089-19094	ABIDE	_	
125-12	19095-19098	USM	_	
125-13	19099-19102	and	_	
125-14	19103-19106	the	_	
125-15	19107-19112	COBRE	_	
125-16	19113-19115	SZ	_	
125-17	19116-19124	training	_	
125-18	19125-19129	data	_	
125-19	19130-19134	sets	_	
125-20	19135-19138	and	_	
125-21	19139-19147	resulted	_	
125-22	19148-19150	in	_	
125-23	19150-19151	:	_	
125-24	19152-19153	1	_	
125-25	19153-19154	)	_	
125-26	19155-19156	a	_	
125-27	19157-19160	set	_	
125-28	19161-19163	of	_	
125-29	19164-19172	features	_	
125-30	19173-19175	or	_	
125-31	19176-19181	edges	_	
125-32	19182-19186	that	_	
125-33	19187-19191	were	_	
125-34	19192-19196	most	_	
125-35	19197-19207	diagnostic	_	
125-36	19208-19210	in	_	
125-37	19211-19225	distinguishing	_	
125-38	19226-19229	ASD	_	
125-39	19229-19230	/	_	
125-40	19230-19232	SZ	_	
125-41	19233-19241	subjects	_	
125-42	19242-19246	from	_	
125-43	19247-19254	healthy	_	
125-44	19255-19263	controls	_	
125-45	19263-19264	.	_	

#Text=The features identified represent the set of edges that differ most significantly for SZ and ASD patients relative to healthy controls. 2) A model generated by training an SVM on just these features which can then be used to predict the class of a new set of subjects in the testing data sets.
126-1	19265-19268	The	_	
126-2	19269-19277	features	_	
126-3	19278-19288	identified	_	
126-4	19289-19298	represent	_	
126-5	19299-19302	the	_	
126-6	19303-19306	set	_	
126-7	19307-19309	of	_	
126-8	19310-19315	edges	_	
126-9	19316-19320	that	_	
126-10	19321-19327	differ	_	
126-11	19328-19332	most	_	
126-12	19333-19346	significantly	_	
126-13	19347-19350	for	_	
126-14	19351-19353	SZ	_	
126-15	19354-19357	and	_	
126-16	19358-19361	ASD	_	
126-17	19362-19370	patients	_	
126-18	19371-19379	relative	_	
126-19	19380-19382	to	_	
126-20	19383-19390	healthy	_	
126-21	19391-19399	controls	_	
126-22	19399-19400	.	_	
126-23	19401-19402	2	_	
126-24	19402-19403	)	_	
126-25	19404-19405	A	_	
126-26	19406-19411	model	_	
126-27	19412-19421	generated	_	
126-28	19422-19424	by	_	
126-29	19425-19433	training	_	
126-30	19434-19436	an	_	
126-31	19437-19440	SVM	_	
126-32	19441-19443	on	_	
126-33	19444-19448	just	_	
126-34	19449-19454	these	_	
126-35	19455-19463	features	_	
126-36	19464-19469	which	_	
126-37	19470-19473	can	_	
126-38	19474-19478	then	_	
126-39	19479-19481	be	_	
126-40	19482-19486	used	_	
126-41	19487-19489	to	_	
126-42	19490-19497	predict	_	
126-43	19498-19501	the	_	
126-44	19502-19507	class	_	
126-45	19508-19510	of	_	
126-46	19511-19512	a	_	
126-47	19513-19516	new	_	
126-48	19517-19520	set	_	
126-49	19521-19523	of	_	
126-50	19524-19532	subjects	_	
126-51	19533-19535	in	_	
126-52	19536-19539	the	_	
126-53	19540-19547	testing	_	
126-54	19548-19552	data	_	
126-55	19553-19557	sets	_	
126-56	19557-19558	.	_	

#Text=ASD diagnostic features
#Text=ROCs of cross-validation accuracy on the a) ASD training-naive test data set as a function of the number of diagnostic features used for prediction.
127-1	19559-19562	ASD	_	
127-2	19563-19573	diagnostic	_	
127-3	19574-19582	features	_	
127-4	19583-19587	ROCs	_	
127-5	19588-19590	of	_	
127-6	19591-19607	cross-validation	_	
127-7	19608-19616	accuracy	_	
127-8	19617-19619	on	_	
127-9	19620-19623	the	_	
127-10	19624-19625	a	_	
127-11	19625-19626	)	_	
127-12	19627-19630	ASD	_	
127-13	19631-19645	training-naive	_	
127-14	19646-19650	test	_	
127-15	19651-19655	data	_	
127-16	19656-19659	set	_	
127-17	19660-19662	as	_	
127-18	19663-19664	a	_	
127-19	19665-19673	function	_	
127-20	19674-19676	of	_	
127-21	19677-19680	the	_	
127-22	19681-19687	number	_	
127-23	19688-19690	of	_	
127-24	19691-19701	diagnostic	_	
127-25	19702-19710	features	_	
127-26	19711-19715	used	_	
127-27	19716-19719	for	_	
127-28	19720-19730	prediction	_	
127-29	19730-19731	.	_	

#Text=Best model performance: of 83% accuracy (75% sensitivity and 89% specificity) was achieved using between 800 and 1000 of the top RFE-determined features. b) SZ training-naive test data set.
128-1	19732-19736	Best	_	
128-2	19737-19742	model	_	
128-3	19743-19754	performance	_	
128-4	19754-19755	:	_	
128-5	19756-19758	of	_	
128-6	19759-19762	83%	_	
128-7	19763-19771	accuracy	_	
128-8	19772-19773	(	_	
128-9	19773-19776	75%	_	
128-10	19777-19788	sensitivity	_	
128-11	19789-19792	and	_	
128-12	19793-19796	89%	_	
128-13	19797-19808	specificity	_	
128-14	19808-19809	)	_	
128-15	19810-19813	was	_	
128-16	19814-19822	achieved	_	
128-17	19823-19828	using	_	
128-18	19829-19836	between	_	
128-19	19837-19840	800	_	
128-20	19841-19844	and	_	
128-21	19845-19849	1000	_	
128-22	19850-19852	of	_	
128-23	19853-19856	the	_	
128-24	19857-19860	top	_	
128-25	19861-19875	RFE-determined	_	
128-26	19876-19884	features	_	
128-27	19884-19885	.	_	
128-28	19886-19887	b	_	
128-29	19887-19888	)	_	
128-30	19889-19891	SZ	_	
128-31	19892-19906	training-naive	_	
128-32	19907-19911	test	_	
128-33	19912-19916	data	_	
128-34	19917-19920	set	_	
128-35	19920-19921	.	_	

#Text=Best performance was achieved using the top 400–600 RFE features which resulted in 80% accuracy with 80% sensitivity (TPR) and 80% specificity (1 − FPR).
129-1	19922-19926	Best	_	
129-2	19927-19938	performance	_	
129-3	19939-19942	was	_	
129-4	19943-19951	achieved	_	
129-5	19952-19957	using	_	
129-6	19958-19961	the	_	
129-7	19962-19965	top	_	
129-8	19966-19969	400	_	
129-9	19969-19970	–	_	
129-10	19970-19973	600	_	
129-11	19974-19977	RFE	_	
129-12	19978-19986	features	_	
129-13	19987-19992	which	_	
129-14	19993-20001	resulted	_	
129-15	20002-20004	in	_	
129-16	20005-20008	80%	_	
129-17	20009-20017	accuracy	_	
129-18	20018-20022	with	_	
129-19	20023-20026	80%	_	
129-20	20027-20038	sensitivity	_	
129-21	20039-20040	(	_	
129-22	20040-20043	TPR	_	
129-23	20043-20044	)	_	
129-24	20045-20048	and	_	
129-25	20049-20052	80%	_	
129-26	20053-20064	specificity	_	
129-27	20065-20066	(	_	
129-28	20066-20067	1	_	
129-29	20067-20068	 	_	
129-30	20068-20069	−	_	
129-31	20069-20070	 	_	
129-32	20070-20073	FPR	_	
129-33	20073-20074	)	_	
129-34	20074-20075	.	_	

#Text=Diagnostic features were determined by RFE on training data sets.
130-1	20076-20086	Diagnostic	_	
130-2	20087-20095	features	_	
130-3	20096-20100	were	_	
130-4	20101-20111	determined	_	
130-5	20112-20114	by	_	
130-6	20115-20118	RFE	_	
130-7	20119-20121	on	_	
130-8	20122-20130	training	_	
130-9	20131-20135	data	_	
130-10	20136-20140	sets	_	
130-11	20140-20141	.	_	

#Text=Performance at chance is represented on the red diagonal.
131-1	20142-20153	Performance	_	
131-2	20154-20156	at	_	
131-3	20157-20163	chance	_	
131-4	20164-20166	is	_	
131-5	20167-20178	represented	_	
131-6	20179-20181	on	_	
131-7	20182-20185	the	_	
131-8	20186-20189	red	_	
131-9	20190-20198	diagonal	_	
131-10	20198-20199	.	_	

#Text=Fig. 1
#Text=Diagnostic features by network.
132-1	20200-20203	Fig	_	
132-2	20203-20204	.	_	
132-3	20205-20206	1	_	
132-4	20207-20217	Diagnostic	_	
132-5	20218-20226	features	_	
132-6	20227-20229	by	_	
132-7	20230-20237	network	_	
132-8	20237-20238	.	_	

#Text=Diagonal elements represent within network edges (edges between different regions of the same network).
133-1	20239-20247	Diagonal	_	
133-2	20248-20256	elements	_	
133-3	20257-20266	represent	_	
133-4	20267-20273	within	_	
133-5	20274-20281	network	_	
133-6	20282-20287	edges	_	
133-7	20288-20289	(	_	
133-8	20289-20294	edges	_	
133-9	20295-20302	between	_	
133-10	20303-20312	different	_	
133-11	20313-20320	regions	_	
133-12	20321-20323	of	_	
133-13	20324-20327	the	_	
133-14	20328-20332	same	_	
133-15	20333-20340	network	_	
133-16	20340-20341	)	_	
133-17	20341-20342	.	_	

#Text=Numbers represent the number of features while the size/colors indicate the ratio of those features that represent increases rather than decreases in connectivity strength relative to controls.
134-1	20343-20350	Numbers	_	
134-2	20351-20360	represent	_	
134-3	20361-20364	the	_	
134-4	20365-20371	number	_	
134-5	20372-20374	of	_	
134-6	20375-20383	features	_	
134-7	20384-20389	while	_	
134-8	20390-20393	the	_	
134-9	20394-20398	size	_	
134-10	20398-20399	/	_	
134-11	20399-20405	colors	_	
134-12	20406-20414	indicate	_	
134-13	20415-20418	the	_	
134-14	20419-20424	ratio	_	
134-15	20425-20427	of	_	
134-16	20428-20433	those	_	
134-17	20434-20442	features	_	
134-18	20443-20447	that	_	
134-19	20448-20457	represent	_	
134-20	20458-20467	increases	_	
134-21	20468-20474	rather	_	
134-22	20475-20479	than	_	
134-23	20480-20489	decreases	_	
134-24	20490-20492	in	_	
134-25	20493-20505	connectivity	_	
134-26	20506-20514	strength	_	
134-27	20515-20523	relative	_	
134-28	20524-20526	to	_	
134-29	20527-20535	controls	_	
134-30	20535-20536	.	_	

#Text=Larger circles/yellow colors indicate a greater proportion of connectivity increases and red a greater proportion of decreases.
135-1	20537-20543	Larger	_	
135-2	20544-20551	circles	_	
135-3	20551-20552	/	_	
135-4	20552-20558	yellow	_	
135-5	20559-20565	colors	_	
135-6	20566-20574	indicate	_	
135-7	20575-20576	a	_	
135-8	20577-20584	greater	_	
135-9	20585-20595	proportion	_	
135-10	20596-20598	of	_	
135-11	20599-20611	connectivity	_	
135-12	20612-20621	increases	_	
135-13	20622-20625	and	_	
135-14	20626-20629	red	_	
135-15	20630-20631	a	_	
135-16	20632-20639	greater	_	
135-17	20640-20650	proportion	_	
135-18	20651-20653	of	_	
135-19	20654-20663	decreases	_	
135-20	20663-20664	.	_	

#Text=Total number of features per network is indicated in the left column. a) In ASD, features cluster within the DMN, salience, ECN, higher order visual and motor networks having the largest number of diagnostic features. b) In SZ, features are also clustered in the DMN and salience networks with less emphasis on the ECN.
136-1	20665-20670	Total	_	
136-2	20671-20677	number	_	
136-3	20678-20680	of	_	
136-4	20681-20689	features	_	
136-5	20690-20693	per	_	
136-6	20694-20701	network	_	
136-7	20702-20704	is	_	
136-8	20705-20714	indicated	_	
136-9	20715-20717	in	_	
136-10	20718-20721	the	_	
136-11	20722-20726	left	_	
136-12	20727-20733	column	_	
136-13	20733-20734	.	_	
136-14	20735-20736	a	_	
136-15	20736-20737	)	_	
136-16	20738-20740	In	_	
136-17	20741-20744	ASD	_	
136-18	20744-20745	,	_	
136-19	20746-20754	features	_	
136-20	20755-20762	cluster	_	
136-21	20763-20769	within	_	
136-22	20770-20773	the	_	
136-23	20774-20777	DMN	_	
136-24	20777-20778	,	_	
136-25	20779-20787	salience	_	
136-26	20787-20788	,	_	
136-27	20789-20792	ECN	_	
136-28	20792-20793	,	_	
136-29	20794-20800	higher	_	
136-30	20801-20806	order	_	
136-31	20807-20813	visual	_	
136-32	20814-20817	and	_	
136-33	20818-20823	motor	_	
136-34	20824-20832	networks	_	
136-35	20833-20839	having	_	
136-36	20840-20843	the	_	
136-37	20844-20851	largest	_	
136-38	20852-20858	number	_	
136-39	20859-20861	of	_	
136-40	20862-20872	diagnostic	_	
136-41	20873-20881	features	_	
136-42	20881-20882	.	_	
136-43	20883-20884	b	_	
136-44	20884-20885	)	_	
136-45	20886-20888	In	_	
136-46	20889-20891	SZ	_	
136-47	20891-20892	,	_	
136-48	20893-20901	features	_	
136-49	20902-20905	are	_	
136-50	20906-20910	also	_	
136-51	20911-20920	clustered	_	
136-52	20921-20923	in	_	
136-53	20924-20927	the	_	
136-54	20928-20931	DMN	_	
136-55	20932-20935	and	_	
136-56	20936-20944	salience	_	
136-57	20945-20953	networks	_	
136-58	20954-20958	with	_	
136-59	20959-20963	less	_	
136-60	20964-20972	emphasis	_	
136-61	20973-20975	on	_	
136-62	20976-20979	the	_	
136-63	20980-20983	ECN	_	
136-64	20983-20984	.	_	

#Text=Fig. 2
#Text=Specificity and sensitivity for ASD classification on untrained data.
137-1	20985-20988	Fig	_	
137-2	20988-20989	.	_	
137-3	20990-20991	2	_	
137-4	20992-21003	Specificity	_	
137-5	21004-21007	and	_	
137-6	21008-21019	sensitivity	_	
137-7	21020-21023	for	_	
137-8	21024-21027	ASD	_	
137-9	21028-21042	classification	_	
137-10	21043-21045	on	_	
137-11	21046-21055	untrained	_	
137-12	21056-21060	data	_	
137-13	21060-21061	.	_	

#Text=Table 1\t \t
#Text=ASD\t \tNumber of features\tSpecificity\tSensitivity\tAccuracy\t \t9\t0.33\t0.33\t33.00%\t \t13\t0.33\t0.5\t42.00%\t \t17\t0.44\t0.33\t39.00%\t \t24\t0.33\t0.75\t54.00%\t \t34\t0.44\t0.42\t43.00%\t \t49\t0.44\t0.5\t47.00%\t \t73\t0.56\t0.75\t66.00%\t \t110\t0.56\t0.67\t62.00%\t \t165\t0.56\t0.75\t65.00%\t \t249\t0.56\t0.75\t65.00%\t \t376\t0.44\t0.75\t60.00%\t \t570\t0.55\t0.75\t65.00%\t \t868\t0.89\t0.75\t83.00%\t \t1321\t0.89\t0.75\t83.00%\t \t2009\t0.78\t0.67\t73.00%\t \t3060\t0.78\t58\t68.00%\t \t
#Text=The RFE procedure was performed on the ASD USM training data set to classify ASD subjects from healthy controls.
138-1	21062-21067	Table	_	
138-2	21068-21069	1	_	
138-3	21073-21076	ASD	_	
138-4	21079-21085	Number	_	
138-5	21086-21088	of	_	
138-6	21089-21097	features	_	
138-7	21098-21109	Specificity	_	
138-8	21110-21121	Sensitivity	_	
138-9	21122-21130	Accuracy	_	
138-10	21133-21134	9	_	
138-11	21135-21139	0.33	_	
138-12	21140-21144	0.33	_	
138-13	21145-21151	33.00%	_	
138-14	21154-21156	13	_	
138-15	21157-21161	0.33	_	
138-16	21162-21165	0.5	_	
138-17	21166-21172	42.00%	_	
138-18	21175-21177	17	_	
138-19	21178-21182	0.44	_	
138-20	21183-21187	0.33	_	
138-21	21188-21194	39.00%	_	
138-22	21197-21199	24	_	
138-23	21200-21204	0.33	_	
138-24	21205-21209	0.75	_	
138-25	21210-21216	54.00%	_	
138-26	21219-21221	34	_	
138-27	21222-21226	0.44	_	
138-28	21227-21231	0.42	_	
138-29	21232-21238	43.00%	_	
138-30	21241-21243	49	_	
138-31	21244-21248	0.44	_	
138-32	21249-21252	0.5	_	
138-33	21253-21259	47.00%	_	
138-34	21262-21264	73	_	
138-35	21265-21269	0.56	_	
138-36	21270-21274	0.75	_	
138-37	21275-21281	66.00%	_	
138-38	21284-21287	110	_	
138-39	21288-21292	0.56	_	
138-40	21293-21297	0.67	_	
138-41	21298-21304	62.00%	_	
138-42	21307-21310	165	_	
138-43	21311-21315	0.56	_	
138-44	21316-21320	0.75	_	
138-45	21321-21327	65.00%	_	
138-46	21330-21333	249	_	
138-47	21334-21338	0.56	_	
138-48	21339-21343	0.75	_	
138-49	21344-21350	65.00%	_	
138-50	21353-21356	376	_	
138-51	21357-21361	0.44	_	
138-52	21362-21366	0.75	_	
138-53	21367-21373	60.00%	_	
138-54	21376-21379	570	_	
138-55	21380-21384	0.55	_	
138-56	21385-21389	0.75	_	
138-57	21390-21396	65.00%	_	
138-58	21399-21402	868	_	
138-59	21403-21407	0.89	_	
138-60	21408-21412	0.75	_	
138-61	21413-21419	83.00%	_	
138-62	21422-21426	1321	_	
138-63	21427-21431	0.89	_	
138-64	21432-21436	0.75	_	
138-65	21437-21443	83.00%	_	
138-66	21446-21450	2009	_	
138-67	21451-21455	0.78	_	
138-68	21456-21460	0.67	_	
138-69	21461-21467	73.00%	_	
138-70	21470-21474	3060	_	
138-71	21475-21479	0.78	_	
138-72	21480-21482	58	_	
138-73	21483-21489	68.00%	_	
138-74	21493-21496	The	_	
138-75	21497-21500	RFE	_	
138-76	21501-21510	procedure	_	
138-77	21511-21514	was	_	
138-78	21515-21524	performed	_	
138-79	21525-21527	on	_	
138-80	21528-21531	the	_	
138-81	21532-21535	ASD	_	
138-82	21536-21539	USM	_	
138-83	21540-21548	training	_	
138-84	21549-21553	data	_	
138-85	21554-21557	set	_	
138-86	21558-21560	to	_	
138-87	21561-21569	classify	_	
138-88	21570-21573	ASD	_	
138-89	21574-21582	subjects	_	
138-90	21583-21587	from	_	
138-91	21588-21595	healthy	_	
138-92	21596-21604	controls	_	
138-93	21604-21605	.	_	

#Text=The procedure resulted in maximum average accuracy over 100 bootstrap samples using 4500 features.
139-1	21606-21609	The	_	
139-2	21610-21619	procedure	_	
139-3	21620-21628	resulted	_	
139-4	21629-21631	in	_	
139-5	21632-21639	maximum	_	
139-6	21640-21647	average	_	
139-7	21648-21656	accuracy	_	
139-8	21657-21661	over	_	
139-9	21662-21665	100	_	
139-10	21666-21675	bootstrap	_	
139-11	21676-21683	samples	_	
139-12	21684-21689	using	_	
139-13	21690-21694	4500	_	
139-14	21695-21703	features	_	
139-15	21703-21704	.	_	

#Text=SVM models for classification of the ASD training set were generated by training an SVM on a range of between 100 and 4500 of the top RFE determined features.
140-1	21705-21708	SVM	_	
140-2	21709-21715	models	_	
140-3	21716-21719	for	_	
140-4	21720-21734	classification	_	
140-5	21735-21737	of	_	
140-6	21738-21741	the	_	
140-7	21742-21745	ASD	_	
140-8	21746-21754	training	_	
140-9	21755-21758	set	_	
140-10	21759-21763	were	_	
140-11	21764-21773	generated	_	
140-12	21774-21776	by	_	
140-13	21777-21785	training	_	
140-14	21786-21788	an	_	
140-15	21789-21792	SVM	_	
140-16	21793-21795	on	_	
140-17	21796-21797	a	_	
140-18	21798-21803	range	_	
140-19	21804-21806	of	_	
140-20	21807-21814	between	_	
140-21	21815-21818	100	_	
140-22	21819-21822	and	_	
140-23	21823-21827	4500	_	
140-24	21828-21830	of	_	
140-25	21831-21834	the	_	
140-26	21835-21838	top	_	
140-27	21839-21842	RFE	_	
140-28	21843-21853	determined	_	
140-29	21854-21862	features	_	
140-30	21862-21863	.	_	

#Text=Classification accuracy dropped steeply if fewer than 100 of these diagnostic features were used.
141-1	21864-21878	Classification	_	
141-2	21879-21887	accuracy	_	
141-3	21888-21895	dropped	_	
141-4	21896-21903	steeply	_	
141-5	21904-21906	if	_	
141-6	21907-21912	fewer	_	
141-7	21913-21917	than	_	
141-8	21918-21921	100	_	
141-9	21922-21924	of	_	
141-10	21925-21930	these	_	
141-11	21931-21941	diagnostic	_	
141-12	21942-21950	features	_	
141-13	21951-21955	were	_	
141-14	21956-21960	used	_	
141-15	21960-21961	.	_	

#Text=In order to determine whether the model generalizes to ASD patients outside of this set, we tested the diagnostic accuracy of these features on an independent testing data set.
142-1	21962-21964	In	_	
142-2	21965-21970	order	_	
142-3	21971-21973	to	_	
142-4	21974-21983	determine	_	
142-5	21984-21991	whether	_	
142-6	21992-21995	the	_	
142-7	21996-22001	model	_	
142-8	22002-22013	generalizes	_	
142-9	22014-22016	to	_	
142-10	22017-22020	ASD	_	
142-11	22021-22029	patients	_	
142-12	22030-22037	outside	_	
142-13	22038-22040	of	_	
142-14	22041-22045	this	_	
142-15	22046-22049	set	_	
142-16	22049-22050	,	_	
142-17	22051-22053	we	_	
142-18	22054-22060	tested	_	
142-19	22061-22064	the	_	
142-20	22065-22075	diagnostic	_	
142-21	22076-22084	accuracy	_	
142-22	22085-22087	of	_	
142-23	22088-22093	these	_	
142-24	22094-22102	features	_	
142-25	22103-22105	on	_	
142-26	22106-22108	an	_	
142-27	22109-22120	independent	_	
142-28	22121-22128	testing	_	
142-29	22129-22133	data	_	
142-30	22134-22137	set	_	
142-31	22137-22138	.	_	

#Text=The features were used to predict the identity of subjects in the training-naive ASD ABIDEII-BNI test data set.
143-1	22139-22142	The	_	
143-2	22143-22151	features	_	
143-3	22152-22156	were	_	
143-4	22157-22161	used	_	
143-5	22162-22164	to	_	
143-6	22165-22172	predict	_	
143-7	22173-22176	the	_	
143-8	22177-22185	identity	_	
143-9	22186-22188	of	_	
143-10	22189-22197	subjects	_	
143-11	22198-22200	in	_	
143-12	22201-22204	the	_	
143-13	22205-22219	training-naive	_	
143-14	22220-22223	ASD	_	
143-15	22224-22235	ABIDEII-BNI	_	
143-16	22236-22240	test	_	
143-17	22241-22245	data	_	
143-18	22246-22249	set	_	
143-19	22249-22250	.	_	

#Text=Receiver operator curves (ROCs) were generated to show classification accuracy on the training-naive data set as a function of the number of the top features used (Fig. 1a).
144-1	22251-22259	Receiver	_	
144-2	22260-22268	operator	_	
144-3	22269-22275	curves	_	
144-4	22276-22277	(	_	
144-5	22277-22281	ROCs	_	
144-6	22281-22282	)	_	
144-7	22283-22287	were	_	
144-8	22288-22297	generated	_	
144-9	22298-22300	to	_	
144-10	22301-22305	show	_	
144-11	22306-22320	classification	_	
144-12	22321-22329	accuracy	_	
144-13	22330-22332	on	_	
144-14	22333-22336	the	_	
144-15	22337-22351	training-naive	_	
144-16	22352-22356	data	_	
144-17	22357-22360	set	_	
144-18	22361-22363	as	_	
144-19	22364-22365	a	_	
144-20	22366-22374	function	_	
144-21	22375-22377	of	_	
144-22	22378-22381	the	_	
144-23	22382-22388	number	_	
144-24	22389-22391	of	_	
144-25	22392-22395	the	_	
144-26	22396-22399	top	_	
144-27	22400-22408	features	_	
144-28	22409-22413	used	_	
144-29	22414-22415	(	_	
144-30	22415-22418	Fig	_	
144-31	22418-22419	.	_	
144-32	22420-22422	1a	_	
144-33	22422-22423	)	_	
144-34	22423-22424	.	_	

#Text=An ROC is a visual representation of the sensitivity and specificity of the model.
145-1	22425-22427	An	_	
145-2	22428-22431	ROC	_	
145-3	22432-22434	is	_	
145-4	22435-22436	a	_	
145-5	22437-22443	visual	_	
145-6	22444-22458	representation	_	
145-7	22459-22461	of	_	
145-8	22462-22465	the	_	
145-9	22466-22477	sensitivity	_	
145-10	22478-22481	and	_	
145-11	22482-22493	specificity	_	
145-12	22494-22496	of	_	
145-13	22497-22500	the	_	
145-14	22501-22506	model	_	
145-15	22506-22507	.	_	

#Text=Sensitivity is the ability to correctly identify ASD subjects or the true positive rate (TPR).
146-1	22508-22519	Sensitivity	_	
146-2	22520-22522	is	_	
146-3	22523-22526	the	_	
146-4	22527-22534	ability	_	
146-5	22535-22537	to	_	
146-6	22538-22547	correctly	_	
146-7	22548-22556	identify	_	
146-8	22557-22560	ASD	_	
146-9	22561-22569	subjects	_	
146-10	22570-22572	or	_	
146-11	22573-22576	the	_	
146-12	22577-22581	true	_	
146-13	22582-22590	positive	_	
146-14	22591-22595	rate	_	
146-15	22596-22597	(	_	
146-16	22597-22600	TPR	_	
146-17	22600-22601	)	_	
146-18	22601-22602	.	_	

#Text=Specificity is the ability to correctly identify healthy individuals or 1 − false positive rate (1 − FPR).
147-1	22603-22614	Specificity	_	
147-2	22615-22617	is	_	
147-3	22618-22621	the	_	
147-4	22622-22629	ability	_	
147-5	22630-22632	to	_	
147-6	22633-22642	correctly	_	
147-7	22643-22651	identify	_	
147-8	22652-22659	healthy	_	
147-9	22660-22671	individuals	_	
147-10	22672-22674	or	_	
147-11	22675-22676	1	_	
147-12	22676-22677	 	_	
147-13	22677-22678	−	_	
147-14	22678-22679	 	_	
147-15	22679-22684	false	_	
147-16	22685-22693	positive	_	
147-17	22694-22698	rate	_	
147-18	22699-22700	(	_	
147-19	22700-22701	1	_	
147-20	22701-22702	 	_	
147-21	22702-22703	−	_	
147-22	22703-22704	 	_	
147-23	22704-22707	FPR	_	
147-24	22707-22708	)	_	
147-25	22708-22709	.	_	

#Text=A perfect model would have 100% sensitivity (TPR = 1) and specificity (FPR = 0).
148-1	22710-22711	A	_	
148-2	22712-22719	perfect	_	
148-3	22720-22725	model	_	
148-4	22726-22731	would	_	
148-5	22732-22736	have	_	
148-6	22737-22741	100%	_	
148-7	22742-22753	sensitivity	_	
148-8	22754-22755	(	_	
148-9	22755-22758	TPR	_	
148-10	22758-22759	 	_	
148-11	22759-22760	=	_	
148-12	22760-22761	 	_	
148-13	22761-22762	1	_	
148-14	22762-22763	)	_	
148-15	22764-22767	and	_	
148-16	22768-22779	specificity	_	
148-17	22780-22781	(	_	
148-18	22781-22784	FPR	_	
148-19	22784-22785	 	_	
148-20	22785-22786	=	_	
148-21	22786-22787	 	_	
148-22	22787-22788	0	_	
148-23	22788-22789	)	_	
148-24	22789-22790	.	_	

#Text=Note that the SVM was never trained on the test data set.
149-1	22791-22795	Note	_	
149-2	22796-22800	that	_	
149-3	22801-22804	the	_	
149-4	22805-22808	SVM	_	
149-5	22809-22812	was	_	
149-6	22813-22818	never	_	
149-7	22819-22826	trained	_	
149-8	22827-22829	on	_	
149-9	22830-22833	the	_	
149-10	22834-22838	test	_	
149-11	22839-22843	data	_	
149-12	22844-22847	set	_	
149-13	22847-22848	.	_	

#Text=Rather, SVM models generated on the training data set with different numbers of the top features identified through the RFE procedure were used to predict the identity of subjects in the ASD test data set.
150-1	22849-22855	Rather	_	
150-2	22855-22856	,	_	
150-3	22857-22860	SVM	_	
150-4	22861-22867	models	_	
150-5	22868-22877	generated	_	
150-6	22878-22880	on	_	
150-7	22881-22884	the	_	
150-8	22885-22893	training	_	
150-9	22894-22898	data	_	
150-10	22899-22902	set	_	
150-11	22903-22907	with	_	
150-12	22908-22917	different	_	
150-13	22918-22925	numbers	_	
150-14	22926-22928	of	_	
150-15	22929-22932	the	_	
150-16	22933-22936	top	_	
150-17	22937-22945	features	_	
150-18	22946-22956	identified	_	
150-19	22957-22964	through	_	
150-20	22965-22968	the	_	
150-21	22969-22972	RFE	_	
150-22	22973-22982	procedure	_	
150-23	22983-22987	were	_	
150-24	22988-22992	used	_	
150-25	22993-22995	to	_	
150-26	22996-23003	predict	_	
150-27	23004-23007	the	_	
150-28	23008-23016	identity	_	
150-29	23017-23019	of	_	
150-30	23020-23028	subjects	_	
150-31	23029-23031	in	_	
150-32	23032-23035	the	_	
150-33	23036-23039	ASD	_	
150-34	23040-23044	test	_	
150-35	23045-23049	data	_	
150-36	23050-23053	set	_	
150-37	23053-23054	.	_	

#Text=Over a range between 800 and 1000 of the top RFE-determined features, the models performed well, with accuracies of 83% (75% sensitivity and 89% specificity) on the ASD test data set (Table 1).
151-1	23055-23059	Over	_	
151-2	23060-23061	a	_	
151-3	23062-23067	range	_	
151-4	23068-23075	between	_	
151-5	23076-23079	800	_	
151-6	23080-23083	and	_	
151-7	23084-23088	1000	_	
151-8	23089-23091	of	_	
151-9	23092-23095	the	_	
151-10	23096-23099	top	_	
151-11	23100-23114	RFE-determined	_	
151-12	23115-23123	features	_	
151-13	23123-23124	,	_	
151-14	23125-23128	the	_	
151-15	23129-23135	models	_	
151-16	23136-23145	performed	_	
151-17	23146-23150	well	_	
151-18	23150-23151	,	_	
151-19	23152-23156	with	_	
151-20	23157-23167	accuracies	_	
151-21	23168-23170	of	_	
151-22	23171-23174	83%	_	
151-23	23175-23176	(	_	
151-24	23176-23179	75%	_	
151-25	23180-23191	sensitivity	_	
151-26	23192-23195	and	_	
151-27	23196-23199	89%	_	
151-28	23200-23211	specificity	_	
151-29	23211-23212	)	_	
151-30	23213-23215	on	_	
151-31	23216-23219	the	_	
151-32	23220-23223	ASD	_	
151-33	23224-23228	test	_	
151-34	23229-23233	data	_	
151-35	23234-23237	set	_	
151-36	23238-23239	(	_	
151-37	23239-23244	Table	_	
151-38	23245-23246	1	_	
151-39	23246-23247	)	_	
151-40	23247-23248	.	_	

#Text=Therefore these edges represent the features that are most diagnostic for ASD and generalize across data sets.
152-1	23249-23258	Therefore	_	
152-2	23259-23264	these	_	
152-3	23265-23270	edges	_	
152-4	23271-23280	represent	_	
152-5	23281-23284	the	_	
152-6	23285-23293	features	_	
152-7	23294-23298	that	_	
152-8	23299-23302	are	_	
152-9	23303-23307	most	_	
152-10	23308-23318	diagnostic	_	
152-11	23319-23322	for	_	
152-12	23323-23326	ASD	_	
152-13	23327-23330	and	_	
152-14	23331-23341	generalize	_	
152-15	23342-23348	across	_	
152-16	23349-23353	data	_	
152-17	23354-23358	sets	_	
152-18	23358-23359	.	_	

#Text=Diagnostic features are distributed across the brain and across networks, with the largest number of diagnostic features clustering within the default mode, salience and executive control networks, higher order visual and motor systems (Fig. 2a).
153-1	23360-23370	Diagnostic	_	
153-2	23371-23379	features	_	
153-3	23380-23383	are	_	
153-4	23384-23395	distributed	_	
153-5	23396-23402	across	_	
153-6	23403-23406	the	_	
153-7	23407-23412	brain	_	
153-8	23413-23416	and	_	
153-9	23417-23423	across	_	
153-10	23424-23432	networks	_	
153-11	23432-23433	,	_	
153-12	23434-23438	with	_	
153-13	23439-23442	the	_	
153-14	23443-23450	largest	_	
153-15	23451-23457	number	_	
153-16	23458-23460	of	_	
153-17	23461-23471	diagnostic	_	
153-18	23472-23480	features	_	
153-19	23481-23491	clustering	_	
153-20	23492-23498	within	_	
153-21	23499-23502	the	_	
153-22	23503-23510	default	_	
153-23	23511-23515	mode	_	
153-24	23515-23516	,	_	
153-25	23517-23525	salience	_	
153-26	23526-23529	and	_	
153-27	23530-23539	executive	_	
153-28	23540-23547	control	_	
153-29	23548-23556	networks	_	
153-30	23556-23557	,	_	
153-31	23558-23564	higher	_	
153-32	23565-23570	order	_	
153-33	23571-23577	visual	_	
153-34	23578-23581	and	_	
153-35	23582-23587	motor	_	
153-36	23588-23595	systems	_	
153-37	23596-23597	(	_	
153-38	23597-23600	Fig	_	
153-39	23600-23601	.	_	
153-40	23602-23604	2a	_	
153-41	23604-23605	)	_	
153-42	23605-23606	.	_	

#Text=Schizophrenia diagnostic features
#Text=Specificity and sensitivity for SZ classification on untrained data.
154-1	23607-23620	Schizophrenia	_	
154-2	23621-23631	diagnostic	_	
154-3	23632-23640	features	_	
154-4	23641-23652	Specificity	_	
154-5	23653-23656	and	_	
154-6	23657-23668	sensitivity	_	
154-7	23669-23672	for	_	
154-8	23673-23675	SZ	_	
154-9	23676-23690	classification	_	
154-10	23691-23693	on	_	
154-11	23694-23703	untrained	_	
154-12	23704-23708	data	_	
154-13	23708-23709	.	_	

#Text=Table 2\t \t
#Text=SZ\t \tNumber of features\tSpecificity\tSensitivity\tAccuracy\t \t12\t0.3\t0.4\t35.00%\t \t16\t0.8\t0.2\t50.00%\t \t22\t0.3\t0.7\t50.00%\t \t31\t0.3\t0.8\t55.00%\t \t45\t0.5\t0.8\t65.00%\t \t66\t0.4\t0.8\t60.00%\t \t99\t0.5\t0.7\t60.00%\t \t149\t0.6\t0.8\t70.00%\t \t225\t0.7\t8\t75.00%\t \t339\t0.7\t8\t75.00%\t \t514\t0.8\t0.8\t80.00%\t \t782\t0.8\t6\t70.00%\t \t1809\t0.7\t0.7\t70.00%\t \t2754\t0.7\t0.7\t70.00%\t \t4195\t0.8\t0.8\t80.00%\t \t5753\t0.8\t0.7\t75.00%\t \t
#Text=The RFE procedure was performed on the SZ COBRE training data set to classify SZ subjects from healthy controls.
155-1	23710-23715	Table	_	
155-2	23716-23717	2	_	
155-3	23721-23723	SZ	_	
155-4	23726-23732	Number	_	
155-5	23733-23735	of	_	
155-6	23736-23744	features	_	
155-7	23745-23756	Specificity	_	
155-8	23757-23768	Sensitivity	_	
155-9	23769-23777	Accuracy	_	
155-10	23780-23782	12	_	
155-11	23783-23786	0.3	_	
155-12	23787-23790	0.4	_	
155-13	23791-23797	35.00%	_	
155-14	23800-23802	16	_	
155-15	23803-23806	0.8	_	
155-16	23807-23810	0.2	_	
155-17	23811-23817	50.00%	_	
155-18	23820-23822	22	_	
155-19	23823-23826	0.3	_	
155-20	23827-23830	0.7	_	
155-21	23831-23837	50.00%	_	
155-22	23840-23842	31	_	
155-23	23843-23846	0.3	_	
155-24	23847-23850	0.8	_	
155-25	23851-23857	55.00%	_	
155-26	23860-23862	45	_	
155-27	23863-23866	0.5	_	
155-28	23867-23870	0.8	_	
155-29	23871-23877	65.00%	_	
155-30	23880-23882	66	_	
155-31	23883-23886	0.4	_	
155-32	23887-23890	0.8	_	
155-33	23891-23897	60.00%	_	
155-34	23900-23902	99	_	
155-35	23903-23906	0.5	_	
155-36	23907-23910	0.7	_	
155-37	23911-23917	60.00%	_	
155-38	23920-23923	149	_	
155-39	23924-23927	0.6	_	
155-40	23928-23931	0.8	_	
155-41	23932-23938	70.00%	_	
155-42	23941-23944	225	_	
155-43	23945-23948	0.7	_	
155-44	23949-23950	8	_	
155-45	23951-23957	75.00%	_	
155-46	23960-23963	339	_	
155-47	23964-23967	0.7	_	
155-48	23968-23969	8	_	
155-49	23970-23976	75.00%	_	
155-50	23979-23982	514	_	
155-51	23983-23986	0.8	_	
155-52	23987-23990	0.8	_	
155-53	23991-23997	80.00%	_	
155-54	24000-24003	782	_	
155-55	24004-24007	0.8	_	
155-56	24008-24009	6	_	
155-57	24010-24016	70.00%	_	
155-58	24019-24023	1809	_	
155-59	24024-24027	0.7	_	
155-60	24028-24031	0.7	_	
155-61	24032-24038	70.00%	_	
155-62	24041-24045	2754	_	
155-63	24046-24049	0.7	_	
155-64	24050-24053	0.7	_	
155-65	24054-24060	70.00%	_	
155-66	24063-24067	4195	_	
155-67	24068-24071	0.8	_	
155-68	24072-24075	0.8	_	
155-69	24076-24082	80.00%	_	
155-70	24085-24089	5753	_	
155-71	24090-24093	0.8	_	
155-72	24094-24097	0.7	_	
155-73	24098-24104	75.00%	_	
155-74	24108-24111	The	_	
155-75	24112-24115	RFE	_	
155-76	24116-24125	procedure	_	
155-77	24126-24129	was	_	
155-78	24130-24139	performed	_	
155-79	24140-24142	on	_	
155-80	24143-24146	the	_	
155-81	24147-24149	SZ	_	
155-82	24150-24155	COBRE	_	
155-83	24156-24164	training	_	
155-84	24165-24169	data	_	
155-85	24170-24173	set	_	
155-86	24174-24176	to	_	
155-87	24177-24185	classify	_	
155-88	24186-24188	SZ	_	
155-89	24189-24197	subjects	_	
155-90	24198-24202	from	_	
155-91	24203-24210	healthy	_	
155-92	24211-24219	controls	_	
155-93	24219-24220	.	_	

#Text=SVM models using these features on the training set were created by training an SVM on the SZ training data using the top 165–4500 features.
156-1	24221-24224	SVM	_	
156-2	24225-24231	models	_	
156-3	24232-24237	using	_	
156-4	24238-24243	these	_	
156-5	24244-24252	features	_	
156-6	24253-24255	on	_	
156-7	24256-24259	the	_	
156-8	24260-24268	training	_	
156-9	24269-24272	set	_	
156-10	24273-24277	were	_	
156-11	24278-24285	created	_	
156-12	24286-24288	by	_	
156-13	24289-24297	training	_	
156-14	24298-24300	an	_	
156-15	24301-24304	SVM	_	
156-16	24305-24307	on	_	
156-17	24308-24311	the	_	
156-18	24312-24314	SZ	_	
156-19	24315-24323	training	_	
156-20	24324-24328	data	_	
156-21	24329-24334	using	_	
156-22	24335-24338	the	_	
156-23	24339-24342	top	_	
156-24	24343-24346	165	_	
156-25	24346-24347	–	_	
156-26	24347-24351	4500	_	
156-27	24352-24360	features	_	
156-28	24360-24361	.	_	

#Text=These features were then used to predict SZ patients in the training-naive SZ test data set.
157-1	24362-24367	These	_	
157-2	24368-24376	features	_	
157-3	24377-24381	were	_	
157-4	24382-24386	then	_	
157-5	24387-24391	used	_	
157-6	24392-24394	to	_	
157-7	24395-24402	predict	_	
157-8	24403-24405	SZ	_	
157-9	24406-24414	patients	_	
157-10	24415-24417	in	_	
157-11	24418-24421	the	_	
157-12	24422-24436	training-naive	_	
157-13	24437-24439	SZ	_	
157-14	24440-24444	test	_	
157-15	24445-24449	data	_	
157-16	24450-24453	set	_	
157-17	24453-24454	.	_	

#Text=ROC curves were generated to show the classification performance on the test data set as a function of the number RFE features used (Fig. 1b).
158-1	24455-24458	ROC	_	
158-2	24459-24465	curves	_	
158-3	24466-24470	were	_	
158-4	24471-24480	generated	_	
158-5	24481-24483	to	_	
158-6	24484-24488	show	_	
158-7	24489-24492	the	_	
158-8	24493-24507	classification	_	
158-9	24508-24519	performance	_	
158-10	24520-24522	on	_	
158-11	24523-24526	the	_	
158-12	24527-24531	test	_	
158-13	24532-24536	data	_	
158-14	24537-24540	set	_	
158-15	24541-24543	as	_	
158-16	24544-24545	a	_	
158-17	24546-24554	function	_	
158-18	24555-24557	of	_	
158-19	24558-24561	the	_	
158-20	24562-24568	number	_	
158-21	24569-24572	RFE	_	
158-22	24573-24581	features	_	
158-23	24582-24586	used	_	
158-24	24587-24588	(	_	
158-25	24588-24591	Fig	_	
158-26	24591-24592	.	_	
158-27	24593-24595	1b	_	
158-28	24595-24596	)	_	
158-29	24596-24597	.	_	

#Text=Again, the SVM was never trained on the SZ test data set.
159-1	24598-24603	Again	_	
159-2	24603-24604	,	_	
159-3	24605-24608	the	_	
159-4	24609-24612	SVM	_	
159-5	24613-24616	was	_	
159-6	24617-24622	never	_	
159-7	24623-24630	trained	_	
159-8	24631-24633	on	_	
159-9	24634-24637	the	_	
159-10	24638-24640	SZ	_	
159-11	24641-24645	test	_	
159-12	24646-24650	data	_	
159-13	24651-24654	set	_	
159-14	24654-24655	.	_	

#Text=Models generated on the training data set with different numbers of the top features identified through the RFE procedure were used to predict the identity of subjects in the SZ testing data set.
160-1	24656-24662	Models	_	
160-2	24663-24672	generated	_	
160-3	24673-24675	on	_	
160-4	24676-24679	the	_	
160-5	24680-24688	training	_	
160-6	24689-24693	data	_	
160-7	24694-24697	set	_	
160-8	24698-24702	with	_	
160-9	24703-24712	different	_	
160-10	24713-24720	numbers	_	
160-11	24721-24723	of	_	
160-12	24724-24727	the	_	
160-13	24728-24731	top	_	
160-14	24732-24740	features	_	
160-15	24741-24751	identified	_	
160-16	24752-24759	through	_	
160-17	24760-24763	the	_	
160-18	24764-24767	RFE	_	
160-19	24768-24777	procedure	_	
160-20	24778-24782	were	_	
160-21	24783-24787	used	_	
160-22	24788-24790	to	_	
160-23	24791-24798	predict	_	
160-24	24799-24802	the	_	
160-25	24803-24811	identity	_	
160-26	24812-24814	of	_	
160-27	24815-24823	subjects	_	
160-28	24824-24826	in	_	
160-29	24827-24830	the	_	
160-30	24831-24833	SZ	_	
160-31	24834-24841	testing	_	
160-32	24842-24846	data	_	
160-33	24847-24850	set	_	
160-34	24850-24851	.	_	

#Text=Fewer features were required to achieve good classification in the SZ test validation data set than in the ASD test validation set.
161-1	24852-24857	Fewer	_	
161-2	24858-24866	features	_	
161-3	24867-24871	were	_	
161-4	24872-24880	required	_	
161-5	24881-24883	to	_	
161-6	24884-24891	achieve	_	
161-7	24892-24896	good	_	
161-8	24897-24911	classification	_	
161-9	24912-24914	in	_	
161-10	24915-24918	the	_	
161-11	24919-24921	SZ	_	
161-12	24922-24926	test	_	
161-13	24927-24937	validation	_	
161-14	24938-24942	data	_	
161-15	24943-24946	set	_	
161-16	24947-24951	than	_	
161-17	24952-24954	in	_	
161-18	24955-24958	the	_	
161-19	24959-24962	ASD	_	
161-20	24963-24967	test	_	
161-21	24968-24978	validation	_	
161-22	24979-24982	set	_	
161-23	24982-24983	.	_	

#Text=Over a range between 400 and 600 of the top RFE-determined features the models performed very well, achieving accuracy of 80% (80% sensitivity and 80% specificity) on the test SZ data set (Table 2).
162-1	24984-24988	Over	_	
162-2	24989-24990	a	_	
162-3	24991-24996	range	_	
162-4	24997-25004	between	_	
162-5	25005-25008	400	_	
162-6	25009-25012	and	_	
162-7	25013-25016	600	_	
162-8	25017-25019	of	_	
162-9	25020-25023	the	_	
162-10	25024-25027	top	_	
162-11	25028-25042	RFE-determined	_	
162-12	25043-25051	features	_	
162-13	25052-25055	the	_	
162-14	25056-25062	models	_	
162-15	25063-25072	performed	_	
162-16	25073-25077	very	_	
162-17	25078-25082	well	_	
162-18	25082-25083	,	_	
162-19	25084-25093	achieving	_	
162-20	25094-25102	accuracy	_	
162-21	25103-25105	of	_	
162-22	25106-25109	80%	_	
162-23	25110-25111	(	_	
162-24	25111-25114	80%	_	
162-25	25115-25126	sensitivity	_	
162-26	25127-25130	and	_	
162-27	25131-25134	80%	_	
162-28	25135-25146	specificity	_	
162-29	25146-25147	)	_	
162-30	25148-25150	on	_	
162-31	25151-25154	the	_	
162-32	25155-25159	test	_	
162-33	25160-25162	SZ	_	
162-34	25163-25167	data	_	
162-35	25168-25171	set	_	
162-36	25172-25173	(	_	
162-37	25173-25178	Table	_	
162-38	25179-25180	2	_	
162-39	25180-25181	)	_	
162-40	25181-25182	.	_	

#Text=These edges are those features that are most diagnostic for SZ across data sets.
163-1	25183-25188	These	_	
163-2	25189-25194	edges	_	
163-3	25195-25198	are	_	
163-4	25199-25204	those	_	
163-5	25205-25213	features	_	
163-6	25214-25218	that	_	
163-7	25219-25222	are	_	
163-8	25223-25227	most	_	
163-9	25228-25238	diagnostic	_	
163-10	25239-25242	for	_	
163-11	25243-25245	SZ	_	
163-12	25246-25252	across	_	
163-13	25253-25257	data	_	
163-14	25258-25262	sets	_	
163-15	25262-25263	.	_	

#Text=Diagnostic features had the largest contributions from the DMN, salience network, and sensory-motor cortices (Fig. 2b).
164-1	25264-25274	Diagnostic	_	
164-2	25275-25283	features	_	
164-3	25284-25287	had	_	
164-4	25288-25291	the	_	
164-5	25292-25299	largest	_	
164-6	25300-25313	contributions	_	
164-7	25314-25318	from	_	
164-8	25319-25322	the	_	
164-9	25323-25326	DMN	_	
164-10	25326-25327	,	_	
164-11	25328-25336	salience	_	
164-12	25337-25344	network	_	
164-13	25344-25345	,	_	
164-14	25346-25349	and	_	
164-15	25350-25363	sensory-motor	_	
164-16	25364-25372	cortices	_	
164-17	25373-25374	(	_	
164-18	25374-25377	Fig	_	
164-19	25377-25378	.	_	
164-20	25379-25381	2b	_	
164-21	25381-25382	)	_	
164-22	25382-25383	.	_	

#Text=ASD and SZ common features
#Text=Features common to both the ASD and SZ models relative to the common control group.
165-1	25384-25387	ASD	_	
165-2	25388-25391	and	_	
165-3	25392-25394	SZ	_	
165-4	25395-25401	common	_	
165-5	25402-25410	features	_	
165-6	25411-25419	Features	_	
165-7	25420-25426	common	_	
165-8	25427-25429	to	_	
165-9	25430-25434	both	_	
165-10	25435-25438	the	_	
165-11	25439-25442	ASD	_	
165-12	25443-25446	and	_	
165-13	25447-25449	SZ	_	
165-14	25450-25456	models	_	
165-15	25457-25465	relative	_	
165-16	25466-25468	to	_	
165-17	25469-25472	the	_	
165-18	25473-25479	common	_	
165-19	25480-25487	control	_	
165-20	25488-25493	group	_	
165-21	25493-25494	.	_	

#Text=Diagonal elements represent within network edges between different regions of the same network.
166-1	25495-25503	Diagonal	_	
166-2	25504-25512	elements	_	
166-3	25513-25522	represent	_	
166-4	25523-25529	within	_	
166-5	25530-25537	network	_	
166-6	25538-25543	edges	_	
166-7	25544-25551	between	_	
166-8	25552-25561	different	_	
166-9	25562-25569	regions	_	
166-10	25570-25572	of	_	
166-11	25573-25576	the	_	
166-12	25577-25581	same	_	
166-13	25582-25589	network	_	
166-14	25589-25590	.	_	

#Text=Numbers represent the number of features within and between networks while the size/colors indicate the ratio of those features that represent increases rather than decreases in connectivity strength relative to controls.
167-1	25591-25598	Numbers	_	
167-2	25599-25608	represent	_	
167-3	25609-25612	the	_	
167-4	25613-25619	number	_	
167-5	25620-25622	of	_	
167-6	25623-25631	features	_	
167-7	25632-25638	within	_	
167-8	25639-25642	and	_	
167-9	25643-25650	between	_	
167-10	25651-25659	networks	_	
167-11	25660-25665	while	_	
167-12	25666-25669	the	_	
167-13	25670-25674	size	_	
167-14	25674-25675	/	_	
167-15	25675-25681	colors	_	
167-16	25682-25690	indicate	_	
167-17	25691-25694	the	_	
167-18	25695-25700	ratio	_	
167-19	25701-25703	of	_	
167-20	25704-25709	those	_	
167-21	25710-25718	features	_	
167-22	25719-25723	that	_	
167-23	25724-25733	represent	_	
167-24	25734-25743	increases	_	
167-25	25744-25750	rather	_	
167-26	25751-25755	than	_	
167-27	25756-25765	decreases	_	
167-28	25766-25768	in	_	
167-29	25769-25781	connectivity	_	
167-30	25782-25790	strength	_	
167-31	25791-25799	relative	_	
167-32	25800-25802	to	_	
167-33	25803-25811	controls	_	
167-34	25811-25812	.	_	

#Text=Larger circles/yellow colors indicate a greater proportion of connectivity increases and red a greater proportion of decreases for a) ASD and b) SZ.
168-1	25813-25819	Larger	_	
168-2	25820-25827	circles	_	
168-3	25827-25828	/	_	
168-4	25828-25834	yellow	_	
168-5	25835-25841	colors	_	
168-6	25842-25850	indicate	_	
168-7	25851-25852	a	_	
168-8	25853-25860	greater	_	
168-9	25861-25871	proportion	_	
168-10	25872-25874	of	_	
168-11	25875-25887	connectivity	_	
168-12	25888-25897	increases	_	
168-13	25898-25901	and	_	
168-14	25902-25905	red	_	
168-15	25906-25907	a	_	
168-16	25908-25915	greater	_	
168-17	25916-25926	proportion	_	
168-18	25927-25929	of	_	
168-19	25930-25939	decreases	_	
168-20	25940-25943	for	_	
168-21	25944-25945	a	_	
168-22	25945-25946	)	_	
168-23	25947-25950	ASD	_	
168-24	25951-25954	and	_	
168-25	25955-25956	b	_	
168-26	25956-25957	)	_	
168-27	25958-25960	SZ	_	
168-28	25960-25961	.	_	

#Text=Total number of features per network is indicated in the left column.
169-1	25962-25967	Total	_	
169-2	25968-25974	number	_	
169-3	25975-25977	of	_	
169-4	25978-25986	features	_	
169-5	25987-25990	per	_	
169-6	25991-25998	network	_	
169-7	25999-26001	is	_	
169-8	26002-26011	indicated	_	
169-9	26012-26014	in	_	
169-10	26015-26018	the	_	
169-11	26019-26023	left	_	
169-12	26024-26030	column	_	
169-13	26030-26031	.	_	

#Text=Overall pattern of connectivity changes in common features across networks are similar for both ASD and SZ.
170-1	26032-26039	Overall	_	
170-2	26040-26047	pattern	_	
170-3	26048-26050	of	_	
170-4	26051-26063	connectivity	_	
170-5	26064-26071	changes	_	
170-6	26072-26074	in	_	
170-7	26075-26081	common	_	
170-8	26082-26090	features	_	
170-9	26091-26097	across	_	
170-10	26098-26106	networks	_	
170-11	26107-26110	are	_	
170-12	26111-26118	similar	_	
170-13	26119-26122	for	_	
170-14	26123-26127	both	_	
170-15	26128-26131	ASD	_	
170-16	26132-26135	and	_	
170-17	26136-26138	SZ	_	
170-18	26138-26139	.	_	

#Text=Fig. 3
#Text=Common features of ASD and SZ models.
171-1	26140-26143	Fig	_	
171-2	26143-26144	.	_	
171-3	26145-26146	3	_	
171-4	26147-26153	Common	_	
171-5	26154-26162	features	_	
171-6	26163-26165	of	_	
171-7	26166-26169	ASD	_	
171-8	26170-26173	and	_	
171-9	26174-26176	SZ	_	
171-10	26177-26183	models	_	
171-11	26183-26184	.	_	

#Text=Common diagnostic features across the disorders are concentrated within the sensory-motor cortex, executive control, salience and default mode networks and cluster in the left hemisphere.
172-1	26185-26191	Common	_	
172-2	26192-26202	diagnostic	_	
172-3	26203-26211	features	_	
172-4	26212-26218	across	_	
172-5	26219-26222	the	_	
172-6	26223-26232	disorders	_	
172-7	26233-26236	are	_	
172-8	26237-26249	concentrated	_	
172-9	26250-26256	within	_	
172-10	26257-26260	the	_	
172-11	26261-26274	sensory-motor	_	
172-12	26275-26281	cortex	_	
172-13	26281-26282	,	_	
172-14	26283-26292	executive	_	
172-15	26293-26300	control	_	
172-16	26300-26301	,	_	
172-17	26302-26310	salience	_	
172-18	26311-26314	and	_	
172-19	26315-26322	default	_	
172-20	26323-26327	mode	_	
172-21	26328-26336	networks	_	
172-22	26337-26340	and	_	
172-23	26341-26348	cluster	_	
172-24	26349-26351	in	_	
172-25	26352-26355	the	_	
172-26	26356-26360	left	_	
172-27	26361-26371	hemisphere	_	
172-28	26371-26372	.	_	

#Text=Fig. 4
#Text=After training SVMs for ASD and SZ against the common control group, we found just under 100 features common to both models.
173-1	26373-26376	Fig	_	
173-2	26376-26377	.	_	
173-3	26378-26379	4	_	
173-4	26380-26385	After	_	
173-5	26386-26394	training	_	
173-6	26395-26399	SVMs	_	
173-7	26400-26403	for	_	
173-8	26404-26407	ASD	_	
173-9	26408-26411	and	_	
173-10	26412-26414	SZ	_	
173-11	26415-26422	against	_	
173-12	26423-26426	the	_	
173-13	26427-26433	common	_	
173-14	26434-26441	control	_	
173-15	26442-26447	group	_	
173-16	26447-26448	,	_	
173-17	26449-26451	we	_	
173-18	26452-26457	found	_	
173-19	26458-26462	just	_	
173-20	26463-26468	under	_	
173-21	26469-26472	100	_	
173-22	26473-26481	features	_	
173-23	26482-26488	common	_	
173-24	26489-26491	to	_	
173-25	26492-26496	both	_	
173-26	26497-26503	models	_	
173-27	26503-26504	.	_	

#Text=Common features are the graph model edge weights whose values are diagnostic for both disorders, but common features may not necessarily be increases (or decreases) relative to controls for both disorders.
174-1	26505-26511	Common	_	
174-2	26512-26520	features	_	
174-3	26521-26524	are	_	
174-4	26525-26528	the	_	
174-5	26529-26534	graph	_	
174-6	26535-26540	model	_	
174-7	26541-26545	edge	_	
174-8	26546-26553	weights	_	
174-9	26554-26559	whose	_	
174-10	26560-26566	values	_	
174-11	26567-26570	are	_	
174-12	26571-26581	diagnostic	_	
174-13	26582-26585	for	_	
174-14	26586-26590	both	_	
174-15	26591-26600	disorders	_	
174-16	26600-26601	,	_	
174-17	26602-26605	but	_	
174-18	26606-26612	common	_	
174-19	26613-26621	features	_	
174-20	26622-26625	may	_	
174-21	26626-26629	not	_	
174-22	26630-26641	necessarily	_	
174-23	26642-26644	be	_	
174-24	26645-26654	increases	_	
174-25	26655-26656	(	_	
174-26	26656-26658	or	_	
174-27	26659-26668	decreases	_	
174-28	26668-26669	)	_	
174-29	26670-26678	relative	_	
174-30	26679-26681	to	_	
174-31	26682-26690	controls	_	
174-32	26691-26694	for	_	
174-33	26695-26699	both	_	
174-34	26700-26709	disorders	_	
174-35	26709-26710	.	_	

#Text=It is possible for a common feature to be indicative of increased connectivity in one disorder and decreased connectivity in the other.
175-1	26711-26713	It	_	
175-2	26714-26716	is	_	
175-3	26717-26725	possible	_	
175-4	26726-26729	for	_	
175-5	26730-26731	a	_	
175-6	26732-26738	common	_	
175-7	26739-26746	feature	_	
175-8	26747-26749	to	_	
175-9	26750-26752	be	_	
175-10	26753-26763	indicative	_	
175-11	26764-26766	of	_	
175-12	26767-26776	increased	_	
175-13	26777-26789	connectivity	_	
175-14	26790-26792	in	_	
175-15	26793-26796	one	_	
175-16	26797-26805	disorder	_	
175-17	26806-26809	and	_	
175-18	26810-26819	decreased	_	
175-19	26820-26832	connectivity	_	
175-20	26833-26835	in	_	
175-21	26836-26839	the	_	
175-22	26840-26845	other	_	
175-23	26845-26846	.	_	

#Text=However, the overall pattern of connectivity changes in common features across networks are similar for both ASD and SZ, with similar patterns of increases relative to decreases.
176-1	26847-26854	However	_	
176-2	26854-26855	,	_	
176-3	26856-26859	the	_	
176-4	26860-26867	overall	_	
176-5	26868-26875	pattern	_	
176-6	26876-26878	of	_	
176-7	26879-26891	connectivity	_	
176-8	26892-26899	changes	_	
176-9	26900-26902	in	_	
176-10	26903-26909	common	_	
176-11	26910-26918	features	_	
176-12	26919-26925	across	_	
176-13	26926-26934	networks	_	
176-14	26935-26938	are	_	
176-15	26939-26946	similar	_	
176-16	26947-26950	for	_	
176-17	26951-26955	both	_	
176-18	26956-26959	ASD	_	
176-19	26960-26963	and	_	
176-20	26964-26966	SZ	_	
176-21	26966-26967	,	_	
176-22	26968-26972	with	_	
176-23	26973-26980	similar	_	
176-24	26981-26989	patterns	_	
176-25	26990-26992	of	_	
176-26	26993-27002	increases	_	
176-27	27003-27011	relative	_	
176-28	27012-27014	to	_	
176-29	27015-27024	decreases	_	
176-30	27024-27025	.	_	

#Text=A small number of features such as those between the salience and ECN networks indicated a greater proportion of increases than decreases for SZ as compared to ASD subjects.
177-1	27026-27027	A	_	
177-2	27028-27033	small	_	
177-3	27034-27040	number	_	
177-4	27041-27043	of	_	
177-5	27044-27052	features	_	
177-6	27053-27057	such	_	
177-7	27058-27060	as	_	
177-8	27061-27066	those	_	
177-9	27067-27074	between	_	
177-10	27075-27078	the	_	
177-11	27079-27087	salience	_	
177-12	27088-27091	and	_	
177-13	27092-27095	ECN	_	
177-14	27096-27104	networks	_	
177-15	27105-27114	indicated	_	
177-16	27115-27116	a	_	
177-17	27117-27124	greater	_	
177-18	27125-27135	proportion	_	
177-19	27136-27138	of	_	
177-20	27139-27148	increases	_	
177-21	27149-27153	than	_	
177-22	27154-27163	decreases	_	
177-23	27164-27167	for	_	
177-24	27168-27170	SZ	_	
177-25	27171-27173	as	_	
177-26	27174-27182	compared	_	
177-27	27183-27185	to	_	
177-28	27186-27189	ASD	_	
177-29	27190-27198	subjects	_	
177-30	27198-27199	.	_	

#Text=The number of increases relative to decreases in these features is shown for ASD in Fig. 3a and for SZ in Fig. 3b.
178-1	27200-27203	The	_	
178-2	27204-27210	number	_	
178-3	27211-27213	of	_	
178-4	27214-27223	increases	_	
178-5	27224-27232	relative	_	
178-6	27233-27235	to	_	
178-7	27236-27245	decreases	_	
178-8	27246-27248	in	_	
178-9	27249-27254	these	_	
178-10	27255-27263	features	_	
178-11	27264-27266	is	_	
178-12	27267-27272	shown	_	
178-13	27273-27276	for	_	
178-14	27277-27280	ASD	_	
178-15	27281-27283	in	_	
178-16	27284-27287	Fig	_	
178-17	27287-27288	.	_	
178-18	27289-27291	3a	_	
178-19	27292-27295	and	_	
178-20	27296-27299	for	_	
178-21	27300-27302	SZ	_	
178-22	27303-27305	in	_	
178-23	27306-27309	Fig	_	
178-24	27309-27310	.	_	
178-25	27311-27313	3b	_	
178-26	27313-27314	.	_	

#Text=About half of the common features are within-network connectivity differences (changes in connectivity between spatially disparate regions of the same network) shown along the diagonal in Fig. 3.
179-1	27315-27320	About	_	
179-2	27321-27325	half	_	
179-3	27326-27328	of	_	
179-4	27329-27332	the	_	
179-5	27333-27339	common	_	
179-6	27340-27348	features	_	
179-7	27349-27352	are	_	
179-8	27353-27367	within-network	_	
179-9	27368-27380	connectivity	_	
179-10	27381-27392	differences	_	
179-11	27393-27394	(	_	
179-12	27394-27401	changes	_	
179-13	27402-27404	in	_	
179-14	27405-27417	connectivity	_	
179-15	27418-27425	between	_	
179-16	27426-27435	spatially	_	
179-17	27436-27445	disparate	_	
179-18	27446-27453	regions	_	
179-19	27454-27456	of	_	
179-20	27457-27460	the	_	
179-21	27461-27465	same	_	
179-22	27466-27473	network	_	
179-23	27473-27474	)	_	
179-24	27475-27480	shown	_	
179-25	27481-27486	along	_	
179-26	27487-27490	the	_	
179-27	27491-27499	diagonal	_	
179-28	27500-27502	in	_	
179-29	27503-27506	Fig	_	
179-30	27506-27507	.	_	
179-31	27508-27509	3	_	
179-32	27509-27510	.	_	

#Text=Common diagnostic features across the disorders are concentrated within the sensory-motor cortex, executive control, salience and default mode networks and were visualized (Fig. 4) using BrainNet Viewer (http://www.nitrc.org/projects/bnv/).
180-1	27511-27517	Common	_	
180-2	27518-27528	diagnostic	_	
180-3	27529-27537	features	_	
180-4	27538-27544	across	_	
180-5	27545-27548	the	_	
180-6	27549-27558	disorders	_	
180-7	27559-27562	are	_	
180-8	27563-27575	concentrated	_	
180-9	27576-27582	within	_	
180-10	27583-27586	the	_	
180-11	27587-27600	sensory-motor	_	
180-12	27601-27607	cortex	_	
180-13	27607-27608	,	_	
180-14	27609-27618	executive	_	
180-15	27619-27626	control	_	
180-16	27626-27627	,	_	
180-17	27628-27636	salience	_	
180-18	27637-27640	and	_	
180-19	27641-27648	default	_	
180-20	27649-27653	mode	_	
180-21	27654-27662	networks	_	
180-22	27663-27666	and	_	
180-23	27667-27671	were	_	
180-24	27672-27682	visualized	_	
180-25	27683-27684	(	_	
180-26	27684-27687	Fig	_	
180-27	27687-27688	.	_	
180-28	27689-27690	4	_	
180-29	27690-27691	)	_	
180-30	27692-27697	using	_	
180-31	27698-27706	BrainNet	_	
180-32	27707-27713	Viewer	_	
180-33	27714-27715	(	_	
180-34	27715-27719	http	_	
180-35	27719-27720	:	_	
180-36	27720-27721	/	_	
180-37	27721-27722	/	_	
180-38	27722-27735	www.nitrc.org	_	
180-39	27735-27736	/	_	
180-40	27736-27744	projects	_	
180-41	27744-27745	/	_	
180-42	27745-27748	bnv	_	
180-43	27748-27749	/	_	
180-44	27749-27750	)	_	
180-45	27750-27751	.	_	

#Text=Features common to ASD and SZ predict deficits in ASD communication skills
#Text=Symptom severity scores for SZ patients were not available in the COBRE and Rutgers data sets.
181-1	27752-27760	Features	_	
181-2	27761-27767	common	_	
181-3	27768-27770	to	_	
181-4	27771-27774	ASD	_	
181-5	27775-27778	and	_	
181-6	27779-27781	SZ	_	
181-7	27782-27789	predict	_	
181-8	27790-27798	deficits	_	
181-9	27799-27801	in	_	
181-10	27802-27805	ASD	_	
181-11	27806-27819	communication	_	
181-12	27820-27826	skills	_	
181-13	27827-27834	Symptom	_	
181-14	27835-27843	severity	_	
181-15	27844-27850	scores	_	
181-16	27851-27854	for	_	
181-17	27855-27857	SZ	_	
181-18	27858-27866	patients	_	
181-19	27867-27871	were	_	
181-20	27872-27875	not	_	
181-21	27876-27885	available	_	
181-22	27886-27888	in	_	
181-23	27889-27892	the	_	
181-24	27893-27898	COBRE	_	
181-25	27899-27902	and	_	
181-26	27903-27910	Rutgers	_	
181-27	27911-27915	data	_	
181-28	27916-27920	sets	_	
181-29	27920-27921	.	_	

#Text=A variety of cognitive assessments were available for ASD patients in the ABIDE data set.
182-1	27922-27923	A	_	
182-2	27924-27931	variety	_	
182-3	27932-27934	of	_	
182-4	27935-27944	cognitive	_	
182-5	27945-27956	assessments	_	
182-6	27957-27961	were	_	
182-7	27962-27971	available	_	
182-8	27972-27975	for	_	
182-9	27976-27979	ASD	_	
182-10	27980-27988	patients	_	
182-11	27989-27991	in	_	
182-12	27992-27995	the	_	
182-13	27996-28001	ABIDE	_	
182-14	28002-28006	data	_	
182-15	28007-28010	set	_	
182-16	28010-28011	.	_	

#Text=Because social deficits are common to both ASD and SZ, we looked for relationships between edge weight strengths in the edges common to both the SZ and ASD models and scores of social and communication deficits in ASD subjects.
183-1	28012-28019	Because	_	
183-2	28020-28026	social	_	
183-3	28027-28035	deficits	_	
183-4	28036-28039	are	_	
183-5	28040-28046	common	_	
183-6	28047-28049	to	_	
183-7	28050-28054	both	_	
183-8	28055-28058	ASD	_	
183-9	28059-28062	and	_	
183-10	28063-28065	SZ	_	
183-11	28065-28066	,	_	
183-12	28067-28069	we	_	
183-13	28070-28076	looked	_	
183-14	28077-28080	for	_	
183-15	28081-28094	relationships	_	
183-16	28095-28102	between	_	
183-17	28103-28107	edge	_	
183-18	28108-28114	weight	_	
183-19	28115-28124	strengths	_	
183-20	28125-28127	in	_	
183-21	28128-28131	the	_	
183-22	28132-28137	edges	_	
183-23	28138-28144	common	_	
183-24	28145-28147	to	_	
183-25	28148-28152	both	_	
183-26	28153-28156	the	_	
183-27	28157-28159	SZ	_	
183-28	28160-28163	and	_	
183-29	28164-28167	ASD	_	
183-30	28168-28174	models	_	
183-31	28175-28178	and	_	
183-32	28179-28185	scores	_	
183-33	28186-28188	of	_	
183-34	28189-28195	social	_	
183-35	28196-28199	and	_	
183-36	28200-28213	communication	_	
183-37	28214-28222	deficits	_	
183-38	28223-28225	in	_	
183-39	28226-28229	ASD	_	
183-40	28230-28238	subjects	_	
183-41	28238-28239	.	_	

#Text=We compared average edge weights of ASD patients relative to controls over the common features to the autism diagnostic observation schedule (ADOS), a standardized assessment of social and communicative abilities.
184-1	28240-28242	We	_	
184-2	28243-28251	compared	_	
184-3	28252-28259	average	_	
184-4	28260-28264	edge	_	
184-5	28265-28272	weights	_	
184-6	28273-28275	of	_	
184-7	28276-28279	ASD	_	
184-8	28280-28288	patients	_	
184-9	28289-28297	relative	_	
184-10	28298-28300	to	_	
184-11	28301-28309	controls	_	
184-12	28310-28314	over	_	
184-13	28315-28318	the	_	
184-14	28319-28325	common	_	
184-15	28326-28334	features	_	
184-16	28335-28337	to	_	
184-17	28338-28341	the	_	
184-18	28342-28348	autism	_	
184-19	28349-28359	diagnostic	_	
184-20	28360-28371	observation	_	
184-21	28372-28380	schedule	_	
184-22	28381-28382	(	_	
184-23	28382-28386	ADOS	_	
184-24	28386-28387	)	_	
184-25	28387-28388	,	_	
184-26	28389-28390	a	_	
184-27	28391-28403	standardized	_	
184-28	28404-28414	assessment	_	
184-29	28415-28417	of	_	
184-30	28418-28424	social	_	
184-31	28425-28428	and	_	
184-32	28429-28442	communicative	_	
184-33	28443-28452	abilities	_	
184-34	28452-28453	.	_	

#Text=Differences in edge weights of the common edges between the two models significantly predicted ADOS social scores, b = −17.24, t(35) = −2.054, p < .05; R2 = 0.11, F(1,35) = 4.219, p < .05.
185-1	28454-28465	Differences	_	
185-2	28466-28468	in	_	
185-3	28469-28473	edge	_	
185-4	28474-28481	weights	_	
185-5	28482-28484	of	_	
185-6	28485-28488	the	_	
185-7	28489-28495	common	_	
185-8	28496-28501	edges	_	
185-9	28502-28509	between	_	
185-10	28510-28513	the	_	
185-11	28514-28517	two	_	
185-12	28518-28524	models	_	
185-13	28525-28538	significantly	_	
185-14	28539-28548	predicted	_	
185-15	28549-28553	ADOS	_	
185-16	28554-28560	social	_	
185-17	28561-28567	scores	_	
185-18	28567-28568	,	_	
185-19	28569-28570	b	_	
185-20	28570-28571	 	_	
185-21	28571-28572	=	_	
185-22	28572-28573	 	_	
185-23	28573-28574	−	_	
185-24	28574-28579	17.24	_	
185-25	28579-28580	,	_	
185-26	28581-28582	t	_	
185-27	28582-28583	(	_	
185-28	28583-28585	35	_	
185-29	28585-28586	)	_	
185-30	28586-28587	 	_	
185-31	28587-28588	=	_	
185-32	28588-28589	 	_	
185-33	28589-28590	−	_	
185-34	28590-28595	2.054	_	
185-35	28595-28596	,	_	
185-36	28597-28598	p	_	
185-37	28598-28599	 	_	
185-38	28599-28600	<	_	
185-39	28600-28601	 	_	
185-40	28601-28604	.05	_	
185-41	28604-28605	;	_	
185-42	28606-28608	R2	_	
185-43	28608-28609	 	_	
185-44	28609-28610	=	_	
185-45	28610-28611	 	_	
185-46	28611-28615	0.11	_	
185-47	28615-28616	,	_	
185-48	28617-28618	F	_	
185-49	28618-28619	(	_	
185-50	28619-28623	1,35	_	
185-51	28623-28624	)	_	
185-52	28624-28625	 	_	
185-53	28625-28626	=	_	
185-54	28626-28627	 	_	
185-55	28627-28632	4.219	_	
185-56	28632-28633	,	_	
185-57	28634-28635	p	_	
185-58	28635-28636	 	_	
185-59	28636-28637	<	_	
185-60	28637-28638	 	_	
185-61	28638-28641	.05	_	
185-62	28641-28642	.	_	

#Text=Decreased average connectivity strength over the edges common to the ASD and SZ models in the DMN were associated with higher ADOS scores and greater communication deficits.
186-1	28643-28652	Decreased	_	
186-2	28653-28660	average	_	
186-3	28661-28673	connectivity	_	
186-4	28674-28682	strength	_	
186-5	28683-28687	over	_	
186-6	28688-28691	the	_	
186-7	28692-28697	edges	_	
186-8	28698-28704	common	_	
186-9	28705-28707	to	_	
186-10	28708-28711	the	_	
186-11	28712-28715	ASD	_	
186-12	28716-28719	and	_	
186-13	28720-28722	SZ	_	
186-14	28723-28729	models	_	
186-15	28730-28732	in	_	
186-16	28733-28736	the	_	
186-17	28737-28740	DMN	_	
186-18	28741-28745	were	_	
186-19	28746-28756	associated	_	
186-20	28757-28761	with	_	
186-21	28762-28768	higher	_	
186-22	28769-28773	ADOS	_	
186-23	28774-28780	scores	_	
186-24	28781-28784	and	_	
186-25	28785-28792	greater	_	
186-26	28793-28806	communication	_	
186-27	28807-28815	deficits	_	
186-28	28815-28816	.	_	

#Text=ASD and SZ disparate features
#Text=Disparate features present in a) ASD model or b) SZ model but not in both models.
187-1	28817-28820	ASD	_	
187-2	28821-28824	and	_	
187-3	28825-28827	SZ	_	
187-4	28828-28837	disparate	_	
187-5	28838-28846	features	_	
187-6	28847-28856	Disparate	_	
187-7	28857-28865	features	_	
187-8	28866-28873	present	_	
187-9	28874-28876	in	_	
187-10	28877-28878	a	_	
187-11	28878-28879	)	_	
187-12	28880-28883	ASD	_	
187-13	28884-28889	model	_	
187-14	28890-28892	or	_	
187-15	28893-28894	b	_	
187-16	28894-28895	)	_	
187-17	28896-28898	SZ	_	
187-18	28899-28904	model	_	
187-19	28905-28908	but	_	
187-20	28909-28912	not	_	
187-21	28913-28915	in	_	
187-22	28916-28920	both	_	
187-23	28921-28927	models	_	
187-24	28927-28928	.	_	

#Text=Connectivity strength differences are relative to healthy individuals in the common control group.
188-1	28929-28941	Connectivity	_	
188-2	28942-28950	strength	_	
188-3	28951-28962	differences	_	
188-4	28963-28966	are	_	
188-5	28967-28975	relative	_	
188-6	28976-28978	to	_	
188-7	28979-28986	healthy	_	
188-8	28987-28998	individuals	_	
188-9	28999-29001	in	_	
188-10	29002-29005	the	_	
188-11	29006-29012	common	_	
188-12	29013-29020	control	_	
188-13	29021-29026	group	_	
188-14	29026-29027	.	_	

#Text=Diagonal elements represent within network edges between different regions of the same network.
189-1	29028-29036	Diagonal	_	
189-2	29037-29045	elements	_	
189-3	29046-29055	represent	_	
189-4	29056-29062	within	_	
189-5	29063-29070	network	_	
189-6	29071-29076	edges	_	
189-7	29077-29084	between	_	
189-8	29085-29094	different	_	
189-9	29095-29102	regions	_	
189-10	29103-29105	of	_	
189-11	29106-29109	the	_	
189-12	29110-29114	same	_	
189-13	29115-29122	network	_	
189-14	29122-29123	.	_	

#Text=Numbers represent the number of features within or between networks, while color and size indicate the ratio of increases to decreases in connectivity strength for those features relative to controls.
190-1	29124-29131	Numbers	_	
190-2	29132-29141	represent	_	
190-3	29142-29145	the	_	
190-4	29146-29152	number	_	
190-5	29153-29155	of	_	
190-6	29156-29164	features	_	
190-7	29165-29171	within	_	
190-8	29172-29174	or	_	
190-9	29175-29182	between	_	
190-10	29183-29191	networks	_	
190-11	29191-29192	,	_	
190-12	29193-29198	while	_	
190-13	29199-29204	color	_	
190-14	29205-29208	and	_	
190-15	29209-29213	size	_	
190-16	29214-29222	indicate	_	
190-17	29223-29226	the	_	
190-18	29227-29232	ratio	_	
190-19	29233-29235	of	_	
190-20	29236-29245	increases	_	
190-21	29246-29248	to	_	
190-22	29249-29258	decreases	_	
190-23	29259-29261	in	_	
190-24	29262-29274	connectivity	_	
190-25	29275-29283	strength	_	
190-26	29284-29287	for	_	
190-27	29288-29293	those	_	
190-28	29294-29302	features	_	
190-29	29303-29311	relative	_	
190-30	29312-29314	to	_	
190-31	29315-29323	controls	_	
190-32	29323-29324	.	_	

#Text=Yellow colors indicate a greater proportion of connectivity increases, red a greater proportion of decreases.
191-1	29325-29331	Yellow	_	
191-2	29332-29338	colors	_	
191-3	29339-29347	indicate	_	
191-4	29348-29349	a	_	
191-5	29350-29357	greater	_	
191-6	29358-29368	proportion	_	
191-7	29369-29371	of	_	
191-8	29372-29384	connectivity	_	
191-9	29385-29394	increases	_	
191-10	29394-29395	,	_	
191-11	29396-29399	red	_	
191-12	29400-29401	a	_	
191-13	29402-29409	greater	_	
191-14	29410-29420	proportion	_	
191-15	29421-29423	of	_	
191-16	29424-29433	decreases	_	
191-17	29433-29434	.	_	

#Text=The DMN and salience networks account for the largest number of features with a mix of increases and decreases in connectivity strength.
192-1	29435-29438	The	_	
192-2	29439-29442	DMN	_	
192-3	29443-29446	and	_	
192-4	29447-29455	salience	_	
192-5	29456-29464	networks	_	
192-6	29465-29472	account	_	
192-7	29473-29476	for	_	
192-8	29477-29480	the	_	
192-9	29481-29488	largest	_	
192-10	29489-29495	number	_	
192-11	29496-29498	of	_	
192-12	29499-29507	features	_	
192-13	29508-29512	with	_	
192-14	29513-29514	a	_	
192-15	29515-29518	mix	_	
192-16	29519-29521	of	_	
192-17	29522-29531	increases	_	
192-18	29532-29535	and	_	
192-19	29536-29545	decreases	_	
192-20	29546-29548	in	_	
192-21	29549-29561	connectivity	_	
192-22	29562-29570	strength	_	
192-23	29570-29571	.	_	

#Text=Fig. 5
#Text=The remaining disparate features between the ASD and SZ models (~1000) represent features found to be diagnostic in either the ASD (Fig. 5a) or SZ (Fig. 5b) models relative to the common control group, but were not present in both models.
193-1	29572-29575	Fig	_	
193-2	29575-29576	.	_	
193-3	29577-29578	5	_	
193-4	29579-29582	The	_	
193-5	29583-29592	remaining	_	
193-6	29593-29602	disparate	_	
193-7	29603-29611	features	_	
193-8	29612-29619	between	_	
193-9	29620-29623	the	_	
193-10	29624-29627	ASD	_	
193-11	29628-29631	and	_	
193-12	29632-29634	SZ	_	
193-13	29635-29641	models	_	
193-14	29642-29643	(	_	
193-15	29643-29644	~	_	
193-16	29644-29648	1000	_	
193-17	29648-29649	)	_	
193-18	29650-29659	represent	_	
193-19	29660-29668	features	_	
193-20	29669-29674	found	_	
193-21	29675-29677	to	_	
193-22	29678-29680	be	_	
193-23	29681-29691	diagnostic	_	
193-24	29692-29694	in	_	
193-25	29695-29701	either	_	
193-26	29702-29705	the	_	
193-27	29706-29709	ASD	_	
193-28	29710-29711	(	_	
193-29	29711-29714	Fig	_	
193-30	29714-29715	.	_	
193-31	29716-29718	5a	_	
193-32	29718-29719	)	_	
193-33	29720-29722	or	_	
193-34	29723-29725	SZ	_	
193-35	29726-29727	(	_	
193-36	29727-29730	Fig	_	
193-37	29730-29731	.	_	
193-38	29732-29734	5b	_	
193-39	29734-29735	)	_	
193-40	29736-29742	models	_	
193-41	29743-29751	relative	_	
193-42	29752-29754	to	_	
193-43	29755-29758	the	_	
193-44	29759-29765	common	_	
193-45	29766-29773	control	_	
193-46	29774-29779	group	_	
193-47	29779-29780	,	_	
193-48	29781-29784	but	_	
193-49	29785-29789	were	_	
193-50	29790-29793	not	_	
193-51	29794-29801	present	_	
193-52	29802-29804	in	_	
193-53	29805-29809	both	_	
193-54	29810-29816	models	_	
193-55	29816-29817	.	_	

#Text=The ASD model required a greater number of features to obtain good classification.
194-1	29818-29821	The	_	
194-2	29822-29825	ASD	_	
194-3	29826-29831	model	_	
194-4	29832-29840	required	_	
194-5	29841-29842	a	_	
194-6	29843-29850	greater	_	
194-7	29851-29857	number	_	
194-8	29858-29860	of	_	
194-9	29861-29869	features	_	
194-10	29870-29872	to	_	
194-11	29873-29879	obtain	_	
194-12	29880-29884	good	_	
194-13	29885-29899	classification	_	
194-14	29899-29900	.	_	

#Text=Both models contain a mixture of increases and decreases in connectivity strength across and within networks.
195-1	29901-29905	Both	_	
195-2	29906-29912	models	_	
195-3	29913-29920	contain	_	
195-4	29921-29922	a	_	
195-5	29923-29930	mixture	_	
195-6	29931-29933	of	_	
195-7	29934-29943	increases	_	
195-8	29944-29947	and	_	
195-9	29948-29957	decreases	_	
195-10	29958-29960	in	_	
195-11	29961-29973	connectivity	_	
195-12	29974-29982	strength	_	
195-13	29983-29989	across	_	
195-14	29990-29993	and	_	
195-15	29994-30000	within	_	
195-16	30001-30009	networks	_	
195-17	30009-30010	.	_	

#Text=The ASD and SZ models exhibited a large number of non-overlapping features within the DMN and the salience network.
196-1	30011-30014	The	_	
196-2	30015-30018	ASD	_	
196-3	30019-30022	and	_	
196-4	30023-30025	SZ	_	
196-5	30026-30032	models	_	
196-6	30033-30042	exhibited	_	
196-7	30043-30044	a	_	
196-8	30045-30050	large	_	
196-9	30051-30057	number	_	
196-10	30058-30060	of	_	
196-11	30061-30076	non-overlapping	_	
196-12	30077-30085	features	_	
196-13	30086-30092	within	_	
196-14	30093-30096	the	_	
196-15	30097-30100	DMN	_	
196-16	30101-30104	and	_	
196-17	30105-30108	the	_	
196-18	30109-30117	salience	_	
196-19	30118-30125	network	_	
196-20	30125-30126	.	_	

#Text=However, a much larger proportion of diagnostic features associated with ASD were within-network changes in the DMN as compared to SZ.
197-1	30127-30134	However	_	
197-2	30134-30135	,	_	
197-3	30136-30137	a	_	
197-4	30138-30142	much	_	
197-5	30143-30149	larger	_	
197-6	30150-30160	proportion	_	
197-7	30161-30163	of	_	
197-8	30164-30174	diagnostic	_	
197-9	30175-30183	features	_	
197-10	30184-30194	associated	_	
197-11	30195-30199	with	_	
197-12	30200-30203	ASD	_	
197-13	30204-30208	were	_	
197-14	30209-30223	within-network	_	
197-15	30224-30231	changes	_	
197-16	30232-30234	in	_	
197-17	30235-30238	the	_	
197-18	30239-30242	DMN	_	
197-19	30243-30245	as	_	
197-20	30246-30254	compared	_	
197-21	30255-30257	to	_	
197-22	30258-30260	SZ	_	
197-23	30260-30261	.	_	

#Text=Features within sensory-motor networks were more prominent in the ASD than SZ model, while changes in the ECN and increases in connectivity in higher level visual processing areas were more prominent in the SZ model.
198-1	30262-30270	Features	_	
198-2	30271-30277	within	_	
198-3	30278-30291	sensory-motor	_	
198-4	30292-30300	networks	_	
198-5	30301-30305	were	_	
198-6	30306-30310	more	_	
198-7	30311-30320	prominent	_	
198-8	30321-30323	in	_	
198-9	30324-30327	the	_	
198-10	30328-30331	ASD	_	
198-11	30332-30336	than	_	
198-12	30337-30339	SZ	_	
198-13	30340-30345	model	_	
198-14	30345-30346	,	_	
198-15	30347-30352	while	_	
198-16	30353-30360	changes	_	
198-17	30361-30363	in	_	
198-18	30364-30367	the	_	
198-19	30368-30371	ECN	_	
198-20	30372-30375	and	_	
198-21	30376-30385	increases	_	
198-22	30386-30388	in	_	
198-23	30389-30401	connectivity	_	
198-24	30402-30404	in	_	
198-25	30405-30411	higher	_	
198-26	30412-30417	level	_	
198-27	30418-30424	visual	_	
198-28	30425-30435	processing	_	
198-29	30436-30441	areas	_	
198-30	30442-30446	were	_	
198-31	30447-30451	more	_	
198-32	30452-30461	prominent	_	
198-33	30462-30464	in	_	
198-34	30465-30468	the	_	
198-35	30469-30471	SZ	_	
198-36	30472-30477	model	_	
198-37	30477-30478	.	_	

#Text=In Sections 3.1.1 and 3.1.2 we reported on the features identified through the RFE procedure when performed on each of the individual training data sets.
199-1	30479-30481	In	_	
199-2	30482-30490	Sections	_	
199-3	30491-30496	3.1.1	_	
199-4	30497-30500	and	_	
199-5	30501-30506	3.1.2	_	
199-6	30507-30509	we	_	
199-7	30510-30518	reported	_	
199-8	30519-30521	on	_	
199-9	30522-30525	the	_	
199-10	30526-30534	features	_	
199-11	30535-30545	identified	_	
199-12	30546-30553	through	_	
199-13	30554-30557	the	_	
199-14	30558-30561	RFE	_	
199-15	30562-30571	procedure	_	
199-16	30572-30576	when	_	
199-17	30577-30586	performed	_	
199-18	30587-30589	on	_	
199-19	30590-30594	each	_	
199-20	30595-30597	of	_	
199-21	30598-30601	the	_	
199-22	30602-30612	individual	_	
199-23	30613-30621	training	_	
199-24	30622-30626	data	_	
199-25	30627-30631	sets	_	
199-26	30631-30632	.	_	

#Text=We compared these features to those identified by performing the same procedure using the common mixed control group, which consisted of an equal number of control subjects from both data sets.
200-1	30633-30635	We	_	
200-2	30636-30644	compared	_	
200-3	30645-30650	these	_	
200-4	30651-30659	features	_	
200-5	30660-30662	to	_	
200-6	30663-30668	those	_	
200-7	30669-30679	identified	_	
200-8	30680-30682	by	_	
200-9	30683-30693	performing	_	
200-10	30694-30697	the	_	
200-11	30698-30702	same	_	
200-12	30703-30712	procedure	_	
200-13	30713-30718	using	_	
200-14	30719-30722	the	_	
200-15	30723-30729	common	_	
200-16	30730-30735	mixed	_	
200-17	30736-30743	control	_	
200-18	30744-30749	group	_	
200-19	30749-30750	,	_	
200-20	30751-30756	which	_	
200-21	30757-30766	consisted	_	
200-22	30767-30769	of	_	
200-23	30770-30772	an	_	
200-24	30773-30778	equal	_	
200-25	30779-30785	number	_	
200-26	30786-30788	of	_	
200-27	30789-30796	control	_	
200-28	30797-30805	subjects	_	
200-29	30806-30810	from	_	
200-30	30811-30815	both	_	
200-31	30816-30820	data	_	
200-32	30821-30825	sets	_	
200-33	30825-30826	.	_	

#Text=From the initial set of potential features, about half of those identified using RFE on the original training data sets were also identified using the hybrid control group.
201-1	30827-30831	From	_	
201-2	30832-30835	the	_	
201-3	30836-30843	initial	_	
201-4	30844-30847	set	_	
201-5	30848-30850	of	_	
201-6	30851-30860	potential	_	
201-7	30861-30869	features	_	
201-8	30869-30870	,	_	
201-9	30871-30876	about	_	
201-10	30877-30881	half	_	
201-11	30882-30884	of	_	
201-12	30885-30890	those	_	
201-13	30891-30901	identified	_	
201-14	30902-30907	using	_	
201-15	30908-30911	RFE	_	
201-16	30912-30914	on	_	
201-17	30915-30918	the	_	
201-18	30919-30927	original	_	
201-19	30928-30936	training	_	
201-20	30937-30941	data	_	
201-21	30942-30946	sets	_	
201-22	30947-30951	were	_	
201-23	30952-30956	also	_	
201-24	30957-30967	identified	_	
201-25	30968-30973	using	_	
201-26	30974-30977	the	_	
201-27	30978-30984	hybrid	_	
201-28	30985-30992	control	_	
201-29	30993-30998	group	_	
201-30	30998-30999	.	_	

#Text=SVM discrimination between SZ and ASD subjects
#Text=ROCs of cross-validation accuracy predicting SZ from ASD patients in the training-naive test data set as a function of the number of diagnostic features used for prediction.
202-1	31000-31003	SVM	_	
202-2	31004-31018	discrimination	_	
202-3	31019-31026	between	_	
202-4	31027-31029	SZ	_	
202-5	31030-31033	and	_	
202-6	31034-31037	ASD	_	
202-7	31038-31046	subjects	_	
202-8	31047-31051	ROCs	_	
202-9	31052-31054	of	_	
202-10	31055-31071	cross-validation	_	
202-11	31072-31080	accuracy	_	
202-12	31081-31091	predicting	_	
202-13	31092-31094	SZ	_	
202-14	31095-31099	from	_	
202-15	31100-31103	ASD	_	
202-16	31104-31112	patients	_	
202-17	31113-31115	in	_	
202-18	31116-31119	the	_	
202-19	31120-31134	training-naive	_	
202-20	31135-31139	test	_	
202-21	31140-31144	data	_	
202-22	31145-31148	set	_	
202-23	31149-31151	as	_	
202-24	31152-31153	a	_	
202-25	31154-31162	function	_	
202-26	31163-31165	of	_	
202-27	31166-31169	the	_	
202-28	31170-31176	number	_	
202-29	31177-31179	of	_	
202-30	31180-31190	diagnostic	_	
202-31	31191-31199	features	_	
202-32	31200-31204	used	_	
202-33	31205-31208	for	_	
202-34	31209-31219	prediction	_	
202-35	31219-31220	.	_	

#Text=Diagnostic features are the combination of the SZ and ASD features when trained against common control group.
203-1	31221-31231	Diagnostic	_	
203-2	31232-31240	features	_	
203-3	31241-31244	are	_	
203-4	31245-31248	the	_	
203-5	31249-31260	combination	_	
203-6	31261-31263	of	_	
203-7	31264-31267	the	_	
203-8	31268-31270	SZ	_	
203-9	31271-31274	and	_	
203-10	31275-31278	ASD	_	
203-11	31279-31287	features	_	
203-12	31288-31292	when	_	
203-13	31293-31300	trained	_	
203-14	31301-31308	against	_	
203-15	31309-31315	common	_	
203-16	31316-31323	control	_	
203-17	31324-31329	group	_	
203-18	31329-31330	.	_	

#Text=Best performance was achieved using the top 40–50 RFE features which resulted in 75% accuracy with 90% sensitivity (TPR) and 60% specificity (1 − FPR).
204-1	31331-31335	Best	_	
204-2	31336-31347	performance	_	
204-3	31348-31351	was	_	
204-4	31352-31360	achieved	_	
204-5	31361-31366	using	_	
204-6	31367-31370	the	_	
204-7	31371-31374	top	_	
204-8	31375-31377	40	_	
204-9	31377-31378	–	_	
204-10	31378-31380	50	_	
204-11	31381-31384	RFE	_	
204-12	31385-31393	features	_	
204-13	31394-31399	which	_	
204-14	31400-31408	resulted	_	
204-15	31409-31411	in	_	
204-16	31412-31415	75%	_	
204-17	31416-31424	accuracy	_	
204-18	31425-31429	with	_	
204-19	31430-31433	90%	_	
204-20	31434-31445	sensitivity	_	
204-21	31446-31447	(	_	
204-22	31447-31450	TPR	_	
204-23	31450-31451	)	_	
204-24	31452-31455	and	_	
204-25	31456-31459	60%	_	
204-26	31460-31471	specificity	_	
204-27	31472-31473	(	_	
204-28	31473-31474	1	_	
204-29	31474-31475	 	_	
204-30	31475-31476	−	_	
204-31	31476-31477	 	_	
204-32	31477-31480	FPR	_	
204-33	31480-31481	)	_	
204-34	31481-31482	.	_	

#Text=Fig. 6
#Text=Features that distinguish ASD from SZ.
205-1	31483-31486	Fig	_	
205-2	31486-31487	.	_	
205-3	31488-31489	6	_	
205-4	31490-31498	Features	_	
205-5	31499-31503	that	_	
205-6	31504-31515	distinguish	_	
205-7	31516-31519	ASD	_	
205-8	31520-31524	from	_	
205-9	31525-31527	SZ	_	
205-10	31527-31528	.	_	

#Text=Diagonal elements represent within network edges between different regions of the same network. a) For ASD relative to SZ, the DMN network accounts for the largest number of features where there are mostly increases in connectivity strength relative to SZ patients. b) SZ relative to ASD.
206-1	31529-31537	Diagonal	_	
206-2	31538-31546	elements	_	
206-3	31547-31556	represent	_	
206-4	31557-31563	within	_	
206-5	31564-31571	network	_	
206-6	31572-31577	edges	_	
206-7	31578-31585	between	_	
206-8	31586-31595	different	_	
206-9	31596-31603	regions	_	
206-10	31604-31606	of	_	
206-11	31607-31610	the	_	
206-12	31611-31615	same	_	
206-13	31616-31623	network	_	
206-14	31623-31624	.	_	
206-15	31625-31626	a	_	
206-16	31626-31627	)	_	
206-17	31628-31631	For	_	
206-18	31632-31635	ASD	_	
206-19	31636-31644	relative	_	
206-20	31645-31647	to	_	
206-21	31648-31650	SZ	_	
206-22	31650-31651	,	_	
206-23	31652-31655	the	_	
206-24	31656-31659	DMN	_	
206-25	31660-31667	network	_	
206-26	31668-31676	accounts	_	
206-27	31677-31680	for	_	
206-28	31681-31684	the	_	
206-29	31685-31692	largest	_	
206-30	31693-31699	number	_	
206-31	31700-31702	of	_	
206-32	31703-31711	features	_	
206-33	31712-31717	where	_	
206-34	31718-31723	there	_	
206-35	31724-31727	are	_	
206-36	31728-31734	mostly	_	
206-37	31735-31744	increases	_	
206-38	31745-31747	in	_	
206-39	31748-31760	connectivity	_	
206-40	31761-31769	strength	_	
206-41	31770-31778	relative	_	
206-42	31779-31781	to	_	
206-43	31782-31784	SZ	_	
206-44	31785-31793	patients	_	
206-45	31793-31794	.	_	
206-46	31795-31796	b	_	
206-47	31796-31797	)	_	
206-48	31798-31800	SZ	_	
206-49	31801-31809	relative	_	
206-50	31810-31812	to	_	
206-51	31813-31816	ASD	_	
206-52	31816-31817	.	_	

#Text=Numbers represent the number of features within or between networks, while color and size indicate the ratio of increases to decreases in connectivity strength in those features.
207-1	31818-31825	Numbers	_	
207-2	31826-31835	represent	_	
207-3	31836-31839	the	_	
207-4	31840-31846	number	_	
207-5	31847-31849	of	_	
207-6	31850-31858	features	_	
207-7	31859-31865	within	_	
207-8	31866-31868	or	_	
207-9	31869-31876	between	_	
207-10	31877-31885	networks	_	
207-11	31885-31886	,	_	
207-12	31887-31892	while	_	
207-13	31893-31898	color	_	
207-14	31899-31902	and	_	
207-15	31903-31907	size	_	
207-16	31908-31916	indicate	_	
207-17	31917-31920	the	_	
207-18	31921-31926	ratio	_	
207-19	31927-31929	of	_	
207-20	31930-31939	increases	_	
207-21	31940-31942	to	_	
207-22	31943-31952	decreases	_	
207-23	31953-31955	in	_	
207-24	31956-31968	connectivity	_	
207-25	31969-31977	strength	_	
207-26	31978-31980	in	_	
207-27	31981-31986	those	_	
207-28	31987-31995	features	_	
207-29	31995-31996	.	_	

#Text=Yellow colors indicate a greater proportion of connectivity increases, red a greater proportion of decreases.
208-1	31997-32003	Yellow	_	
208-2	32004-32010	colors	_	
208-3	32011-32019	indicate	_	
208-4	32020-32021	a	_	
208-5	32022-32029	greater	_	
208-6	32030-32040	proportion	_	
208-7	32041-32043	of	_	
208-8	32044-32056	connectivity	_	
208-9	32057-32066	increases	_	
208-10	32066-32067	,	_	
208-11	32068-32071	red	_	
208-12	32072-32073	a	_	
208-13	32074-32081	greater	_	
208-14	32082-32092	proportion	_	
208-15	32093-32095	of	_	
208-16	32096-32105	decreases	_	
208-17	32105-32106	.	_	

#Text=Fig. 7
#Text=Specificity and sensitivity for classification of ASD patients from SZ patients in untrained testing data sets.
209-1	32107-32110	Fig	_	
209-2	32110-32111	.	_	
209-3	32112-32113	7	_	
209-4	32114-32125	Specificity	_	
209-5	32126-32129	and	_	
209-6	32130-32141	sensitivity	_	
209-7	32142-32145	for	_	
209-8	32146-32160	classification	_	
209-9	32161-32163	of	_	
209-10	32164-32167	ASD	_	
209-11	32168-32176	patients	_	
209-12	32177-32181	from	_	
209-13	32182-32184	SZ	_	
209-14	32185-32193	patients	_	
209-15	32194-32196	in	_	
209-16	32197-32206	untrained	_	
209-17	32207-32214	testing	_	
209-18	32215-32219	data	_	
209-19	32220-32224	sets	_	
209-20	32224-32225	.	_	

#Text=Table 3\t \t
#Text=SZ/ASD\t \tNumber of features\tSpecificity\tSensitivity\tAccuracy\t \t5\t0.5\t0.6\t55.00%\t \t35\t0.6\t0.6\t60.00%\t \t41\t0.6\t0.9\t75.00%\t \t47\t0.6\t0.9\t75.00%\t \t53\t0.6\t0.7\t65.00%\t \t82\t0.3\t0.7\t50.00%\t \t118\t0.2\t0.6\t40.00%\t \t300\t0.3\t0.5\t40.00%\t \t590\t0.3\t0.4\t35.00%\t \t
#Text=An SVM was trained using the combined common and distinct features across the ASD and SZ models to determine whether they could be used to classify ASD from SZ subjects.
210-1	32226-32231	Table	_	
210-2	32232-32233	3	_	
210-3	32237-32239	SZ	_	
210-4	32239-32240	/	_	
210-5	32240-32243	ASD	_	
210-6	32246-32252	Number	_	
210-7	32253-32255	of	_	
210-8	32256-32264	features	_	
210-9	32265-32276	Specificity	_	
210-10	32277-32288	Sensitivity	_	
210-11	32289-32297	Accuracy	_	
210-12	32300-32301	5	_	
210-13	32302-32305	0.5	_	
210-14	32306-32309	0.6	_	
210-15	32310-32316	55.00%	_	
210-16	32319-32321	35	_	
210-17	32322-32325	0.6	_	
210-18	32326-32329	0.6	_	
210-19	32330-32336	60.00%	_	
210-20	32339-32341	41	_	
210-21	32342-32345	0.6	_	
210-22	32346-32349	0.9	_	
210-23	32350-32356	75.00%	_	
210-24	32359-32361	47	_	
210-25	32362-32365	0.6	_	
210-26	32366-32369	0.9	_	
210-27	32370-32376	75.00%	_	
210-28	32379-32381	53	_	
210-29	32382-32385	0.6	_	
210-30	32386-32389	0.7	_	
210-31	32390-32396	65.00%	_	
210-32	32399-32401	82	_	
210-33	32402-32405	0.3	_	
210-34	32406-32409	0.7	_	
210-35	32410-32416	50.00%	_	
210-36	32419-32422	118	_	
210-37	32423-32426	0.2	_	
210-38	32427-32430	0.6	_	
210-39	32431-32437	40.00%	_	
210-40	32440-32443	300	_	
210-41	32444-32447	0.3	_	
210-42	32448-32451	0.5	_	
210-43	32452-32458	40.00%	_	
210-44	32461-32464	590	_	
210-45	32465-32468	0.3	_	
210-46	32469-32472	0.4	_	
210-47	32473-32479	35.00%	_	
210-48	32483-32485	An	_	
210-49	32486-32489	SVM	_	
210-50	32490-32493	was	_	
210-51	32494-32501	trained	_	
210-52	32502-32507	using	_	
210-53	32508-32511	the	_	
210-54	32512-32520	combined	_	
210-55	32521-32527	common	_	
210-56	32528-32531	and	_	
210-57	32532-32540	distinct	_	
210-58	32541-32549	features	_	
210-59	32550-32556	across	_	
210-60	32557-32560	the	_	
210-61	32561-32564	ASD	_	
210-62	32565-32568	and	_	
210-63	32569-32571	SZ	_	
210-64	32572-32578	models	_	
210-65	32579-32581	to	_	
210-66	32582-32591	determine	_	
210-67	32592-32599	whether	_	
210-68	32600-32604	they	_	
210-69	32605-32610	could	_	
210-70	32611-32613	be	_	
210-71	32614-32618	used	_	
210-72	32619-32621	to	_	
210-73	32622-32630	classify	_	
210-74	32631-32634	ASD	_	
210-75	32635-32639	from	_	
210-76	32640-32642	SZ	_	
210-77	32643-32651	subjects	_	
210-78	32651-32652	.	_	

#Text=We were able to successfully classify ASD patients from SZ patients from the training data sets achieving 98% accuracy with 10-fold cross-validation.
211-1	32653-32655	We	_	
211-2	32656-32660	were	_	
211-3	32661-32665	able	_	
211-4	32666-32668	to	_	
211-5	32669-32681	successfully	_	
211-6	32682-32690	classify	_	
211-7	32691-32694	ASD	_	
211-8	32695-32703	patients	_	
211-9	32704-32708	from	_	
211-10	32709-32711	SZ	_	
211-11	32712-32720	patients	_	
211-12	32721-32725	from	_	
211-13	32726-32729	the	_	
211-14	32730-32738	training	_	
211-15	32739-32743	data	_	
211-16	32744-32748	sets	_	
211-17	32749-32758	achieving	_	
211-18	32759-32762	98%	_	
211-19	32763-32771	accuracy	_	
211-20	32772-32776	with	_	
211-21	32777-32779	10	_	
211-22	32779-32780	-	_	
211-23	32780-32784	fold	_	
211-24	32785-32801	cross-validation	_	
211-25	32801-32802	.	_	

#Text=To test the generalizability of these features in their ability to distinguish ASD from SZ subjects, these features were used to predict group membership in ASD and SZ subjects from the validation data sets.
212-1	32803-32805	To	_	
212-2	32806-32810	test	_	
212-3	32811-32814	the	_	
212-4	32815-32831	generalizability	_	
212-5	32832-32834	of	_	
212-6	32835-32840	these	_	
212-7	32841-32849	features	_	
212-8	32850-32852	in	_	
212-9	32853-32858	their	_	
212-10	32859-32866	ability	_	
212-11	32867-32869	to	_	
212-12	32870-32881	distinguish	_	
212-13	32882-32885	ASD	_	
212-14	32886-32890	from	_	
212-15	32891-32893	SZ	_	
212-16	32894-32902	subjects	_	
212-17	32902-32903	,	_	
212-18	32904-32909	these	_	
212-19	32910-32918	features	_	
212-20	32919-32923	were	_	
212-21	32924-32928	used	_	
212-22	32929-32931	to	_	
212-23	32932-32939	predict	_	
212-24	32940-32945	group	_	
212-25	32946-32956	membership	_	
212-26	32957-32959	in	_	
212-27	32960-32963	ASD	_	
212-28	32964-32967	and	_	
212-29	32968-32970	SZ	_	
212-30	32971-32979	subjects	_	
212-31	32980-32984	from	_	
212-32	32985-32988	the	_	
212-33	32989-32999	validation	_	
212-34	33000-33004	data	_	
212-35	33005-33009	sets	_	
212-36	33009-33010	.	_	

#Text=Again, the SVM model was trained on the training data sets and the resulting model was used to predict membership in the validation set based on this model.
213-1	33011-33016	Again	_	
213-2	33016-33017	,	_	
213-3	33018-33021	the	_	
213-4	33022-33025	SVM	_	
213-5	33026-33031	model	_	
213-6	33032-33035	was	_	
213-7	33036-33043	trained	_	
213-8	33044-33046	on	_	
213-9	33047-33050	the	_	
213-10	33051-33059	training	_	
213-11	33060-33064	data	_	
213-12	33065-33069	sets	_	
213-13	33070-33073	and	_	
213-14	33074-33077	the	_	
213-15	33078-33087	resulting	_	
213-16	33088-33093	model	_	
213-17	33094-33097	was	_	
213-18	33098-33102	used	_	
213-19	33103-33105	to	_	
213-20	33106-33113	predict	_	
213-21	33114-33124	membership	_	
213-22	33125-33127	in	_	
213-23	33128-33131	the	_	
213-24	33132-33142	validation	_	
213-25	33143-33146	set	_	
213-26	33147-33152	based	_	
213-27	33153-33155	on	_	
213-28	33156-33160	this	_	
213-29	33161-33166	model	_	
213-30	33166-33167	.	_	

#Text=As in the other validation procedures, we explored the diagnostic utility of the features for the purpose of distinguishing ASD from SZ subjects by using different numbers of the most significant features determined from the SVM model parameter weights resulting from training on the training data sets (Table 3).
214-1	33168-33170	As	_	
214-2	33171-33173	in	_	
214-3	33174-33177	the	_	
214-4	33178-33183	other	_	
214-5	33184-33194	validation	_	
214-6	33195-33205	procedures	_	
214-7	33205-33206	,	_	
214-8	33207-33209	we	_	
214-9	33210-33218	explored	_	
214-10	33219-33222	the	_	
214-11	33223-33233	diagnostic	_	
214-12	33234-33241	utility	_	
214-13	33242-33244	of	_	
214-14	33245-33248	the	_	
214-15	33249-33257	features	_	
214-16	33258-33261	for	_	
214-17	33262-33265	the	_	
214-18	33266-33273	purpose	_	
214-19	33274-33276	of	_	
214-20	33277-33291	distinguishing	_	
214-21	33292-33295	ASD	_	
214-22	33296-33300	from	_	
214-23	33301-33303	SZ	_	
214-24	33304-33312	subjects	_	
214-25	33313-33315	by	_	
214-26	33316-33321	using	_	
214-27	33322-33331	different	_	
214-28	33332-33339	numbers	_	
214-29	33340-33342	of	_	
214-30	33343-33346	the	_	
214-31	33347-33351	most	_	
214-32	33352-33363	significant	_	
214-33	33364-33372	features	_	
214-34	33373-33383	determined	_	
214-35	33384-33388	from	_	
214-36	33389-33392	the	_	
214-37	33393-33396	SVM	_	
214-38	33397-33402	model	_	
214-39	33403-33412	parameter	_	
214-40	33413-33420	weights	_	
214-41	33421-33430	resulting	_	
214-42	33431-33435	from	_	
214-43	33436-33444	training	_	
214-44	33445-33447	on	_	
214-45	33448-33451	the	_	
214-46	33452-33460	training	_	
214-47	33461-33465	data	_	
214-48	33466-33470	sets	_	
214-49	33471-33472	(	_	
214-50	33472-33477	Table	_	
214-51	33478-33479	3	_	
214-52	33479-33480	)	_	
214-53	33480-33481	.	_	

#Text=Using 40–50 features we obtained 75% accuracy when predicting class membership in the ASD and SZ validation data sets (Fig. 6).
215-1	33482-33487	Using	_	
215-2	33488-33490	40	_	
215-3	33490-33491	–	_	
215-4	33491-33493	50	_	
215-5	33494-33502	features	_	
215-6	33503-33505	we	_	
215-7	33506-33514	obtained	_	
215-8	33515-33518	75%	_	
215-9	33519-33527	accuracy	_	
215-10	33528-33532	when	_	
215-11	33533-33543	predicting	_	
215-12	33544-33549	class	_	
215-13	33550-33560	membership	_	
215-14	33561-33563	in	_	
215-15	33564-33567	the	_	
215-16	33568-33571	ASD	_	
215-17	33572-33575	and	_	
215-18	33576-33578	SZ	_	
215-19	33579-33589	validation	_	
215-20	33590-33594	data	_	
215-21	33595-33599	sets	_	
215-22	33600-33601	(	_	
215-23	33601-33604	Fig	_	
215-24	33604-33605	.	_	
215-25	33606-33607	6	_	
215-26	33607-33608	)	_	
215-27	33608-33609	.	_	

#Text=When examining the edge weights of these features in ASD and SZ patients (Fig. 7) a striking difference in the pattern of increases and decreases is readily apparent.
216-1	33610-33614	When	_	
216-2	33615-33624	examining	_	
216-3	33625-33628	the	_	
216-4	33629-33633	edge	_	
216-5	33634-33641	weights	_	
216-6	33642-33644	of	_	
216-7	33645-33650	these	_	
216-8	33651-33659	features	_	
216-9	33660-33662	in	_	
216-10	33663-33666	ASD	_	
216-11	33667-33670	and	_	
216-12	33671-33673	SZ	_	
216-13	33674-33682	patients	_	
216-14	33683-33684	(	_	
216-15	33684-33687	Fig	_	
216-16	33687-33688	.	_	
216-17	33689-33690	7	_	
216-18	33690-33691	)	_	
216-19	33692-33693	a	_	
216-20	33694-33702	striking	_	
216-21	33703-33713	difference	_	
216-22	33714-33716	in	_	
216-23	33717-33720	the	_	
216-24	33721-33728	pattern	_	
216-25	33729-33731	of	_	
216-26	33732-33741	increases	_	
216-27	33742-33745	and	_	
216-28	33746-33755	decreases	_	
216-29	33756-33758	is	_	
216-30	33759-33766	readily	_	
216-31	33767-33775	apparent	_	
216-32	33775-33776	.	_	

#Text=In the feature set that distinguishes ASD from SZ subjects, ASD is characterized by increases rather than decreases in connectivity strength in nearly all connections between and within networks.
217-1	33777-33779	In	_	
217-2	33780-33783	the	_	
217-3	33784-33791	feature	_	
217-4	33792-33795	set	_	
217-5	33796-33800	that	_	
217-6	33801-33814	distinguishes	_	
217-7	33815-33818	ASD	_	
217-8	33819-33823	from	_	
217-9	33824-33826	SZ	_	
217-10	33827-33835	subjects	_	
217-11	33835-33836	,	_	
217-12	33837-33840	ASD	_	
217-13	33841-33843	is	_	
217-14	33844-33857	characterized	_	
217-15	33858-33860	by	_	
217-16	33861-33870	increases	_	
217-17	33871-33877	rather	_	
217-18	33878-33882	than	_	
217-19	33883-33892	decreases	_	
217-20	33893-33895	in	_	
217-21	33896-33908	connectivity	_	
217-22	33909-33917	strength	_	
217-23	33918-33920	in	_	
217-24	33921-33927	nearly	_	
217-25	33928-33931	all	_	
217-26	33932-33943	connections	_	
217-27	33944-33951	between	_	
217-28	33952-33955	and	_	
217-29	33956-33962	within	_	
217-30	33963-33971	networks	_	
217-31	33971-33972	.	_	

#Text=While DMN connectivity is prominent in the feature sets for both disorders, the DMN is also the most diagnostic network for distinguishing ASD from SZ.
218-1	33973-33978	While	_	
218-2	33979-33982	DMN	_	
218-3	33983-33995	connectivity	_	
218-4	33996-33998	is	_	
218-5	33999-34008	prominent	_	
218-6	34009-34011	in	_	
218-7	34012-34015	the	_	
218-8	34016-34023	feature	_	
218-9	34024-34028	sets	_	
218-10	34029-34032	for	_	
218-11	34033-34037	both	_	
218-12	34038-34047	disorders	_	
218-13	34047-34048	,	_	
218-14	34049-34052	the	_	
218-15	34053-34056	DMN	_	
218-16	34057-34059	is	_	
218-17	34060-34064	also	_	
218-18	34065-34068	the	_	
218-19	34069-34073	most	_	
218-20	34074-34084	diagnostic	_	
218-21	34085-34092	network	_	
218-22	34093-34096	for	_	
218-23	34097-34111	distinguishing	_	
218-24	34112-34115	ASD	_	
218-25	34116-34120	from	_	
218-26	34121-34123	SZ	_	
218-27	34123-34124	.	_	

#Text=Examining the specific edges involved, SZ exhibited decreased connectivity strength in all DMN connections except those between the posterior cingulate and supplementary motor cortex, and between the precuneus and lateral occipital cortex.
219-1	34125-34134	Examining	_	
219-2	34135-34138	the	_	
219-3	34139-34147	specific	_	
219-4	34148-34153	edges	_	
219-5	34154-34162	involved	_	
219-6	34162-34163	,	_	
219-7	34164-34166	SZ	_	
219-8	34167-34176	exhibited	_	
219-9	34177-34186	decreased	_	
219-10	34187-34199	connectivity	_	
219-11	34200-34208	strength	_	
219-12	34209-34211	in	_	
219-13	34212-34215	all	_	
219-14	34216-34219	DMN	_	
219-15	34220-34231	connections	_	
219-16	34232-34238	except	_	
219-17	34239-34244	those	_	
219-18	34245-34252	between	_	
219-19	34253-34256	the	_	
219-20	34257-34266	posterior	_	
219-21	34267-34276	cingulate	_	
219-22	34277-34280	and	_	
219-23	34281-34294	supplementary	_	
219-24	34295-34300	motor	_	
219-25	34301-34307	cortex	_	
219-26	34307-34308	,	_	
219-27	34309-34312	and	_	
219-28	34313-34320	between	_	
219-29	34321-34324	the	_	
219-30	34325-34334	precuneus	_	
219-31	34335-34338	and	_	
219-32	34339-34346	lateral	_	
219-33	34347-34356	occipital	_	
219-34	34357-34363	cortex	_	
219-35	34363-34364	.	_	

#Text=Discussion
#Text=From a diagnostic point of view, there is considerable interest in identifying biomarkers for psychiatric disorders such as ASD and SZ.
220-1	34365-34375	Discussion	_	
220-2	34376-34380	From	_	
220-3	34381-34382	a	_	
220-4	34383-34393	diagnostic	_	
220-5	34394-34399	point	_	
220-6	34400-34402	of	_	
220-7	34403-34407	view	_	
220-8	34407-34408	,	_	
220-9	34409-34414	there	_	
220-10	34415-34417	is	_	
220-11	34418-34430	considerable	_	
220-12	34431-34439	interest	_	
220-13	34440-34442	in	_	
220-14	34443-34454	identifying	_	
220-15	34455-34465	biomarkers	_	
220-16	34466-34469	for	_	
220-17	34470-34481	psychiatric	_	
220-18	34482-34491	disorders	_	
220-19	34492-34496	such	_	
220-20	34497-34499	as	_	
220-21	34500-34503	ASD	_	
220-22	34504-34507	and	_	
220-23	34508-34510	SZ	_	
220-24	34510-34511	.	_	

#Text=However, there is a recognition that symptoms in many psychiatric disorders lie along a continuum with some degree of overlap across disorders.
221-1	34512-34519	However	_	
221-2	34519-34520	,	_	
221-3	34521-34526	there	_	
221-4	34527-34529	is	_	
221-5	34530-34531	a	_	
221-6	34532-34543	recognition	_	
221-7	34544-34548	that	_	
221-8	34549-34557	symptoms	_	
221-9	34558-34560	in	_	
221-10	34561-34565	many	_	
221-11	34566-34577	psychiatric	_	
221-12	34578-34587	disorders	_	
221-13	34588-34591	lie	_	
221-14	34592-34597	along	_	
221-15	34598-34599	a	_	
221-16	34600-34609	continuum	_	
221-17	34610-34614	with	_	
221-18	34615-34619	some	_	
221-19	34620-34626	degree	_	
221-20	34627-34629	of	_	
221-21	34630-34637	overlap	_	
221-22	34638-34644	across	_	
221-23	34645-34654	disorders	_	
221-24	34654-34655	.	_	

#Text=Despite the similarities between ASD and SZ, particularly in social cognitive deficits and their overlapping etiologies, they are seldom studied comparatively.
222-1	34656-34663	Despite	_	
222-2	34664-34667	the	_	
222-3	34668-34680	similarities	_	
222-4	34681-34688	between	_	
222-5	34689-34692	ASD	_	
222-6	34693-34696	and	_	
222-7	34697-34699	SZ	_	
222-8	34699-34700	,	_	
222-9	34701-34713	particularly	_	
222-10	34714-34716	in	_	
222-11	34717-34723	social	_	
222-12	34724-34733	cognitive	_	
222-13	34734-34742	deficits	_	
222-14	34743-34746	and	_	
222-15	34747-34752	their	_	
222-16	34753-34764	overlapping	_	
222-17	34765-34775	etiologies	_	
222-18	34775-34776	,	_	
222-19	34777-34781	they	_	
222-20	34782-34785	are	_	
222-21	34786-34792	seldom	_	
222-22	34793-34800	studied	_	
222-23	34801-34814	comparatively	_	
222-24	34814-34815	.	_	

#Text=In their separate literatures, aberrant connectivity has been the focus of study in both ASD and SZ, because it is believed that their cognitive deficits may be caused by the impaired ability to integrate information across functionally distributed brain areas.
223-1	34816-34818	In	_	
223-2	34819-34824	their	_	
223-3	34825-34833	separate	_	
223-4	34834-34845	literatures	_	
223-5	34845-34846	,	_	
223-6	34847-34855	aberrant	_	
223-7	34856-34868	connectivity	_	
223-8	34869-34872	has	_	
223-9	34873-34877	been	_	
223-10	34878-34881	the	_	
223-11	34882-34887	focus	_	
223-12	34888-34890	of	_	
223-13	34891-34896	study	_	
223-14	34897-34899	in	_	
223-15	34900-34904	both	_	
223-16	34905-34908	ASD	_	
223-17	34909-34912	and	_	
223-18	34913-34915	SZ	_	
223-19	34915-34916	,	_	
223-20	34917-34924	because	_	
223-21	34925-34927	it	_	
223-22	34928-34930	is	_	
223-23	34931-34939	believed	_	
223-24	34940-34944	that	_	
223-25	34945-34950	their	_	
223-26	34951-34960	cognitive	_	
223-27	34961-34969	deficits	_	
223-28	34970-34973	may	_	
223-29	34974-34976	be	_	
223-30	34977-34983	caused	_	
223-31	34984-34986	by	_	
223-32	34987-34990	the	_	
223-33	34991-34999	impaired	_	
223-34	35000-35007	ability	_	
223-35	35008-35010	to	_	
223-36	35011-35020	integrate	_	
223-37	35021-35032	information	_	
223-38	35033-35039	across	_	
223-39	35040-35052	functionally	_	
223-40	35053-35064	distributed	_	
223-41	35065-35070	brain	_	
223-42	35071-35076	areas	_	
223-43	35076-35077	.	_	

#Text=However, studies of connectivity differences in both ASD and SZ have yielded conflicting results, particularly those that have focused on average connectivity changes between specific brain regions.
224-1	35078-35085	However	_	
224-2	35085-35086	,	_	
224-3	35087-35094	studies	_	
224-4	35095-35097	of	_	
224-5	35098-35110	connectivity	_	
224-6	35111-35122	differences	_	
224-7	35123-35125	in	_	
224-8	35126-35130	both	_	
224-9	35131-35134	ASD	_	
224-10	35135-35138	and	_	
224-11	35139-35141	SZ	_	
224-12	35142-35146	have	_	
224-13	35147-35154	yielded	_	
224-14	35155-35166	conflicting	_	
224-15	35167-35174	results	_	
224-16	35174-35175	,	_	
224-17	35176-35188	particularly	_	
224-18	35189-35194	those	_	
224-19	35195-35199	that	_	
224-20	35200-35204	have	_	
224-21	35205-35212	focused	_	
224-22	35213-35215	on	_	
224-23	35216-35223	average	_	
224-24	35224-35236	connectivity	_	
224-25	35237-35244	changes	_	
224-26	35245-35252	between	_	
224-27	35253-35261	specific	_	
224-28	35262-35267	brain	_	
224-29	35268-35275	regions	_	
224-30	35275-35276	.	_	

#Text=This highlights the difficulty of using regional connectivity differences between just one or two regions to characterize complex disorders such as ASD and SZ.
225-1	35277-35281	This	_	
225-2	35282-35292	highlights	_	
225-3	35293-35296	the	_	
225-4	35297-35307	difficulty	_	
225-5	35308-35310	of	_	
225-6	35311-35316	using	_	
225-7	35317-35325	regional	_	
225-8	35326-35338	connectivity	_	
225-9	35339-35350	differences	_	
225-10	35351-35358	between	_	
225-11	35359-35363	just	_	
225-12	35364-35367	one	_	
225-13	35368-35370	or	_	
225-14	35371-35374	two	_	
225-15	35375-35382	regions	_	
225-16	35383-35385	to	_	
225-17	35386-35398	characterize	_	
225-18	35399-35406	complex	_	
225-19	35407-35416	disorders	_	
225-20	35417-35421	such	_	
225-21	35422-35424	as	_	
225-22	35425-35428	ASD	_	
225-23	35429-35432	and	_	
225-24	35433-35435	SZ	_	
225-25	35435-35436	.	_	

#Text=Even if individual features did reach statistical significance, this would not be sufficient for use as a biomarker, since there is still considerable overlap in the distributions of regional connectivity strengths between patients and controls.
226-1	35437-35441	Even	_	
226-2	35442-35444	if	_	
226-3	35445-35455	individual	_	
226-4	35456-35464	features	_	
226-5	35465-35468	did	_	
226-6	35469-35474	reach	_	
226-7	35475-35486	statistical	_	
226-8	35487-35499	significance	_	
226-9	35499-35500	,	_	
226-10	35501-35505	this	_	
226-11	35506-35511	would	_	
226-12	35512-35515	not	_	
226-13	35516-35518	be	_	
226-14	35519-35529	sufficient	_	
226-15	35530-35533	for	_	
226-16	35534-35537	use	_	
226-17	35538-35540	as	_	
226-18	35541-35542	a	_	
226-19	35543-35552	biomarker	_	
226-20	35552-35553	,	_	
226-21	35554-35559	since	_	
226-22	35560-35565	there	_	
226-23	35566-35568	is	_	
226-24	35569-35574	still	_	
226-25	35575-35587	considerable	_	
226-26	35588-35595	overlap	_	
226-27	35596-35598	in	_	
226-28	35599-35602	the	_	
226-29	35603-35616	distributions	_	
226-30	35617-35619	of	_	
226-31	35620-35628	regional	_	
226-32	35629-35641	connectivity	_	
226-33	35642-35651	strengths	_	
226-34	35652-35659	between	_	
226-35	35660-35668	patients	_	
226-36	35669-35672	and	_	
226-37	35673-35681	controls	_	
226-38	35681-35682	.	_	

#Text=Multivariate pattern analysis, on the other hand, can reliably distinguish patients from healthy controls by identifying a set of features that in combination best describe the deviations from normal connectivity patterns.
227-1	35683-35695	Multivariate	_	
227-2	35696-35703	pattern	_	
227-3	35704-35712	analysis	_	
227-4	35712-35713	,	_	
227-5	35714-35716	on	_	
227-6	35717-35720	the	_	
227-7	35721-35726	other	_	
227-8	35727-35731	hand	_	
227-9	35731-35732	,	_	
227-10	35733-35736	can	_	
227-11	35737-35745	reliably	_	
227-12	35746-35757	distinguish	_	
227-13	35758-35766	patients	_	
227-14	35767-35771	from	_	
227-15	35772-35779	healthy	_	
227-16	35780-35788	controls	_	
227-17	35789-35791	by	_	
227-18	35792-35803	identifying	_	
227-19	35804-35805	a	_	
227-20	35806-35809	set	_	
227-21	35810-35812	of	_	
227-22	35813-35821	features	_	
227-23	35822-35826	that	_	
227-24	35827-35829	in	_	
227-25	35830-35841	combination	_	
227-26	35842-35846	best	_	
227-27	35847-35855	describe	_	
227-28	35856-35859	the	_	
227-29	35860-35870	deviations	_	
227-30	35871-35875	from	_	
227-31	35876-35882	normal	_	
227-32	35883-35895	connectivity	_	
227-33	35896-35904	patterns	_	
227-34	35904-35905	.	_	

#Text=In addition, this technique makes use of the mixture of increases and decreases in regional connectivity strength to help distinguish groups.
228-1	35906-35908	In	_	
228-2	35909-35917	addition	_	
228-3	35917-35918	,	_	
228-4	35919-35923	this	_	
228-5	35924-35933	technique	_	
228-6	35934-35939	makes	_	
228-7	35940-35943	use	_	
228-8	35944-35946	of	_	
228-9	35947-35950	the	_	
228-10	35951-35958	mixture	_	
228-11	35959-35961	of	_	
228-12	35962-35971	increases	_	
228-13	35972-35975	and	_	
228-14	35976-35985	decreases	_	
228-15	35986-35988	in	_	
228-16	35989-35997	regional	_	
228-17	35998-36010	connectivity	_	
228-18	36011-36019	strength	_	
228-19	36020-36022	to	_	
228-20	36023-36027	help	_	
228-21	36028-36039	distinguish	_	
228-22	36040-36046	groups	_	
228-23	36046-36047	.	_	

#Text=In contrast, univariate techniques typically require averaging over regional changes which may account for some of the conflicting results in the literature.
229-1	36048-36050	In	_	
229-2	36051-36059	contrast	_	
229-3	36059-36060	,	_	
229-4	36061-36071	univariate	_	
229-5	36072-36082	techniques	_	
229-6	36083-36092	typically	_	
229-7	36093-36100	require	_	
229-8	36101-36110	averaging	_	
229-9	36111-36115	over	_	
229-10	36116-36124	regional	_	
229-11	36125-36132	changes	_	
229-12	36133-36138	which	_	
229-13	36139-36142	may	_	
229-14	36143-36150	account	_	
229-15	36151-36154	for	_	
229-16	36155-36159	some	_	
229-17	36160-36162	of	_	
229-18	36163-36166	the	_	
229-19	36167-36178	conflicting	_	
229-20	36179-36186	results	_	
229-21	36187-36189	in	_	
229-22	36190-36193	the	_	
229-23	36194-36204	literature	_	
229-24	36204-36205	.	_	

#Text=Classification accuracy
#Text=For both SZ and ASD, we generated SVM models on an optimized set of diagnostic features identified through a feature elimination procedure.
230-1	36206-36220	Classification	_	
230-2	36221-36229	accuracy	_	
230-3	36230-36233	For	_	
230-4	36234-36238	both	_	
230-5	36239-36241	SZ	_	
230-6	36242-36245	and	_	
230-7	36246-36249	ASD	_	
230-8	36249-36250	,	_	
230-9	36251-36253	we	_	
230-10	36254-36263	generated	_	
230-11	36264-36267	SVM	_	
230-12	36268-36274	models	_	
230-13	36275-36277	on	_	
230-14	36278-36280	an	_	
230-15	36281-36290	optimized	_	
230-16	36291-36294	set	_	
230-17	36295-36297	of	_	
230-18	36298-36308	diagnostic	_	
230-19	36309-36317	features	_	
230-20	36318-36328	identified	_	
230-21	36329-36336	through	_	
230-22	36337-36338	a	_	
230-23	36339-36346	feature	_	
230-24	36347-36358	elimination	_	
230-25	36359-36368	procedure	_	
230-26	36368-36369	.	_	

#Text=We then tested these models on independent data sets to see if they generalize.
231-1	36370-36372	We	_	
231-2	36373-36377	then	_	
231-3	36378-36384	tested	_	
231-4	36385-36390	these	_	
231-5	36391-36397	models	_	
231-6	36398-36400	on	_	
231-7	36401-36412	independent	_	
231-8	36413-36417	data	_	
231-9	36418-36422	sets	_	
231-10	36423-36425	to	_	
231-11	36426-36429	see	_	
231-12	36430-36432	if	_	
231-13	36433-36437	they	_	
231-14	36438-36448	generalize	_	
231-15	36448-36449	.	_	

#Text=We found that the most significant features from each classification set did generalize and allowed us to obtain good classification accuracies on our testing data sets.
232-1	36450-36452	We	_	
232-2	36453-36458	found	_	
232-3	36459-36463	that	_	
232-4	36464-36467	the	_	
232-5	36468-36472	most	_	
232-6	36473-36484	significant	_	
232-7	36485-36493	features	_	
232-8	36494-36498	from	_	
232-9	36499-36503	each	_	
232-10	36504-36518	classification	_	
232-11	36519-36522	set	_	
232-12	36523-36526	did	_	
232-13	36527-36537	generalize	_	
232-14	36538-36541	and	_	
232-15	36542-36549	allowed	_	
232-16	36550-36552	us	_	
232-17	36553-36555	to	_	
232-18	36556-36562	obtain	_	
232-19	36563-36567	good	_	
232-20	36568-36582	classification	_	
232-21	36583-36593	accuracies	_	
232-22	36594-36596	on	_	
232-23	36597-36600	our	_	
232-24	36601-36608	testing	_	
232-25	36609-36613	data	_	
232-26	36614-36618	sets	_	
232-27	36618-36619	.	_	

#Text=We obtained 83% accuracy on the ASD validation data set and 80% accuracy on the SZ validation data set.
233-1	36620-36622	We	_	
233-2	36623-36631	obtained	_	
233-3	36632-36635	83%	_	
233-4	36636-36644	accuracy	_	
233-5	36645-36647	on	_	
233-6	36648-36651	the	_	
233-7	36652-36655	ASD	_	
233-8	36656-36666	validation	_	
233-9	36667-36671	data	_	
233-10	36672-36675	set	_	
233-11	36676-36679	and	_	
233-12	36680-36683	80%	_	
233-13	36684-36692	accuracy	_	
233-14	36693-36695	on	_	
233-15	36696-36699	the	_	
233-16	36700-36702	SZ	_	
233-17	36703-36713	validation	_	
233-18	36714-36718	data	_	
233-19	36719-36722	set	_	
233-20	36722-36723	.	_	

#Text=Many studies using multivariate classifiers have been previously carried out for both disorders (see and for schizophrenia review; autism).
234-1	36724-36728	Many	_	
234-2	36729-36736	studies	_	
234-3	36737-36742	using	_	
234-4	36743-36755	multivariate	_	
234-5	36756-36767	classifiers	_	
234-6	36768-36772	have	_	
234-7	36773-36777	been	_	
234-8	36778-36788	previously	_	
234-9	36789-36796	carried	_	
234-10	36797-36800	out	_	
234-11	36801-36804	for	_	
234-12	36805-36809	both	_	
234-13	36810-36819	disorders	_	
234-14	36820-36821	(	_	
234-15	36821-36824	see	_	
234-16	36825-36828	and	_	
234-17	36829-36832	for	_	
234-18	36833-36846	schizophrenia	_	
234-19	36847-36853	review	_	
234-20	36853-36854	;	_	
234-21	36855-36861	autism	_	
234-22	36861-36862	)	_	
234-23	36862-36863	.	_	

#Text=The overwhelming majority of such studies cross-validate their models using a leave one out, leave two out, or 10-fold cross validation scheme.
235-1	36864-36867	The	_	
235-2	36868-36880	overwhelming	_	
235-3	36881-36889	majority	_	
235-4	36890-36892	of	_	
235-5	36893-36897	such	_	
235-6	36898-36905	studies	_	
235-7	36906-36920	cross-validate	_	
235-8	36921-36926	their	_	
235-9	36927-36933	models	_	
235-10	36934-36939	using	_	
235-11	36940-36941	a	_	
235-12	36942-36947	leave	_	
235-13	36948-36951	one	_	
235-14	36952-36955	out	_	
235-15	36955-36956	,	_	
235-16	36957-36962	leave	_	
235-17	36963-36966	two	_	
235-18	36967-36970	out	_	
235-19	36970-36971	,	_	
235-20	36972-36974	or	_	
235-21	36975-36977	10	_	
235-22	36977-36978	-	_	
235-23	36978-36982	fold	_	
235-24	36983-36988	cross	_	
235-25	36989-36999	validation	_	
235-26	37000-37006	scheme	_	
235-27	37006-37007	.	_	

#Text=Very few test the generalization of their models on independent data sets.
236-1	37008-37012	Very	_	
236-2	37013-37016	few	_	
236-3	37017-37021	test	_	
236-4	37022-37025	the	_	
236-5	37026-37040	generalization	_	
236-6	37041-37043	of	_	
236-7	37044-37049	their	_	
236-8	37050-37056	models	_	
236-9	37057-37059	on	_	
236-10	37060-37071	independent	_	
236-11	37072-37076	data	_	
236-12	37077-37081	sets	_	
236-13	37081-37082	.	_	

#Text=For example, in one recent study of ASD 81% classification accuracy was achieved using SVM and leave two out cross validation of MRI structural images.
237-1	37083-37086	For	_	
237-2	37087-37094	example	_	
237-3	37094-37095	,	_	
237-4	37096-37098	in	_	
237-5	37099-37102	one	_	
237-6	37103-37109	recent	_	
237-7	37110-37115	study	_	
237-8	37116-37118	of	_	
237-9	37119-37122	ASD	_	
237-10	37123-37126	81%	_	
237-11	37127-37141	classification	_	
237-12	37142-37150	accuracy	_	
237-13	37151-37154	was	_	
237-14	37155-37163	achieved	_	
237-15	37164-37169	using	_	
237-16	37170-37173	SVM	_	
237-17	37174-37177	and	_	
237-18	37178-37183	leave	_	
237-19	37184-37187	two	_	
237-20	37188-37191	out	_	
237-21	37192-37197	cross	_	
237-22	37198-37208	validation	_	
237-23	37209-37211	of	_	
237-24	37212-37215	MRI	_	
237-25	37216-37226	structural	_	
237-26	37227-37233	images	_	
237-27	37233-37234	.	_	

#Text=They identified differences in grey matter structure in frontal, parietal, and limbic regions as well as the basal ganglia.
238-1	37235-37239	They	_	
238-2	37240-37250	identified	_	
238-3	37251-37262	differences	_	
238-4	37263-37265	in	_	
238-5	37266-37270	grey	_	
238-6	37271-37277	matter	_	
238-7	37278-37287	structure	_	
238-8	37288-37290	in	_	
238-9	37291-37298	frontal	_	
238-10	37298-37299	,	_	
238-11	37300-37308	parietal	_	
238-12	37308-37309	,	_	
238-13	37310-37313	and	_	
238-14	37314-37320	limbic	_	
238-15	37321-37328	regions	_	
238-16	37329-37331	as	_	
238-17	37332-37336	well	_	
238-18	37337-37339	as	_	
238-19	37340-37343	the	_	
238-20	37344-37349	basal	_	
238-21	37350-37357	ganglia	_	
238-22	37357-37358	.	_	

#Text=In another large multi-site study of 964 autistics, 60% accuracy was achieved using functional connectivity and leave one out cross-validation.
239-1	37359-37361	In	_	
239-2	37362-37369	another	_	
239-3	37370-37375	large	_	
239-4	37376-37386	multi-site	_	
239-5	37387-37392	study	_	
239-6	37393-37395	of	_	
239-7	37396-37399	964	_	
239-8	37400-37409	autistics	_	
239-9	37409-37410	,	_	
239-10	37411-37414	60%	_	
239-11	37415-37423	accuracy	_	
239-12	37424-37427	was	_	
239-13	37428-37436	achieved	_	
239-14	37437-37442	using	_	
239-15	37443-37453	functional	_	
239-16	37454-37466	connectivity	_	
239-17	37467-37470	and	_	
239-18	37471-37476	leave	_	
239-19	37477-37480	one	_	
239-20	37481-37484	out	_	
239-21	37485-37501	cross-validation	_	
239-22	37501-37502	.	_	

#Text=They identified features in DMN, temporal regions and the intraparietal sulcus.
240-1	37503-37507	They	_	
240-2	37508-37518	identified	_	
240-3	37519-37527	features	_	
240-4	37528-37530	in	_	
240-5	37531-37534	DMN	_	
240-6	37534-37535	,	_	
240-7	37536-37544	temporal	_	
240-8	37545-37552	regions	_	
240-9	37553-37556	and	_	
240-10	37557-37560	the	_	
240-11	37561-37574	intraparietal	_	
240-12	37575-37581	sulcus	_	
240-13	37581-37582	.	_	

#Text=Similar studies have been carried out in the schizophrenia literature.
241-1	37583-37590	Similar	_	
241-2	37591-37598	studies	_	
241-3	37599-37603	have	_	
241-4	37604-37608	been	_	
241-5	37609-37616	carried	_	
241-6	37617-37620	out	_	
241-7	37621-37623	in	_	
241-8	37624-37627	the	_	
241-9	37628-37641	schizophrenia	_	
241-10	37642-37652	literature	_	
241-11	37652-37653	.	_	

#Text=One such study reported 85% classification accuracy using SVM with 10-fold cross validation on functional connectivity measures.
242-1	37654-37657	One	_	
242-2	37658-37662	such	_	
242-3	37663-37668	study	_	
242-4	37669-37677	reported	_	
242-5	37678-37681	85%	_	
242-6	37682-37696	classification	_	
242-7	37697-37705	accuracy	_	
242-8	37706-37711	using	_	
242-9	37712-37715	SVM	_	
242-10	37716-37720	with	_	
242-11	37721-37723	10	_	
242-12	37723-37724	-	_	
242-13	37724-37728	fold	_	
242-14	37729-37734	cross	_	
242-15	37735-37745	validation	_	
242-16	37746-37748	on	_	
242-17	37749-37759	functional	_	
242-18	37760-37772	connectivity	_	
242-19	37773-37781	measures	_	
242-20	37781-37782	.	_	

#Text=Another study achieved 93% accuracy using Fishers' linear discriminant analysis.
243-1	37783-37790	Another	_	
243-2	37791-37796	study	_	
243-3	37797-37805	achieved	_	
243-4	37806-37809	93%	_	
243-5	37810-37818	accuracy	_	
243-6	37819-37824	using	_	
243-7	37825-37832	Fishers	_	
243-8	37832-37833	'	_	
243-9	37834-37840	linear	_	
243-10	37841-37853	discriminant	_	
243-11	37854-37862	analysis	_	
243-12	37862-37863	.	_	

#Text=Their analysis identified the DMN, temporal and visual regions as the most significant classification features.
244-1	37864-37869	Their	_	
244-2	37870-37878	analysis	_	
244-3	37879-37889	identified	_	
244-4	37890-37893	the	_	
244-5	37894-37897	DMN	_	
244-6	37897-37898	,	_	
244-7	37899-37907	temporal	_	
244-8	37908-37911	and	_	
244-9	37912-37918	visual	_	
244-10	37919-37926	regions	_	
244-11	37927-37929	as	_	
244-12	37930-37933	the	_	
244-13	37934-37938	most	_	
244-14	37939-37950	significant	_	
244-15	37951-37965	classification	_	
244-16	37966-37974	features	_	
244-17	37974-37975	.	_	

#Text=By testing our classification models on independent data sets over a range of the top diagnostic features, we showed that the features determined to have the most predictive power on our training data sets, determined based on the SVM model coefficients, generalized to independent training-naive data sets and that validation accuracies decrease as the number of diagnostic features becomes insufficient.
245-1	37976-37978	By	_	
245-2	37979-37986	testing	_	
245-3	37987-37990	our	_	
245-4	37991-38005	classification	_	
245-5	38006-38012	models	_	
245-6	38013-38015	on	_	
245-7	38016-38027	independent	_	
245-8	38028-38032	data	_	
245-9	38033-38037	sets	_	
245-10	38038-38042	over	_	
245-11	38043-38044	a	_	
245-12	38045-38050	range	_	
245-13	38051-38053	of	_	
245-14	38054-38057	the	_	
245-15	38058-38061	top	_	
245-16	38062-38072	diagnostic	_	
245-17	38073-38081	features	_	
245-18	38081-38082	,	_	
245-19	38083-38085	we	_	
245-20	38086-38092	showed	_	
245-21	38093-38097	that	_	
245-22	38098-38101	the	_	
245-23	38102-38110	features	_	
245-24	38111-38121	determined	_	
245-25	38122-38124	to	_	
245-26	38125-38129	have	_	
245-27	38130-38133	the	_	
245-28	38134-38138	most	_	
245-29	38139-38149	predictive	_	
245-30	38150-38155	power	_	
245-31	38156-38158	on	_	
245-32	38159-38162	our	_	
245-33	38163-38171	training	_	
245-34	38172-38176	data	_	
245-35	38177-38181	sets	_	
245-36	38181-38182	,	_	
245-37	38183-38193	determined	_	
245-38	38194-38199	based	_	
245-39	38200-38202	on	_	
245-40	38203-38206	the	_	
245-41	38207-38210	SVM	_	
245-42	38211-38216	model	_	
245-43	38217-38229	coefficients	_	
245-44	38229-38230	,	_	
245-45	38231-38242	generalized	_	
245-46	38243-38245	to	_	
245-47	38246-38257	independent	_	
245-48	38258-38272	training-naive	_	
245-49	38273-38277	data	_	
245-50	38278-38282	sets	_	
245-51	38283-38286	and	_	
245-52	38287-38291	that	_	
245-53	38292-38302	validation	_	
245-54	38303-38313	accuracies	_	
245-55	38314-38322	decrease	_	
245-56	38323-38325	as	_	
245-57	38326-38329	the	_	
245-58	38330-38336	number	_	
245-59	38337-38339	of	_	
245-60	38340-38350	diagnostic	_	
245-61	38351-38359	features	_	
245-62	38360-38367	becomes	_	
245-63	38368-38380	insufficient	_	
245-64	38380-38381	.	_	

#Text=Divergent features of ASD and SZ
#Text=The diagnostic features we identified through the RFE procedure were distributed across the brain, which supports the hypothesis that impaired integration of information across distributed brain areas is a hallmark of both ASD and SZ.
246-1	38382-38391	Divergent	_	
246-2	38392-38400	features	_	
246-3	38401-38403	of	_	
246-4	38404-38407	ASD	_	
246-5	38408-38411	and	_	
246-6	38412-38414	SZ	_	
246-7	38415-38418	The	_	
246-8	38419-38429	diagnostic	_	
246-9	38430-38438	features	_	
246-10	38439-38441	we	_	
246-11	38442-38452	identified	_	
246-12	38453-38460	through	_	
246-13	38461-38464	the	_	
246-14	38465-38468	RFE	_	
246-15	38469-38478	procedure	_	
246-16	38479-38483	were	_	
246-17	38484-38495	distributed	_	
246-18	38496-38502	across	_	
246-19	38503-38506	the	_	
246-20	38507-38512	brain	_	
246-21	38512-38513	,	_	
246-22	38514-38519	which	_	
246-23	38520-38528	supports	_	
246-24	38529-38532	the	_	
246-25	38533-38543	hypothesis	_	
246-26	38544-38548	that	_	
246-27	38549-38557	impaired	_	
246-28	38558-38569	integration	_	
246-29	38570-38572	of	_	
246-30	38573-38584	information	_	
246-31	38585-38591	across	_	
246-32	38592-38603	distributed	_	
246-33	38604-38609	brain	_	
246-34	38610-38615	areas	_	
246-35	38616-38618	is	_	
246-36	38619-38620	a	_	
246-37	38621-38629	hallmark	_	
246-38	38630-38632	of	_	
246-39	38633-38637	both	_	
246-40	38638-38641	ASD	_	
246-41	38642-38645	and	_	
246-42	38646-38648	SZ	_	
246-43	38648-38649	.	_	

#Text=Both disorders exhibited a large number of changes in connectivity in the DMN and salience networks.
247-1	38650-38654	Both	_	
247-2	38655-38664	disorders	_	
247-3	38665-38674	exhibited	_	
247-4	38675-38676	a	_	
247-5	38677-38682	large	_	
247-6	38683-38689	number	_	
247-7	38690-38692	of	_	
247-8	38693-38700	changes	_	
247-9	38701-38703	in	_	
247-10	38704-38716	connectivity	_	
247-11	38717-38719	in	_	
247-12	38720-38723	the	_	
247-13	38724-38727	DMN	_	
247-14	38728-38731	and	_	
247-15	38732-38740	salience	_	
247-16	38741-38749	networks	_	
247-17	38749-38750	.	_	

#Text=However, the two disorders dissociate in terms of the specific pattern of alterations.
248-1	38751-38758	However	_	
248-2	38758-38759	,	_	
248-3	38760-38763	the	_	
248-4	38764-38767	two	_	
248-5	38768-38777	disorders	_	
248-6	38778-38788	dissociate	_	
248-7	38789-38791	in	_	
248-8	38792-38797	terms	_	
248-9	38798-38800	of	_	
248-10	38801-38804	the	_	
248-11	38805-38813	specific	_	
248-12	38814-38821	pattern	_	
248-13	38822-38824	of	_	
248-14	38825-38836	alterations	_	
248-15	38836-38837	.	_	

#Text=ASD showed a greater proportion of within-network changes in the DMN and reduced connectivity between DMN and language areas.
249-1	38838-38841	ASD	_	
249-2	38842-38848	showed	_	
249-3	38849-38850	a	_	
249-4	38851-38858	greater	_	
249-5	38859-38869	proportion	_	
249-6	38870-38872	of	_	
249-7	38873-38887	within-network	_	
249-8	38888-38895	changes	_	
249-9	38896-38898	in	_	
249-10	38899-38902	the	_	
249-11	38903-38906	DMN	_	
249-12	38907-38910	and	_	
249-13	38911-38918	reduced	_	
249-14	38919-38931	connectivity	_	
249-15	38932-38939	between	_	
249-16	38940-38943	DMN	_	
249-17	38944-38947	and	_	
249-18	38948-38956	language	_	
249-19	38957-38962	areas	_	
249-20	38962-38963	.	_	

#Text=In contrast, SZ changes between DMN and language areas were largely increases in connectivity.
250-1	38964-38966	In	_	
250-2	38967-38975	contrast	_	
250-3	38975-38976	,	_	
250-4	38977-38979	SZ	_	
250-5	38980-38987	changes	_	
250-6	38988-38995	between	_	
250-7	38996-38999	DMN	_	
250-8	39000-39003	and	_	
250-9	39004-39012	language	_	
250-10	39013-39018	areas	_	
250-11	39019-39023	were	_	
250-12	39024-39031	largely	_	
250-13	39032-39041	increases	_	
250-14	39042-39044	in	_	
250-15	39045-39057	connectivity	_	
250-16	39057-39058	.	_	

#Text=Diametric changes in connectivity were also identified within the ECN where ASD exhibited largely decreases in connectivity relative to controls and SZ largely increases.
251-1	39059-39068	Diametric	_	
251-2	39069-39076	changes	_	
251-3	39077-39079	in	_	
251-4	39080-39092	connectivity	_	
251-5	39093-39097	were	_	
251-6	39098-39102	also	_	
251-7	39103-39113	identified	_	
251-8	39114-39120	within	_	
251-9	39121-39124	the	_	
251-10	39125-39128	ECN	_	
251-11	39129-39134	where	_	
251-12	39135-39138	ASD	_	
251-13	39139-39148	exhibited	_	
251-14	39149-39156	largely	_	
251-15	39157-39166	decreases	_	
251-16	39167-39169	in	_	
251-17	39170-39182	connectivity	_	
251-18	39183-39191	relative	_	
251-19	39192-39194	to	_	
251-20	39195-39203	controls	_	
251-21	39204-39207	and	_	
251-22	39208-39210	SZ	_	
251-23	39211-39218	largely	_	
251-24	39219-39228	increases	_	
251-25	39228-39229	.	_	

#Text=The ECN is involved in execution of voluntary control of behavioral responses to salient stimuli and has been identified as a loci of changes in connectivity in SZ.
252-1	39230-39233	The	_	
252-2	39234-39237	ECN	_	
252-3	39238-39240	is	_	
252-4	39241-39249	involved	_	
252-5	39250-39252	in	_	
252-6	39253-39262	execution	_	
252-7	39263-39265	of	_	
252-8	39266-39275	voluntary	_	
252-9	39276-39283	control	_	
252-10	39284-39286	of	_	
252-11	39287-39297	behavioral	_	
252-12	39298-39307	responses	_	
252-13	39308-39310	to	_	
252-14	39311-39318	salient	_	
252-15	39319-39326	stimuli	_	
252-16	39327-39330	and	_	
252-17	39331-39334	has	_	
252-18	39335-39339	been	_	
252-19	39340-39350	identified	_	
252-20	39351-39353	as	_	
252-21	39354-39355	a	_	
252-22	39356-39360	loci	_	
252-23	39361-39363	of	_	
252-24	39364-39371	changes	_	
252-25	39372-39374	in	_	
252-26	39375-39387	connectivity	_	
252-27	39388-39390	in	_	
252-28	39391-39393	SZ	_	
252-29	39393-39394	.	_	

#Text=It is unclear however whether changes in ECN associated with ASD are a primary cause of dysfunction or the result of dysfunction in lower-level sensory processing.
253-1	39395-39397	It	_	
253-2	39398-39400	is	_	
253-3	39401-39408	unclear	_	
253-4	39409-39416	however	_	
253-5	39417-39424	whether	_	
253-6	39425-39432	changes	_	
253-7	39433-39435	in	_	
253-8	39436-39439	ECN	_	
253-9	39440-39450	associated	_	
253-10	39451-39455	with	_	
253-11	39456-39459	ASD	_	
253-12	39460-39463	are	_	
253-13	39464-39465	a	_	
253-14	39466-39473	primary	_	
253-15	39474-39479	cause	_	
253-16	39480-39482	of	_	
253-17	39483-39494	dysfunction	_	
253-18	39495-39497	or	_	
253-19	39498-39501	the	_	
253-20	39502-39508	result	_	
253-21	39509-39511	of	_	
253-22	39512-39523	dysfunction	_	
253-23	39524-39526	in	_	
253-24	39527-39538	lower-level	_	
253-25	39539-39546	sensory	_	
253-26	39547-39557	processing	_	
253-27	39557-39558	.	_	

#Text=In fact, a much larger proportion of diagnostic features were found in sensory-motor regions in ASD than were identified in SZ patients.
254-1	39559-39561	In	_	
254-2	39562-39566	fact	_	
254-3	39566-39567	,	_	
254-4	39568-39569	a	_	
254-5	39570-39574	much	_	
254-6	39575-39581	larger	_	
254-7	39582-39592	proportion	_	
254-8	39593-39595	of	_	
254-9	39596-39606	diagnostic	_	
254-10	39607-39615	features	_	
254-11	39616-39620	were	_	
254-12	39621-39626	found	_	
254-13	39627-39629	in	_	
254-14	39630-39643	sensory-motor	_	
254-15	39644-39651	regions	_	
254-16	39652-39654	in	_	
254-17	39655-39658	ASD	_	
254-18	39659-39663	than	_	
254-19	39664-39668	were	_	
254-20	39669-39679	identified	_	
254-21	39680-39682	in	_	
254-22	39683-39685	SZ	_	
254-23	39686-39694	patients	_	
254-24	39694-39695	.	_	

#Text=The role of the sensory-motor cortex in social cognition has been studied in the context of the mirror-neuron system, where it is believed that individuals make sense of the actions and emotions of others.
255-1	39696-39699	The	_	
255-2	39700-39704	role	_	
255-3	39705-39707	of	_	
255-4	39708-39711	the	_	
255-5	39712-39725	sensory-motor	_	
255-6	39726-39732	cortex	_	
255-7	39733-39735	in	_	
255-8	39736-39742	social	_	
255-9	39743-39752	cognition	_	
255-10	39753-39756	has	_	
255-11	39757-39761	been	_	
255-12	39762-39769	studied	_	
255-13	39770-39772	in	_	
255-14	39773-39776	the	_	
255-15	39777-39784	context	_	
255-16	39785-39787	of	_	
255-17	39788-39791	the	_	
255-18	39792-39805	mirror-neuron	_	
255-19	39806-39812	system	_	
255-20	39812-39813	,	_	
255-21	39814-39819	where	_	
255-22	39820-39822	it	_	
255-23	39823-39825	is	_	
255-24	39826-39834	believed	_	
255-25	39835-39839	that	_	
255-26	39840-39851	individuals	_	
255-27	39852-39856	make	_	
255-28	39857-39862	sense	_	
255-29	39863-39865	of	_	
255-30	39866-39869	the	_	
255-31	39870-39877	actions	_	
255-32	39878-39881	and	_	
255-33	39882-39890	emotions	_	
255-34	39891-39893	of	_	
255-35	39894-39900	others	_	
255-36	39900-39901	.	_	

#Text=Mirror neurons were originally discovered in the pre-motor cortex of macaque monkeys.
256-1	39902-39908	Mirror	_	
256-2	39909-39916	neurons	_	
256-3	39917-39921	were	_	
256-4	39922-39932	originally	_	
256-5	39933-39943	discovered	_	
256-6	39944-39946	in	_	
256-7	39947-39950	the	_	
256-8	39951-39960	pre-motor	_	
256-9	39961-39967	cortex	_	
256-10	39968-39970	of	_	
256-11	39971-39978	macaque	_	
256-12	39979-39986	monkeys	_	
256-13	39986-39987	.	_	

#Text=They are known to fire during goal-oriented motor action, but also in response to observing the same action performed by another individual.
257-1	39988-39992	They	_	
257-2	39993-39996	are	_	
257-3	39997-40002	known	_	
257-4	40003-40005	to	_	
257-5	40006-40010	fire	_	
257-6	40011-40017	during	_	
257-7	40018-40031	goal-oriented	_	
257-8	40032-40037	motor	_	
257-9	40038-40044	action	_	
257-10	40044-40045	,	_	
257-11	40046-40049	but	_	
257-12	40050-40054	also	_	
257-13	40055-40057	in	_	
257-14	40058-40066	response	_	
257-15	40067-40069	to	_	
257-16	40070-40079	observing	_	
257-17	40080-40083	the	_	
257-18	40084-40088	same	_	
257-19	40089-40095	action	_	
257-20	40096-40105	performed	_	
257-21	40106-40108	by	_	
257-22	40109-40116	another	_	
257-23	40117-40127	individual	_	
257-24	40127-40128	.	_	

#Text=Previous studies have indicated dysfunction of the mirror-neuron system in both ASD and SZ patients.
258-1	40129-40137	Previous	_	
258-2	40138-40145	studies	_	
258-3	40146-40150	have	_	
258-4	40151-40160	indicated	_	
258-5	40161-40172	dysfunction	_	
258-6	40173-40175	of	_	
258-7	40176-40179	the	_	
258-8	40180-40193	mirror-neuron	_	
258-9	40194-40200	system	_	
258-10	40201-40203	in	_	
258-11	40204-40208	both	_	
258-12	40209-40212	ASD	_	
258-13	40213-40216	and	_	
258-14	40217-40219	SZ	_	
258-15	40220-40228	patients	_	
258-16	40228-40229	.	_	

#Text=In addition, the ASD model required more features for accurate classification than were required for SZ subjects.
259-1	40230-40232	In	_	
259-2	40233-40241	addition	_	
259-3	40241-40242	,	_	
259-4	40243-40246	the	_	
259-5	40247-40250	ASD	_	
259-6	40251-40256	model	_	
259-7	40257-40265	required	_	
259-8	40266-40270	more	_	
259-9	40271-40279	features	_	
259-10	40280-40283	for	_	
259-11	40284-40292	accurate	_	
259-12	40293-40307	classification	_	
259-13	40308-40312	than	_	
259-14	40313-40317	were	_	
259-15	40318-40326	required	_	
259-16	40327-40330	for	_	
259-17	40331-40333	SZ	_	
259-18	40334-40342	subjects	_	
259-19	40342-40343	.	_	

#Text=This may be due to the onset of the disorder early during brain development.
260-1	40344-40348	This	_	
260-2	40349-40352	may	_	
260-3	40353-40355	be	_	
260-4	40356-40359	due	_	
260-5	40360-40362	to	_	
260-6	40363-40366	the	_	
260-7	40367-40372	onset	_	
260-8	40373-40375	of	_	
260-9	40376-40379	the	_	
260-10	40380-40388	disorder	_	
260-11	40389-40394	early	_	
260-12	40395-40401	during	_	
260-13	40402-40407	brain	_	
260-14	40408-40419	development	_	
260-15	40419-40420	.	_	

#Text=It has been suggested that early changes in sensory processing of facial features, for example, lead to changes in the perceived salience of such features and eventually to altered attentional processing and social impairments in ASD.
261-1	40421-40423	It	_	
261-2	40424-40427	has	_	
261-3	40428-40432	been	_	
261-4	40433-40442	suggested	_	
261-5	40443-40447	that	_	
261-6	40448-40453	early	_	
261-7	40454-40461	changes	_	
261-8	40462-40464	in	_	
261-9	40465-40472	sensory	_	
261-10	40473-40483	processing	_	
261-11	40484-40486	of	_	
261-12	40487-40493	facial	_	
261-13	40494-40502	features	_	
261-14	40502-40503	,	_	
261-15	40504-40507	for	_	
261-16	40508-40515	example	_	
261-17	40515-40516	,	_	
261-18	40517-40521	lead	_	
261-19	40522-40524	to	_	
261-20	40525-40532	changes	_	
261-21	40533-40535	in	_	
261-22	40536-40539	the	_	
261-23	40540-40549	perceived	_	
261-24	40550-40558	salience	_	
261-25	40559-40561	of	_	
261-26	40562-40566	such	_	
261-27	40567-40575	features	_	
261-28	40576-40579	and	_	
261-29	40580-40590	eventually	_	
261-30	40591-40593	to	_	
261-31	40594-40601	altered	_	
261-32	40602-40613	attentional	_	
261-33	40614-40624	processing	_	
261-34	40625-40628	and	_	
261-35	40629-40635	social	_	
261-36	40636-40647	impairments	_	
261-37	40648-40650	in	_	
261-38	40651-40654	ASD	_	
261-39	40654-40655	.	_	

#Text=Therefore, aberrant function and connectivity early in development may lead to compound changes later in development for higher level skills that are dependent on more elementary or sensory-level function.
262-1	40656-40665	Therefore	_	
262-2	40665-40666	,	_	
262-3	40667-40675	aberrant	_	
262-4	40676-40684	function	_	
262-5	40685-40688	and	_	
262-6	40689-40701	connectivity	_	
262-7	40702-40707	early	_	
262-8	40708-40710	in	_	
262-9	40711-40722	development	_	
262-10	40723-40726	may	_	
262-11	40727-40731	lead	_	
262-12	40732-40734	to	_	
262-13	40735-40743	compound	_	
262-14	40744-40751	changes	_	
262-15	40752-40757	later	_	
262-16	40758-40760	in	_	
262-17	40761-40772	development	_	
262-18	40773-40776	for	_	
262-19	40777-40783	higher	_	
262-20	40784-40789	level	_	
262-21	40790-40796	skills	_	
262-22	40797-40801	that	_	
262-23	40802-40805	are	_	
262-24	40806-40815	dependent	_	
262-25	40816-40818	on	_	
262-26	40819-40823	more	_	
262-27	40824-40834	elementary	_	
262-28	40835-40837	or	_	
262-29	40838-40851	sensory-level	_	
262-30	40852-40860	function	_	
262-31	40860-40861	.	_	

#Text=Common features of ASD and SZ
#Text=The ability to behave in a context appropriate manner is dependent on recognition of socially relevant sensory information, and inferences based on learned constructs such as theory of mind.
263-1	40862-40868	Common	_	
263-2	40869-40877	features	_	
263-3	40878-40880	of	_	
263-4	40881-40884	ASD	_	
263-5	40885-40888	and	_	
263-6	40889-40891	SZ	_	
263-7	40892-40895	The	_	
263-8	40896-40903	ability	_	
263-9	40904-40906	to	_	
263-10	40907-40913	behave	_	
263-11	40914-40916	in	_	
263-12	40917-40918	a	_	
263-13	40919-40926	context	_	
263-14	40927-40938	appropriate	_	
263-15	40939-40945	manner	_	
263-16	40946-40948	is	_	
263-17	40949-40958	dependent	_	
263-18	40959-40961	on	_	
263-19	40962-40973	recognition	_	
263-20	40974-40976	of	_	
263-21	40977-40985	socially	_	
263-22	40986-40994	relevant	_	
263-23	40995-41002	sensory	_	
263-24	41003-41014	information	_	
263-25	41014-41015	,	_	
263-26	41016-41019	and	_	
263-27	41020-41030	inferences	_	
263-28	41031-41036	based	_	
263-29	41037-41039	on	_	
263-30	41040-41047	learned	_	
263-31	41048-41058	constructs	_	
263-32	41059-41063	such	_	
263-33	41064-41066	as	_	
263-34	41067-41073	theory	_	
263-35	41074-41076	of	_	
263-36	41077-41081	mind	_	
263-37	41081-41082	.	_	

#Text=Accordingly, in our study, the overwhelming majority of diagnostic features identified for both ASD and SZ are in the salience and default mode networks.
264-1	41083-41094	Accordingly	_	
264-2	41094-41095	,	_	
264-3	41096-41098	in	_	
264-4	41099-41102	our	_	
264-5	41103-41108	study	_	
264-6	41108-41109	,	_	
264-7	41110-41113	the	_	
264-8	41114-41126	overwhelming	_	
264-9	41127-41135	majority	_	
264-10	41136-41138	of	_	
264-11	41139-41149	diagnostic	_	
264-12	41150-41158	features	_	
264-13	41159-41169	identified	_	
264-14	41170-41173	for	_	
264-15	41174-41178	both	_	
264-16	41179-41182	ASD	_	
264-17	41183-41186	and	_	
264-18	41187-41189	SZ	_	
264-19	41190-41193	are	_	
264-20	41194-41196	in	_	
264-21	41197-41200	the	_	
264-22	41201-41209	salience	_	
264-23	41210-41213	and	_	
264-24	41214-41221	default	_	
264-25	41222-41226	mode	_	
264-26	41227-41235	networks	_	
264-27	41235-41236	.	_	

#Text=The DMN is believed to be essential to theory of mind abilities, while the salience network contributes to a variety of cognitive abilities including communication, social behavior and self-awareness.
265-1	41237-41240	The	_	
265-2	41241-41244	DMN	_	
265-3	41245-41247	is	_	
265-4	41248-41256	believed	_	
265-5	41257-41259	to	_	
265-6	41260-41262	be	_	
265-7	41263-41272	essential	_	
265-8	41273-41275	to	_	
265-9	41276-41282	theory	_	
265-10	41283-41285	of	_	
265-11	41286-41290	mind	_	
265-12	41291-41300	abilities	_	
265-13	41300-41301	,	_	
265-14	41302-41307	while	_	
265-15	41308-41311	the	_	
265-16	41312-41320	salience	_	
265-17	41321-41328	network	_	
265-18	41329-41340	contributes	_	
265-19	41341-41343	to	_	
265-20	41344-41345	a	_	
265-21	41346-41353	variety	_	
265-22	41354-41356	of	_	
265-23	41357-41366	cognitive	_	
265-24	41367-41376	abilities	_	
265-25	41377-41386	including	_	
265-26	41387-41400	communication	_	
265-27	41400-41401	,	_	
265-28	41402-41408	social	_	
265-29	41409-41417	behavior	_	
265-30	41418-41421	and	_	
265-31	41422-41436	self-awareness	_	
265-32	41436-41437	.	_	

#Text=Both networks have been previously implicated in a variety of brain disorders including SZ and ASD.
266-1	41438-41442	Both	_	
266-2	41443-41451	networks	_	
266-3	41452-41456	have	_	
266-4	41457-41461	been	_	
266-5	41462-41472	previously	_	
266-6	41473-41483	implicated	_	
266-7	41484-41486	in	_	
266-8	41487-41488	a	_	
266-9	41489-41496	variety	_	
266-10	41497-41499	of	_	
266-11	41500-41505	brain	_	
266-12	41506-41515	disorders	_	
266-13	41516-41525	including	_	
266-14	41526-41528	SZ	_	
266-15	41529-41532	and	_	
266-16	41533-41536	ASD	_	
266-17	41536-41537	.	_	

#Text=For example, in autism is it known that the relative salience of social queues including facial expressions are impaired.
267-1	41538-41541	For	_	
267-2	41542-41549	example	_	
267-3	41549-41550	,	_	
267-4	41551-41553	in	_	
267-5	41554-41560	autism	_	
267-6	41561-41563	is	_	
267-7	41564-41566	it	_	
267-8	41567-41572	known	_	
267-9	41573-41577	that	_	
267-10	41578-41581	the	_	
267-11	41582-41590	relative	_	
267-12	41591-41599	salience	_	
267-13	41600-41602	of	_	
267-14	41603-41609	social	_	
267-15	41610-41616	queues	_	
267-16	41617-41626	including	_	
267-17	41627-41633	facial	_	
267-18	41634-41645	expressions	_	
267-19	41646-41649	are	_	
267-20	41650-41658	impaired	_	
267-21	41658-41659	.	_	

#Text=In schizophrenia, misattribution of salience to external and internal stimuli may be a cause of positive symptoms such as hallucinations.
268-1	41660-41662	In	_	
268-2	41663-41676	schizophrenia	_	
268-3	41676-41677	,	_	
268-4	41678-41692	misattribution	_	
268-5	41693-41695	of	_	
268-6	41696-41704	salience	_	
268-7	41705-41707	to	_	
268-8	41708-41716	external	_	
268-9	41717-41720	and	_	
268-10	41721-41729	internal	_	
268-11	41730-41737	stimuli	_	
268-12	41738-41741	may	_	
268-13	41742-41744	be	_	
268-14	41745-41746	a	_	
268-15	41747-41752	cause	_	
268-16	41753-41755	of	_	
268-17	41756-41764	positive	_	
268-18	41765-41773	symptoms	_	
268-19	41774-41778	such	_	
268-20	41779-41781	as	_	
268-21	41782-41796	hallucinations	_	
268-22	41796-41797	.	_	

#Text=The DMN is an important part of association cortex.
269-1	41798-41801	The	_	
269-2	41802-41805	DMN	_	
269-3	41806-41808	is	_	
269-4	41809-41811	an	_	
269-5	41812-41821	important	_	
269-6	41822-41826	part	_	
269-7	41827-41829	of	_	
269-8	41830-41841	association	_	
269-9	41842-41848	cortex	_	
269-10	41848-41849	.	_	

#Text=The DMN has connections to supplementary motor areas, frontal eye fields involved in control of visual attention, and reciprocal connections to thalamic nuclei that in-turn connect exclusively with higher association cortices.
270-1	41850-41853	The	_	
270-2	41854-41857	DMN	_	
270-3	41858-41861	has	_	
270-4	41862-41873	connections	_	
270-5	41874-41876	to	_	
270-6	41877-41890	supplementary	_	
270-7	41891-41896	motor	_	
270-8	41897-41902	areas	_	
270-9	41902-41903	,	_	
270-10	41904-41911	frontal	_	
270-11	41912-41915	eye	_	
270-12	41916-41922	fields	_	
270-13	41923-41931	involved	_	
270-14	41932-41934	in	_	
270-15	41935-41942	control	_	
270-16	41943-41945	of	_	
270-17	41946-41952	visual	_	
270-18	41953-41962	attention	_	
270-19	41962-41963	,	_	
270-20	41964-41967	and	_	
270-21	41968-41978	reciprocal	_	
270-22	41979-41990	connections	_	
270-23	41991-41993	to	_	
270-24	41994-42002	thalamic	_	
270-25	42003-42009	nuclei	_	
270-26	42010-42014	that	_	
270-27	42015-42022	in-turn	_	
270-28	42023-42030	connect	_	
270-29	42031-42042	exclusively	_	
270-30	42043-42047	with	_	
270-31	42048-42054	higher	_	
270-32	42055-42066	association	_	
270-33	42067-42075	cortices	_	
270-34	42075-42076	.	_	

#Text=While there is little debate that the DMN is activated during theory of mind and other self-reflexive tasks, the function of the DMN is not well understood.
271-1	42077-42082	While	_	
271-2	42083-42088	there	_	
271-3	42089-42091	is	_	
271-4	42092-42098	little	_	
271-5	42099-42105	debate	_	
271-6	42106-42110	that	_	
271-7	42111-42114	the	_	
271-8	42115-42118	DMN	_	
271-9	42119-42121	is	_	
271-10	42122-42131	activated	_	
271-11	42132-42138	during	_	
271-12	42139-42145	theory	_	
271-13	42146-42148	of	_	
271-14	42149-42153	mind	_	
271-15	42154-42157	and	_	
271-16	42158-42163	other	_	
271-17	42164-42178	self-reflexive	_	
271-18	42179-42184	tasks	_	
271-19	42184-42185	,	_	
271-20	42186-42189	the	_	
271-21	42190-42198	function	_	
271-22	42199-42201	of	_	
271-23	42202-42205	the	_	
271-24	42206-42209	DMN	_	
271-25	42210-42212	is	_	
271-26	42213-42216	not	_	
271-27	42217-42221	well	_	
271-28	42222-42232	understood	_	
271-29	42232-42233	.	_	

#Text=Many studies have identified the DMN as a collection of areas that are structural and functional hubs, acting as a common connection point for many other brain areas.
272-1	42234-42238	Many	_	
272-2	42239-42246	studies	_	
272-3	42247-42251	have	_	
272-4	42252-42262	identified	_	
272-5	42263-42266	the	_	
272-6	42267-42270	DMN	_	
272-7	42271-42273	as	_	
272-8	42274-42275	a	_	
272-9	42276-42286	collection	_	
272-10	42287-42289	of	_	
272-11	42290-42295	areas	_	
272-12	42296-42300	that	_	
272-13	42301-42304	are	_	
272-14	42305-42315	structural	_	
272-15	42316-42319	and	_	
272-16	42320-42330	functional	_	
272-17	42331-42335	hubs	_	
272-18	42335-42336	,	_	
272-19	42337-42343	acting	_	
272-20	42344-42346	as	_	
272-21	42347-42348	a	_	
272-22	42349-42355	common	_	
272-23	42356-42366	connection	_	
272-24	42367-42372	point	_	
272-25	42373-42376	for	_	
272-26	42377-42381	many	_	
272-27	42382-42387	other	_	
272-28	42388-42393	brain	_	
272-29	42394-42399	areas	_	
272-30	42399-42400	.	_	

#Text=The DMN may play a key role in integrating executive control and salience networks, as was reported recently in the context of an n-back working memory task.
273-1	42401-42404	The	_	
273-2	42405-42408	DMN	_	
273-3	42409-42412	may	_	
273-4	42413-42417	play	_	
273-5	42418-42419	a	_	
273-6	42420-42423	key	_	
273-7	42424-42428	role	_	
273-8	42429-42431	in	_	
273-9	42432-42443	integrating	_	
273-10	42444-42453	executive	_	
273-11	42454-42461	control	_	
273-12	42462-42465	and	_	
273-13	42466-42474	salience	_	
273-14	42475-42483	networks	_	
273-15	42483-42484	,	_	
273-16	42485-42487	as	_	
273-17	42488-42491	was	_	
273-18	42492-42500	reported	_	
273-19	42501-42509	recently	_	
273-20	42510-42512	in	_	
273-21	42513-42516	the	_	
273-22	42517-42524	context	_	
273-23	42525-42527	of	_	
273-24	42528-42530	an	_	
273-25	42531-42537	n-back	_	
273-26	42538-42545	working	_	
273-27	42546-42552	memory	_	
273-28	42553-42557	task	_	
273-29	42557-42558	.	_	

#Text=As the task load elevated, functional connectivity increased between the salience network and the default mode and executive control networks.
274-1	42559-42561	As	_	
274-2	42562-42565	the	_	
274-3	42566-42570	task	_	
274-4	42571-42575	load	_	
274-5	42576-42584	elevated	_	
274-6	42584-42585	,	_	
274-7	42586-42596	functional	_	
274-8	42597-42609	connectivity	_	
274-9	42610-42619	increased	_	
274-10	42620-42627	between	_	
274-11	42628-42631	the	_	
274-12	42632-42640	salience	_	
274-13	42641-42648	network	_	
274-14	42649-42652	and	_	
274-15	42653-42656	the	_	
274-16	42657-42664	default	_	
274-17	42665-42669	mode	_	
274-18	42670-42673	and	_	
274-19	42674-42683	executive	_	
274-20	42684-42691	control	_	
274-21	42692-42700	networks	_	
274-22	42700-42701	.	_	

#Text=Interestingly, there is evidence that the DMN may integrate with salience networks in a graded manner.
275-1	42702-42715	Interestingly	_	
275-2	42715-42716	,	_	
275-3	42717-42722	there	_	
275-4	42723-42725	is	_	
275-5	42726-42734	evidence	_	
275-6	42735-42739	that	_	
275-7	42740-42743	the	_	
275-8	42744-42747	DMN	_	
275-9	42748-42751	may	_	
275-10	42752-42761	integrate	_	
275-11	42762-42766	with	_	
275-12	42767-42775	salience	_	
275-13	42776-42784	networks	_	
275-14	42785-42787	in	_	
275-15	42788-42789	a	_	
275-16	42790-42796	graded	_	
275-17	42797-42803	manner	_	
275-18	42803-42804	.	_	

#Text=In a very large study of resting state functional connectivity, smoothly varying gradients of connectivity were found between each region of the DMN and salience network.
276-1	42805-42807	In	_	
276-2	42808-42809	a	_	
276-3	42810-42814	very	_	
276-4	42815-42820	large	_	
276-5	42821-42826	study	_	
276-6	42827-42829	of	_	
276-7	42830-42837	resting	_	
276-8	42838-42843	state	_	
276-9	42844-42854	functional	_	
276-10	42855-42867	connectivity	_	
276-11	42867-42868	,	_	
276-12	42869-42877	smoothly	_	
276-13	42878-42885	varying	_	
276-14	42886-42895	gradients	_	
276-15	42896-42898	of	_	
276-16	42899-42911	connectivity	_	
276-17	42912-42916	were	_	
276-18	42917-42922	found	_	
276-19	42923-42930	between	_	
276-20	42931-42935	each	_	
276-21	42936-42942	region	_	
276-22	42943-42945	of	_	
276-23	42946-42949	the	_	
276-24	42950-42953	DMN	_	
276-25	42954-42957	and	_	
276-26	42958-42966	salience	_	
276-27	42967-42974	network	_	
276-28	42974-42975	.	_	

#Text=These connectivity gradients were found to strengthen with maturity.
277-1	42976-42981	These	_	
277-2	42982-42994	connectivity	_	
277-3	42995-43004	gradients	_	
277-4	43005-43009	were	_	
277-5	43010-43015	found	_	
277-6	43016-43018	to	_	
277-7	43019-43029	strengthen	_	
277-8	43030-43034	with	_	
277-9	43035-43043	maturity	_	
277-10	43043-43044	.	_	

#Text=It is possible that aberrant balance between these gradients of connectivity develop as a result of improper pruning and fine tuning over the course of development leading to dysfunction.
278-1	43045-43047	It	_	
278-2	43048-43050	is	_	
278-3	43051-43059	possible	_	
278-4	43060-43064	that	_	
278-5	43065-43073	aberrant	_	
278-6	43074-43081	balance	_	
278-7	43082-43089	between	_	
278-8	43090-43095	these	_	
278-9	43096-43105	gradients	_	
278-10	43106-43108	of	_	
278-11	43109-43121	connectivity	_	
278-12	43122-43129	develop	_	
278-13	43130-43132	as	_	
278-14	43133-43134	a	_	
278-15	43135-43141	result	_	
278-16	43142-43144	of	_	
278-17	43145-43153	improper	_	
278-18	43154-43161	pruning	_	
278-19	43162-43165	and	_	
278-20	43166-43170	fine	_	
278-21	43171-43177	tuning	_	
278-22	43178-43182	over	_	
278-23	43183-43186	the	_	
278-24	43187-43193	course	_	
278-25	43194-43196	of	_	
278-26	43197-43208	development	_	
278-27	43209-43216	leading	_	
278-28	43217-43219	to	_	
278-29	43220-43231	dysfunction	_	
278-30	43231-43232	.	_	

#Text=Therefore, the changing interaction of these networks over the course of brain development is one possible explanation for why cognitive deficits similar to those of ASD do not manifest in SZ till early adulthood.
279-1	43233-43242	Therefore	_	
279-2	43242-43243	,	_	
279-3	43244-43247	the	_	
279-4	43248-43256	changing	_	
279-5	43257-43268	interaction	_	
279-6	43269-43271	of	_	
279-7	43272-43277	these	_	
279-8	43278-43286	networks	_	
279-9	43287-43291	over	_	
279-10	43292-43295	the	_	
279-11	43296-43302	course	_	
279-12	43303-43305	of	_	
279-13	43306-43311	brain	_	
279-14	43312-43323	development	_	
279-15	43324-43326	is	_	
279-16	43327-43330	one	_	
279-17	43331-43339	possible	_	
279-18	43340-43351	explanation	_	
279-19	43352-43355	for	_	
279-20	43356-43359	why	_	
279-21	43360-43369	cognitive	_	
279-22	43370-43378	deficits	_	
279-23	43379-43386	similar	_	
279-24	43387-43389	to	_	
279-25	43390-43395	those	_	
279-26	43396-43398	of	_	
279-27	43399-43402	ASD	_	
279-28	43403-43405	do	_	
279-29	43406-43409	not	_	
279-30	43410-43418	manifest	_	
279-31	43419-43421	in	_	
279-32	43422-43424	SZ	_	
279-33	43425-43429	till	_	
279-34	43430-43435	early	_	
279-35	43436-43445	adulthood	_	
279-36	43445-43446	.	_	

#Text=A graded response between key networks may also contribute to the spectrum of cognitive deficits observed when this system is compromised.
280-1	43447-43448	A	_	
280-2	43449-43455	graded	_	
280-3	43456-43464	response	_	
280-4	43465-43472	between	_	
280-5	43473-43476	key	_	
280-6	43477-43485	networks	_	
280-7	43486-43489	may	_	
280-8	43490-43494	also	_	
280-9	43495-43505	contribute	_	
280-10	43506-43508	to	_	
280-11	43509-43512	the	_	
280-12	43513-43521	spectrum	_	
280-13	43522-43524	of	_	
280-14	43525-43534	cognitive	_	
280-15	43535-43543	deficits	_	
280-16	43544-43552	observed	_	
280-17	43553-43557	when	_	
280-18	43558-43562	this	_	
280-19	43563-43569	system	_	
280-20	43570-43572	is	_	
280-21	43573-43584	compromised	_	
280-22	43584-43585	.	_	

#Text=Discriminating ASD from SZ
#Text=A small subset of the common and divergent features that distinguished either ASD or SZ from controls had diagnostic importance for classifying ASD from SZ subjects.
281-1	43586-43600	Discriminating	_	
281-2	43601-43604	ASD	_	
281-3	43605-43609	from	_	
281-4	43610-43612	SZ	_	
281-5	43613-43614	A	_	
281-6	43615-43620	small	_	
281-7	43621-43627	subset	_	
281-8	43628-43630	of	_	
281-9	43631-43634	the	_	
281-10	43635-43641	common	_	
281-11	43642-43645	and	_	
281-12	43646-43655	divergent	_	
281-13	43656-43664	features	_	
281-14	43665-43669	that	_	
281-15	43670-43683	distinguished	_	
281-16	43684-43690	either	_	
281-17	43691-43694	ASD	_	
281-18	43695-43697	or	_	
281-19	43698-43700	SZ	_	
281-20	43701-43705	from	_	
281-21	43706-43714	controls	_	
281-22	43715-43718	had	_	
281-23	43719-43729	diagnostic	_	
281-24	43730-43740	importance	_	
281-25	43741-43744	for	_	
281-26	43745-43756	classifying	_	
281-27	43757-43760	ASD	_	
281-28	43761-43765	from	_	
281-29	43766-43768	SZ	_	
281-30	43769-43777	subjects	_	
281-31	43777-43778	.	_	

#Text=This subset was dominated by features in the DMN.
282-1	43779-43783	This	_	
282-2	43784-43790	subset	_	
282-3	43791-43794	was	_	
282-4	43795-43804	dominated	_	
282-5	43805-43807	by	_	
282-6	43808-43816	features	_	
282-7	43817-43819	in	_	
282-8	43820-43823	the	_	
282-9	43824-43827	DMN	_	
282-10	43827-43828	.	_	

#Text=Our results indicate that relative to SZ patients (rather than controls), ASD is associated with stronger connectivity in DMN connections, while weaker connectivity was found in SZ patients for the same edges.
283-1	43829-43832	Our	_	
283-2	43833-43840	results	_	
283-3	43841-43849	indicate	_	
283-4	43850-43854	that	_	
283-5	43855-43863	relative	_	
283-6	43864-43866	to	_	
283-7	43867-43869	SZ	_	
283-8	43870-43878	patients	_	
283-9	43879-43880	(	_	
283-10	43880-43886	rather	_	
283-11	43887-43891	than	_	
283-12	43892-43900	controls	_	
283-13	43900-43901	)	_	
283-14	43901-43902	,	_	
283-15	43903-43906	ASD	_	
283-16	43907-43909	is	_	
283-17	43910-43920	associated	_	
283-18	43921-43925	with	_	
283-19	43926-43934	stronger	_	
283-20	43935-43947	connectivity	_	
283-21	43948-43950	in	_	
283-22	43951-43954	DMN	_	
283-23	43955-43966	connections	_	
283-24	43966-43967	,	_	
283-25	43968-43973	while	_	
283-26	43974-43980	weaker	_	
283-27	43981-43993	connectivity	_	
283-28	43994-43997	was	_	
283-29	43998-44003	found	_	
283-30	44004-44006	in	_	
283-31	44007-44009	SZ	_	
283-32	44010-44018	patients	_	
283-33	44019-44022	for	_	
283-34	44023-44026	the	_	
283-35	44027-44031	same	_	
283-36	44032-44037	edges	_	
283-37	44037-44038	.	_	

#Text=Positive symptoms associated with SZ, such as hallucinations, are one of the main characteristics that distinguish SZ from ASD.
284-1	44039-44047	Positive	_	
284-2	44048-44056	symptoms	_	
284-3	44057-44067	associated	_	
284-4	44068-44072	with	_	
284-5	44073-44075	SZ	_	
284-6	44075-44076	,	_	
284-7	44077-44081	such	_	
284-8	44082-44084	as	_	
284-9	44085-44099	hallucinations	_	
284-10	44099-44100	,	_	
284-11	44101-44104	are	_	
284-12	44105-44108	one	_	
284-13	44109-44111	of	_	
284-14	44112-44115	the	_	
284-15	44116-44120	main	_	
284-16	44121-44136	characteristics	_	
284-17	44137-44141	that	_	
284-18	44142-44153	distinguish	_	
284-19	44154-44156	SZ	_	
284-20	44157-44161	from	_	
284-21	44162-44165	ASD	_	
284-22	44165-44166	.	_	

#Text=Positive symptoms in SZ are reportedly correlated with increased functional connectivity between the posterior regions of the DMN and the salience network.
285-1	44167-44175	Positive	_	
285-2	44176-44184	symptoms	_	
285-3	44185-44187	in	_	
285-4	44188-44190	SZ	_	
285-5	44191-44194	are	_	
285-6	44195-44205	reportedly	_	
285-7	44206-44216	correlated	_	
285-8	44217-44221	with	_	
285-9	44222-44231	increased	_	
285-10	44232-44242	functional	_	
285-11	44243-44255	connectivity	_	
285-12	44256-44263	between	_	
285-13	44264-44267	the	_	
285-14	44268-44277	posterior	_	
285-15	44278-44285	regions	_	
285-16	44286-44288	of	_	
285-17	44289-44292	the	_	
285-18	44293-44296	DMN	_	
285-19	44297-44300	and	_	
285-20	44301-44304	the	_	
285-21	44305-44313	salience	_	
285-22	44314-44321	network	_	
285-23	44321-44322	.	_	

#Text=Our results suggest that such increases involve connections specifically between the posterior cingulate and supplementary motor cortex, and between the precuneus and lateral occipital cortex.
286-1	44323-44326	Our	_	
286-2	44327-44334	results	_	
286-3	44335-44342	suggest	_	
286-4	44343-44347	that	_	
286-5	44348-44352	such	_	
286-6	44353-44362	increases	_	
286-7	44363-44370	involve	_	
286-8	44371-44382	connections	_	
286-9	44383-44395	specifically	_	
286-10	44396-44403	between	_	
286-11	44404-44407	the	_	
286-12	44408-44417	posterior	_	
286-13	44418-44427	cingulate	_	
286-14	44428-44431	and	_	
286-15	44432-44445	supplementary	_	
286-16	44446-44451	motor	_	
286-17	44452-44458	cortex	_	
286-18	44458-44459	,	_	
286-19	44460-44463	and	_	
286-20	44464-44471	between	_	
286-21	44472-44475	the	_	
286-22	44476-44485	precuneus	_	
286-23	44486-44489	and	_	
286-24	44490-44497	lateral	_	
286-25	44498-44507	occipital	_	
286-26	44508-44514	cortex	_	
286-27	44514-44515	.	_	

#Text=In addition, some studies have indicated that negative symptoms in SZ, such as impaired social cognition, are associated with decreased connectivity with anterior parts of the DMN in medial prefrontal cortex.
287-1	44516-44518	In	_	
287-2	44519-44527	addition	_	
287-3	44527-44528	,	_	
287-4	44529-44533	some	_	
287-5	44534-44541	studies	_	
287-6	44542-44546	have	_	
287-7	44547-44556	indicated	_	
287-8	44557-44561	that	_	
287-9	44562-44570	negative	_	
287-10	44571-44579	symptoms	_	
287-11	44580-44582	in	_	
287-12	44583-44585	SZ	_	
287-13	44585-44586	,	_	
287-14	44587-44591	such	_	
287-15	44592-44594	as	_	
287-16	44595-44603	impaired	_	
287-17	44604-44610	social	_	
287-18	44611-44620	cognition	_	
287-19	44620-44621	,	_	
287-20	44622-44625	are	_	
287-21	44626-44636	associated	_	
287-22	44637-44641	with	_	
287-23	44642-44651	decreased	_	
287-24	44652-44664	connectivity	_	
287-25	44665-44669	with	_	
287-26	44670-44678	anterior	_	
287-27	44679-44684	parts	_	
287-28	44685-44687	of	_	
287-29	44688-44691	the	_	
287-30	44692-44695	DMN	_	
287-31	44696-44698	in	_	
287-32	44699-44705	medial	_	
287-33	44706-44716	prefrontal	_	
287-34	44717-44723	cortex	_	
287-35	44723-44724	.	_	

#Text=Impaired social cognition related to theory of mind abilities, tasks that typically recruit DMN structures, has also consistently been associated with reduced activation of the DMN in ASD.
288-1	44725-44733	Impaired	_	
288-2	44734-44740	social	_	
288-3	44741-44750	cognition	_	
288-4	44751-44758	related	_	
288-5	44759-44761	to	_	
288-6	44762-44768	theory	_	
288-7	44769-44771	of	_	
288-8	44772-44776	mind	_	
288-9	44777-44786	abilities	_	
288-10	44786-44787	,	_	
288-11	44788-44793	tasks	_	
288-12	44794-44798	that	_	
288-13	44799-44808	typically	_	
288-14	44809-44816	recruit	_	
288-15	44817-44820	DMN	_	
288-16	44821-44831	structures	_	
288-17	44831-44832	,	_	
288-18	44833-44836	has	_	
288-19	44837-44841	also	_	
288-20	44842-44854	consistently	_	
288-21	44855-44859	been	_	
288-22	44860-44870	associated	_	
288-23	44871-44875	with	_	
288-24	44876-44883	reduced	_	
288-25	44884-44894	activation	_	
288-26	44895-44897	of	_	
288-27	44898-44901	the	_	
288-28	44902-44905	DMN	_	
288-29	44906-44908	in	_	
288-30	44909-44912	ASD	_	
288-31	44912-44913	.	_	

#Text=However, our results suggest that SZ subjects have weaker connectivity over specific edges within anterior DMN regions particularly related to connections to the paracingulate.
289-1	44914-44921	However	_	
289-2	44921-44922	,	_	
289-3	44923-44926	our	_	
289-4	44927-44934	results	_	
289-5	44935-44942	suggest	_	
289-6	44943-44947	that	_	
289-7	44948-44950	SZ	_	
289-8	44951-44959	subjects	_	
289-9	44960-44964	have	_	
289-10	44965-44971	weaker	_	
289-11	44972-44984	connectivity	_	
289-12	44985-44989	over	_	
289-13	44990-44998	specific	_	
289-14	44999-45004	edges	_	
289-15	45005-45011	within	_	
289-16	45012-45020	anterior	_	
289-17	45021-45024	DMN	_	
289-18	45025-45032	regions	_	
289-19	45033-45045	particularly	_	
289-20	45046-45053	related	_	
289-21	45054-45056	to	_	
289-22	45057-45068	connections	_	
289-23	45069-45071	to	_	
289-24	45072-45075	the	_	
289-25	45076-45089	paracingulate	_	
289-26	45089-45090	.	_	

#Text=As we were able to use these features to successfully classify ASD from SZ subjects in our validation data sets, we have demonstrated that multivariate machine learning techniques can be used to distinguish between disorders even when there is considerable overlap in their symptoms.
290-1	45091-45093	As	_	
290-2	45094-45096	we	_	
290-3	45097-45101	were	_	
290-4	45102-45106	able	_	
290-5	45107-45109	to	_	
290-6	45110-45113	use	_	
290-7	45114-45119	these	_	
290-8	45120-45128	features	_	
290-9	45129-45131	to	_	
290-10	45132-45144	successfully	_	
290-11	45145-45153	classify	_	
290-12	45154-45157	ASD	_	
290-13	45158-45162	from	_	
290-14	45163-45165	SZ	_	
290-15	45166-45174	subjects	_	
290-16	45175-45177	in	_	
290-17	45178-45181	our	_	
290-18	45182-45192	validation	_	
290-19	45193-45197	data	_	
290-20	45198-45202	sets	_	
290-21	45202-45203	,	_	
290-22	45204-45206	we	_	
290-23	45207-45211	have	_	
290-24	45212-45224	demonstrated	_	
290-25	45225-45229	that	_	
290-26	45230-45242	multivariate	_	
290-27	45243-45250	machine	_	
290-28	45251-45259	learning	_	
290-29	45260-45270	techniques	_	
290-30	45271-45274	can	_	
290-31	45275-45277	be	_	
290-32	45278-45282	used	_	
290-33	45283-45285	to	_	
290-34	45286-45297	distinguish	_	
290-35	45298-45305	between	_	
290-36	45306-45315	disorders	_	
290-37	45316-45320	even	_	
290-38	45321-45325	when	_	
290-39	45326-45331	there	_	
290-40	45332-45334	is	_	
290-41	45335-45347	considerable	_	
290-42	45348-45355	overlap	_	
290-43	45356-45358	in	_	
290-44	45359-45364	their	_	
290-45	45365-45373	symptoms	_	
290-46	45373-45374	.	_	

#Text=Limitations of the current study
#Text=The RFE method we employed demonstrates that there are characteristic changes in the patterns of resting state connectivity that generalize to patient populations outside of our training sets.
291-1	45375-45386	Limitations	_	
291-2	45387-45389	of	_	
291-3	45390-45393	the	_	
291-4	45394-45401	current	_	
291-5	45402-45407	study	_	
291-6	45408-45411	The	_	
291-7	45412-45415	RFE	_	
291-8	45416-45422	method	_	
291-9	45423-45425	we	_	
291-10	45426-45434	employed	_	
291-11	45435-45447	demonstrates	_	
291-12	45448-45452	that	_	
291-13	45453-45458	there	_	
291-14	45459-45462	are	_	
291-15	45463-45477	characteristic	_	
291-16	45478-45485	changes	_	
291-17	45486-45488	in	_	
291-18	45489-45492	the	_	
291-19	45493-45501	patterns	_	
291-20	45502-45504	of	_	
291-21	45505-45512	resting	_	
291-22	45513-45518	state	_	
291-23	45519-45531	connectivity	_	
291-24	45532-45536	that	_	
291-25	45537-45547	generalize	_	
291-26	45548-45550	to	_	
291-27	45551-45558	patient	_	
291-28	45559-45570	populations	_	
291-29	45571-45578	outside	_	
291-30	45579-45581	of	_	
291-31	45582-45585	our	_	
291-32	45586-45594	training	_	
291-33	45595-45599	sets	_	
291-34	45599-45600	.	_	

#Text=A specific challenge to be met in identifying diagnostic biomarkers from resting state functional connectivity is to find the best set of features to maximize diagnostic capability.
292-1	45601-45602	A	_	
292-2	45603-45611	specific	_	
292-3	45612-45621	challenge	_	
292-4	45622-45624	to	_	
292-5	45625-45627	be	_	
292-6	45628-45631	met	_	
292-7	45632-45634	in	_	
292-8	45635-45646	identifying	_	
292-9	45647-45657	diagnostic	_	
292-10	45658-45668	biomarkers	_	
292-11	45669-45673	from	_	
292-12	45674-45681	resting	_	
292-13	45682-45687	state	_	
292-14	45688-45698	functional	_	
292-15	45699-45711	connectivity	_	
292-16	45712-45714	is	_	
292-17	45715-45717	to	_	
292-18	45718-45722	find	_	
292-19	45723-45726	the	_	
292-20	45727-45731	best	_	
292-21	45732-45735	set	_	
292-22	45736-45738	of	_	
292-23	45739-45747	features	_	
292-24	45748-45750	to	_	
292-25	45751-45759	maximize	_	
292-26	45760-45770	diagnostic	_	
292-27	45771-45781	capability	_	
292-28	45781-45782	.	_	

#Text=The set of ROIs we used, while comprehensive in their representative coverage of functional brain areas, nonetheless has sparse coverage over the whole brain.
293-1	45783-45786	The	_	
293-2	45787-45790	set	_	
293-3	45791-45793	of	_	
293-4	45794-45798	ROIs	_	
293-5	45799-45801	we	_	
293-6	45802-45806	used	_	
293-7	45806-45807	,	_	
293-8	45808-45813	while	_	
293-9	45814-45827	comprehensive	_	
293-10	45828-45830	in	_	
293-11	45831-45836	their	_	
293-12	45837-45851	representative	_	
293-13	45852-45860	coverage	_	
293-14	45861-45863	of	_	
293-15	45864-45874	functional	_	
293-16	45875-45880	brain	_	
293-17	45881-45886	areas	_	
293-18	45886-45887	,	_	
293-19	45888-45899	nonetheless	_	
293-20	45900-45903	has	_	
293-21	45904-45910	sparse	_	
293-22	45911-45919	coverage	_	
293-23	45920-45924	over	_	
293-24	45925-45928	the	_	
293-25	45929-45934	whole	_	
293-26	45935-45940	brain	_	
293-27	45940-45941	.	_	

#Text=Future work should explore similar analysis using a voxel level approach to determine if there are better features to use for this purpose.
294-1	45942-45948	Future	_	
294-2	45949-45953	work	_	
294-3	45954-45960	should	_	
294-4	45961-45968	explore	_	
294-5	45969-45976	similar	_	
294-6	45977-45985	analysis	_	
294-7	45986-45991	using	_	
294-8	45992-45993	a	_	
294-9	45994-45999	voxel	_	
294-10	46000-46005	level	_	
294-11	46006-46014	approach	_	
294-12	46015-46017	to	_	
294-13	46018-46027	determine	_	
294-14	46028-46030	if	_	
294-15	46031-46036	there	_	
294-16	46037-46040	are	_	
294-17	46041-46047	better	_	
294-18	46048-46056	features	_	
294-19	46057-46059	to	_	
294-20	46060-46063	use	_	
294-21	46064-46067	for	_	
294-22	46068-46072	this	_	
294-23	46073-46080	purpose	_	
294-24	46080-46081	.	_	

#Text=Additionally, because we did not have access to symptom severity measures in our schizophrenic patients, we were not able to explicitly associate common connectivity differences in ASD and SZ to measures of symptom severity in SZ patients.
295-1	46082-46094	Additionally	_	
295-2	46094-46095	,	_	
295-3	46096-46103	because	_	
295-4	46104-46106	we	_	
295-5	46107-46110	did	_	
295-6	46111-46114	not	_	
295-7	46115-46119	have	_	
295-8	46120-46126	access	_	
295-9	46127-46129	to	_	
295-10	46130-46137	symptom	_	
295-11	46138-46146	severity	_	
295-12	46147-46155	measures	_	
295-13	46156-46158	in	_	
295-14	46159-46162	our	_	
295-15	46163-46176	schizophrenic	_	
295-16	46177-46185	patients	_	
295-17	46185-46186	,	_	
295-18	46187-46189	we	_	
295-19	46190-46194	were	_	
295-20	46195-46198	not	_	
295-21	46199-46203	able	_	
295-22	46204-46206	to	_	
295-23	46207-46217	explicitly	_	
295-24	46218-46227	associate	_	
295-25	46228-46234	common	_	
295-26	46235-46247	connectivity	_	
295-27	46248-46259	differences	_	
295-28	46260-46262	in	_	
295-29	46263-46266	ASD	_	
295-30	46267-46270	and	_	
295-31	46271-46273	SZ	_	
295-32	46274-46276	to	_	
295-33	46277-46285	measures	_	
295-34	46286-46288	of	_	
295-35	46289-46296	symptom	_	
295-36	46297-46305	severity	_	
295-37	46306-46308	in	_	
295-38	46309-46311	SZ	_	
295-39	46312-46320	patients	_	
295-40	46320-46321	.	_	

#Text=Finally the sample size of the SZ test data was small.
296-1	46322-46329	Finally	_	
296-2	46330-46333	the	_	
296-3	46334-46340	sample	_	
296-4	46341-46345	size	_	
296-5	46346-46348	of	_	
296-6	46349-46352	the	_	
296-7	46353-46355	SZ	_	
296-8	46356-46360	test	_	
296-9	46361-46365	data	_	
296-10	46366-46369	was	_	
296-11	46370-46375	small	_	
296-12	46375-46376	.	_	

#Text=Future studies would explore the utility of identified features over several data sets for greater certainty of diagnostic utility.
297-1	46377-46383	Future	_	
297-2	46384-46391	studies	_	
297-3	46392-46397	would	_	
297-4	46398-46405	explore	_	
297-5	46406-46409	the	_	
297-6	46410-46417	utility	_	
297-7	46418-46420	of	_	
297-8	46421-46431	identified	_	
297-9	46432-46440	features	_	
297-10	46441-46445	over	_	
297-11	46446-46453	several	_	
297-12	46454-46458	data	_	
297-13	46459-46463	sets	_	
297-14	46464-46467	for	_	
297-15	46468-46475	greater	_	
297-16	46476-46485	certainty	_	
297-17	46486-46488	of	_	
297-18	46489-46499	diagnostic	_	
297-19	46500-46507	utility	_	
297-20	46507-46508	.	_	

#Text=However, few studies attempt to validate classifier models on data sets outside of the training set.
298-1	46509-46516	However	_	
298-2	46516-46517	,	_	
298-3	46518-46521	few	_	
298-4	46522-46529	studies	_	
298-5	46530-46537	attempt	_	
298-6	46538-46540	to	_	
298-7	46541-46549	validate	_	
298-8	46550-46560	classifier	_	
298-9	46561-46567	models	_	
298-10	46568-46570	on	_	
298-11	46571-46575	data	_	
298-12	46576-46580	sets	_	
298-13	46581-46588	outside	_	
298-14	46589-46591	of	_	
298-15	46592-46595	the	_	
298-16	46596-46604	training	_	
298-17	46605-46608	set	_	
298-18	46608-46609	.	_	

#Text=We achieved good classification accuracy on this small data set as well as the larger ASD test set, suggesting that our model features are based in disease specific changes in connectivity that may generalize to other patient populations.
299-1	46610-46612	We	_	
299-2	46613-46621	achieved	_	
299-3	46622-46626	good	_	
299-4	46627-46641	classification	_	
299-5	46642-46650	accuracy	_	
299-6	46651-46653	on	_	
299-7	46654-46658	this	_	
299-8	46659-46664	small	_	
299-9	46665-46669	data	_	
299-10	46670-46673	set	_	
299-11	46674-46676	as	_	
299-12	46677-46681	well	_	
299-13	46682-46684	as	_	
299-14	46685-46688	the	_	
299-15	46689-46695	larger	_	
299-16	46696-46699	ASD	_	
299-17	46700-46704	test	_	
299-18	46705-46708	set	_	
299-19	46708-46709	,	_	
299-20	46710-46720	suggesting	_	
299-21	46721-46725	that	_	
299-22	46726-46729	our	_	
299-23	46730-46735	model	_	
299-24	46736-46744	features	_	
299-25	46745-46748	are	_	
299-26	46749-46754	based	_	
299-27	46755-46757	in	_	
299-28	46758-46765	disease	_	
299-29	46766-46774	specific	_	
299-30	46775-46782	changes	_	
299-31	46783-46785	in	_	
299-32	46786-46798	connectivity	_	
299-33	46799-46803	that	_	
299-34	46804-46807	may	_	
299-35	46808-46818	generalize	_	
299-36	46819-46821	to	_	
299-37	46822-46827	other	_	
299-38	46828-46835	patient	_	
299-39	46836-46847	populations	_	
299-40	46847-46848	.	_	

#Text=Conclusion
#Text=In summary, in this study, we identified common changes in connectivity between ASD and SZ and showed that these changes predict deficits in communication skills in ASD patients.
300-1	46849-46859	Conclusion	_	
300-2	46860-46862	In	_	
300-3	46863-46870	summary	_	
300-4	46870-46871	,	_	
300-5	46872-46874	in	_	
300-6	46875-46879	this	_	
300-7	46880-46885	study	_	
300-8	46885-46886	,	_	
300-9	46887-46889	we	_	
300-10	46890-46900	identified	_	
300-11	46901-46907	common	_	
300-12	46908-46915	changes	_	
300-13	46916-46918	in	_	
300-14	46919-46931	connectivity	_	
300-15	46932-46939	between	_	
300-16	46940-46943	ASD	_	
300-17	46944-46947	and	_	
300-18	46948-46950	SZ	_	
300-19	46951-46954	and	_	
300-20	46955-46961	showed	_	
300-21	46962-46966	that	_	
300-22	46967-46972	these	_	
300-23	46973-46980	changes	_	
300-24	46981-46988	predict	_	
300-25	46989-46997	deficits	_	
300-26	46998-47000	in	_	
300-27	47001-47014	communication	_	
300-28	47015-47021	skills	_	
300-29	47022-47024	in	_	
300-30	47025-47028	ASD	_	
300-31	47029-47037	patients	_	
300-32	47037-47038	.	_	

#Text=Our results suggest that common social cognitive deficits associated with ASD and SZ may be related to changes in connectivity within higher order association cortex in the DMN and salience network.
301-1	47039-47042	Our	_	
301-2	47043-47050	results	_	
301-3	47051-47058	suggest	_	
301-4	47059-47063	that	_	
301-5	47064-47070	common	_	
301-6	47071-47077	social	_	
301-7	47078-47087	cognitive	_	
301-8	47088-47096	deficits	_	
301-9	47097-47107	associated	_	
301-10	47108-47112	with	_	
301-11	47113-47116	ASD	_	
301-12	47117-47120	and	_	
301-13	47121-47123	SZ	_	
301-14	47124-47127	may	_	
301-15	47128-47130	be	_	
301-16	47131-47138	related	_	
301-17	47139-47141	to	_	
301-18	47142-47149	changes	_	
301-19	47150-47152	in	_	
301-20	47153-47165	connectivity	_	
301-21	47166-47172	within	_	
301-22	47173-47179	higher	_	
301-23	47180-47185	order	_	
301-24	47186-47197	association	_	
301-25	47198-47204	cortex	_	
301-26	47205-47207	in	_	
301-27	47208-47211	the	_	
301-28	47212-47215	DMN	_	
301-29	47216-47219	and	_	
301-30	47220-47228	salience	_	
301-31	47229-47236	network	_	
301-32	47236-47237	.	_	

#Text=In addition, we have identified divergent changes in connectivity and showed that these features can be used to discriminate ASD and SZ patients.
302-1	47238-47240	In	_	
302-2	47241-47249	addition	_	
302-3	47249-47250	,	_	
302-4	47251-47253	we	_	
302-5	47254-47258	have	_	
302-6	47259-47269	identified	_	
302-7	47270-47279	divergent	_	
302-8	47280-47287	changes	_	
302-9	47288-47290	in	_	
302-10	47291-47303	connectivity	_	
302-11	47304-47307	and	_	
302-12	47308-47314	showed	_	
302-13	47315-47319	that	_	
302-14	47320-47325	these	_	
302-15	47326-47334	features	_	
302-16	47335-47338	can	_	
302-17	47339-47341	be	_	
302-18	47342-47346	used	_	
302-19	47347-47349	to	_	
302-20	47350-47362	discriminate	_	
302-21	47363-47366	ASD	_	
302-22	47367-47370	and	_	
302-23	47371-47373	SZ	_	
302-24	47374-47382	patients	_	
302-25	47382-47383	.	_	

#Text=These features resulted in classification accuracies well above chance performance in training-naive data sets, suggesting that these models may generalize across patient populations.
303-1	47384-47389	These	_	
303-2	47390-47398	features	_	
303-3	47399-47407	resulted	_	
303-4	47408-47410	in	_	
303-5	47411-47425	classification	_	
303-6	47426-47436	accuracies	_	
303-7	47437-47441	well	_	
303-8	47442-47447	above	_	
303-9	47448-47454	chance	_	
303-10	47455-47466	performance	_	
303-11	47467-47469	in	_	
303-12	47470-47484	training-naive	_	
303-13	47485-47489	data	_	
303-14	47490-47494	sets	_	
303-15	47494-47495	,	_	
303-16	47496-47506	suggesting	_	
303-17	47507-47511	that	_	
303-18	47512-47517	these	_	
303-19	47518-47524	models	_	
303-20	47525-47528	may	_	
303-21	47529-47539	generalize	_	
303-22	47540-47546	across	_	
303-23	47547-47554	patient	_	
303-24	47555-47566	populations	_	
303-25	47566-47567	.	_	

#Text=Relative to healthy individuals, there were more disparate than common features of the two disorders, but only a few features had diagnostic significance in distinguishing the two populations.
304-1	47568-47576	Relative	_	
304-2	47577-47579	to	_	
304-3	47580-47587	healthy	_	
304-4	47588-47599	individuals	_	
304-5	47599-47600	,	_	
304-6	47601-47606	there	_	
304-7	47607-47611	were	_	
304-8	47612-47616	more	_	
304-9	47617-47626	disparate	_	
304-10	47627-47631	than	_	
304-11	47632-47638	common	_	
304-12	47639-47647	features	_	
304-13	47648-47650	of	_	
304-14	47651-47654	the	_	
304-15	47655-47658	two	_	
304-16	47659-47668	disorders	_	
304-17	47668-47669	,	_	
304-18	47670-47673	but	_	
304-19	47674-47678	only	_	
304-20	47679-47680	a	_	
304-21	47681-47684	few	_	
304-22	47685-47693	features	_	
304-23	47694-47697	had	_	
304-24	47698-47708	diagnostic	_	
304-25	47709-47721	significance	_	
304-26	47722-47724	in	_	
304-27	47725-47739	distinguishing	_	
304-28	47740-47743	the	_	
304-29	47744-47747	two	_	
304-30	47748-47759	populations	_	
304-31	47759-47760	.	_	

#Text=Relative to SZ patients, the distinguishing features of ASD were increases in connectivity within higher order visual processing areas and the DMN.
305-1	47761-47769	Relative	_	
305-2	47770-47772	to	_	
305-3	47773-47775	SZ	_	
305-4	47776-47784	patients	_	
305-5	47784-47785	,	_	
305-6	47786-47789	the	_	
305-7	47790-47804	distinguishing	_	
305-8	47805-47813	features	_	
305-9	47814-47816	of	_	
305-10	47817-47820	ASD	_	
305-11	47821-47825	were	_	
305-12	47826-47835	increases	_	
305-13	47836-47838	in	_	
305-14	47839-47851	connectivity	_	
305-15	47852-47858	within	_	
305-16	47859-47865	higher	_	
305-17	47866-47871	order	_	
305-18	47872-47878	visual	_	
305-19	47879-47889	processing	_	
305-20	47890-47895	areas	_	
305-21	47896-47899	and	_	
305-22	47900-47903	the	_	
305-23	47904-47907	DMN	_	
305-24	47907-47908	.	_	

#Text=When disorders exhibit considerable overlap in their symptoms, as is the case in ASD and SZ, comparative studies can yield insights into the changes in connectivity that lead to common deficits.
306-1	47909-47913	When	_	
306-2	47914-47923	disorders	_	
306-3	47924-47931	exhibit	_	
306-4	47932-47944	considerable	_	
306-5	47945-47952	overlap	_	
306-6	47953-47955	in	_	
306-7	47956-47961	their	_	
306-8	47962-47970	symptoms	_	
306-9	47970-47971	,	_	
306-10	47972-47974	as	_	
306-11	47975-47977	is	_	
306-12	47978-47981	the	_	
306-13	47982-47986	case	_	
306-14	47987-47989	in	_	
306-15	47990-47993	ASD	_	
306-16	47994-47997	and	_	
306-17	47998-48000	SZ	_	
306-18	48000-48001	,	_	
306-19	48002-48013	comparative	_	
306-20	48014-48021	studies	_	
306-21	48022-48025	can	_	
306-22	48026-48031	yield	_	
306-23	48032-48040	insights	_	
306-24	48041-48045	into	_	
306-25	48046-48049	the	_	
306-26	48050-48057	changes	_	
306-27	48058-48060	in	_	
306-28	48061-48073	connectivity	_	
306-29	48074-48078	that	_	
306-30	48079-48083	lead	_	
306-31	48084-48086	to	_	
306-32	48087-48093	common	_	
306-33	48094-48102	deficits	_	
306-34	48102-48103	.	_	

#Text=References
#Text=
#Text=Decreased interhemispheric functional connectivity in autism
#Text=Functional connectivity magnetic resonance imaging classification of autism
#Text=Connectivity gradients between the default mode and attention control networks
#Text=
#Text=Attention does not modulate neural responses to social stimuli in autism spectrum disorders
#Text=
#Text=Spontaneous low-frequency fluctuations in the BOLD signal in schizophrenic patients: anomalies in the default network
#Text=
#Text=Self-projection and the brain
#Text=Altered functional and anatomical connectivity in schizophrenia
#Text=The precuneus: a review of its functional anatomy and behavioural correlates
#Text=Functional connectivity in a baseline resting-state network in autism
#Text=Comparative genomics of autism and schizophrenia
#Text=The nature of overinclusive thinking in schizophrenia
#Text=A review of challenges in the use of fMRI for disease classification/characterization and a projection pursuit application from a multi-site fMRI schizophrenia study
#Text=High classification accuracy for schizophrenia with rest and task fMRI data
#Text=Investigating the predictive value of whole-brain structural MR scans in autism: a pattern classification approach
#Text=Mirror neuron activity associated with social impairments but not age in autism spectrum disorder
#Text=Schizophrenia, neuroimaging and connectomics
#Text=
#Text=A unifying view of the basis of social cognition
#Text=Gene selection for cancer classification using support vector machines
#Text=Brain reading using full brain support vector machines for object recognition: there is no “face” identification area
#Text=Scale-free exponents of resting state provide a biomarker for typical and atypical brain activity
#Text=A global optimization method for robust affine registration of brain images
#Text=Improved optimisation for the robust and accurate linear registration and motion correction of brain images
#Text=Functional and anatomical cortical underconnectivity in autism: evidence from an fMRI study of an executive function task and corpus callosum morphometry
#Text=Detecting neuroimaging biomarker for schizophrenia: a meta-analysis of multivariate pattern recognition studies
#Text=Understanding executive control in autism spectrum disorders in the lab and in the real world
#Text=Studies in the childhood psychoses.
307-1	48104-48114	References	_	
307-2	48116-48125	Decreased	_	
307-3	48126-48142	interhemispheric	_	
307-4	48143-48153	functional	_	
307-5	48154-48166	connectivity	_	
307-6	48167-48169	in	_	
307-7	48170-48176	autism	_	
307-8	48177-48187	Functional	_	
307-9	48188-48200	connectivity	_	
307-10	48201-48209	magnetic	_	
307-11	48210-48219	resonance	_	
307-12	48220-48227	imaging	_	
307-13	48228-48242	classification	_	
307-14	48243-48245	of	_	
307-15	48246-48252	autism	_	
307-16	48253-48265	Connectivity	_	
307-17	48266-48275	gradients	_	
307-18	48276-48283	between	_	
307-19	48284-48287	the	_	
307-20	48288-48295	default	_	
307-21	48296-48300	mode	_	
307-22	48301-48304	and	_	
307-23	48305-48314	attention	_	
307-24	48315-48322	control	_	
307-25	48323-48331	networks	_	
307-26	48333-48342	Attention	_	
307-27	48343-48347	does	_	
307-28	48348-48351	not	_	
307-29	48352-48360	modulate	_	
307-30	48361-48367	neural	_	
307-31	48368-48377	responses	_	
307-32	48378-48380	to	_	
307-33	48381-48387	social	_	
307-34	48388-48395	stimuli	_	
307-35	48396-48398	in	_	
307-36	48399-48405	autism	_	
307-37	48406-48414	spectrum	_	
307-38	48415-48424	disorders	_	
307-39	48426-48437	Spontaneous	_	
307-40	48438-48451	low-frequency	_	
307-41	48452-48464	fluctuations	_	
307-42	48465-48467	in	_	
307-43	48468-48471	the	_	
307-44	48472-48476	BOLD	_	
307-45	48477-48483	signal	_	
307-46	48484-48486	in	_	
307-47	48487-48500	schizophrenic	_	
307-48	48501-48509	patients	_	
307-49	48509-48510	:	_	
307-50	48511-48520	anomalies	_	
307-51	48521-48523	in	_	
307-52	48524-48527	the	_	
307-53	48528-48535	default	_	
307-54	48536-48543	network	_	
307-55	48545-48560	Self-projection	_	
307-56	48561-48564	and	_	
307-57	48565-48568	the	_	
307-58	48569-48574	brain	_	
307-59	48575-48582	Altered	_	
307-60	48583-48593	functional	_	
307-61	48594-48597	and	_	
307-62	48598-48608	anatomical	_	
307-63	48609-48621	connectivity	_	
307-64	48622-48624	in	_	
307-65	48625-48638	schizophrenia	_	
307-66	48639-48642	The	_	
307-67	48643-48652	precuneus	_	
307-68	48652-48653	:	_	
307-69	48654-48655	a	_	
307-70	48656-48662	review	_	
307-71	48663-48665	of	_	
307-72	48666-48669	its	_	
307-73	48670-48680	functional	_	
307-74	48681-48688	anatomy	_	
307-75	48689-48692	and	_	
307-76	48693-48704	behavioural	_	
307-77	48705-48715	correlates	_	
307-78	48716-48726	Functional	_	
307-79	48727-48739	connectivity	_	
307-80	48740-48742	in	_	
307-81	48743-48744	a	_	
307-82	48745-48753	baseline	_	
307-83	48754-48767	resting-state	_	
307-84	48768-48775	network	_	
307-85	48776-48778	in	_	
307-86	48779-48785	autism	_	
307-87	48786-48797	Comparative	_	
307-88	48798-48806	genomics	_	
307-89	48807-48809	of	_	
307-90	48810-48816	autism	_	
307-91	48817-48820	and	_	
307-92	48821-48834	schizophrenia	_	
307-93	48835-48838	The	_	
307-94	48839-48845	nature	_	
307-95	48846-48848	of	_	
307-96	48849-48862	overinclusive	_	
307-97	48863-48871	thinking	_	
307-98	48872-48874	in	_	
307-99	48875-48888	schizophrenia	_	
307-100	48889-48890	A	_	
307-101	48891-48897	review	_	
307-102	48898-48900	of	_	
307-103	48901-48911	challenges	_	
307-104	48912-48914	in	_	
307-105	48915-48918	the	_	
307-106	48919-48922	use	_	
307-107	48923-48925	of	_	
307-108	48926-48930	fMRI	_	
307-109	48931-48934	for	_	
307-110	48935-48942	disease	_	
307-111	48943-48957	classification	_	
307-112	48957-48958	/	_	
307-113	48958-48974	characterization	_	
307-114	48975-48978	and	_	
307-115	48979-48980	a	_	
307-116	48981-48991	projection	_	
307-117	48992-48999	pursuit	_	
307-118	49000-49011	application	_	
307-119	49012-49016	from	_	
307-120	49017-49018	a	_	
307-121	49019-49029	multi-site	_	
307-122	49030-49034	fMRI	_	
307-123	49035-49048	schizophrenia	_	
307-124	49049-49054	study	_	
307-125	49055-49059	High	_	
307-126	49060-49074	classification	_	
307-127	49075-49083	accuracy	_	
307-128	49084-49087	for	_	
307-129	49088-49101	schizophrenia	_	
307-130	49102-49106	with	_	
307-131	49107-49111	rest	_	
307-132	49112-49115	and	_	
307-133	49116-49120	task	_	
307-134	49121-49125	fMRI	_	
307-135	49126-49130	data	_	
307-136	49131-49144	Investigating	_	
307-137	49145-49148	the	_	
307-138	49149-49159	predictive	_	
307-139	49160-49165	value	_	
307-140	49166-49168	of	_	
307-141	49169-49180	whole-brain	_	
307-142	49181-49191	structural	_	
307-143	49192-49194	MR	_	
307-144	49195-49200	scans	_	
307-145	49201-49203	in	_	
307-146	49204-49210	autism	_	
307-147	49210-49211	:	_	
307-148	49212-49213	a	_	
307-149	49214-49221	pattern	_	
307-150	49222-49236	classification	_	
307-151	49237-49245	approach	_	
307-152	49246-49252	Mirror	_	
307-153	49253-49259	neuron	_	
307-154	49260-49268	activity	_	
307-155	49269-49279	associated	_	
307-156	49280-49284	with	_	
307-157	49285-49291	social	_	
307-158	49292-49303	impairments	_	
307-159	49304-49307	but	_	
307-160	49308-49311	not	_	
307-161	49312-49315	age	_	
307-162	49316-49318	in	_	
307-163	49319-49325	autism	_	
307-164	49326-49334	spectrum	_	
307-165	49335-49343	disorder	_	
307-166	49344-49357	Schizophrenia	_	
307-167	49357-49358	,	_	
307-168	49359-49371	neuroimaging	_	
307-169	49372-49375	and	_	
307-170	49376-49388	connectomics	_	
307-171	49390-49391	A	_	
307-172	49392-49400	unifying	_	
307-173	49401-49405	view	_	
307-174	49406-49408	of	_	
307-175	49409-49412	the	_	
307-176	49413-49418	basis	_	
307-177	49419-49421	of	_	
307-178	49422-49428	social	_	
307-179	49429-49438	cognition	_	
307-180	49439-49443	Gene	_	
307-181	49444-49453	selection	_	
307-182	49454-49457	for	_	
307-183	49458-49464	cancer	_	
307-184	49465-49479	classification	_	
307-185	49480-49485	using	_	
307-186	49486-49493	support	_	
307-187	49494-49500	vector	_	
307-188	49501-49509	machines	_	
307-189	49510-49515	Brain	_	
307-190	49516-49523	reading	_	
307-191	49524-49529	using	_	
307-192	49530-49534	full	_	
307-193	49535-49540	brain	_	
307-194	49541-49548	support	_	
307-195	49549-49555	vector	_	
307-196	49556-49564	machines	_	
307-197	49565-49568	for	_	
307-198	49569-49575	object	_	
307-199	49576-49587	recognition	_	
307-200	49587-49588	:	_	
307-201	49589-49594	there	_	
307-202	49595-49597	is	_	
307-203	49598-49600	no	_	
307-204	49601-49602	“	_	
307-205	49602-49606	face	_	
307-206	49606-49607	”	_	
307-207	49608-49622	identification	_	
307-208	49623-49627	area	_	
307-209	49628-49638	Scale-free	_	
307-210	49639-49648	exponents	_	
307-211	49649-49651	of	_	
307-212	49652-49659	resting	_	
307-213	49660-49665	state	_	
307-214	49666-49673	provide	_	
307-215	49674-49675	a	_	
307-216	49676-49685	biomarker	_	
307-217	49686-49689	for	_	
307-218	49690-49697	typical	_	
307-219	49698-49701	and	_	
307-220	49702-49710	atypical	_	
307-221	49711-49716	brain	_	
307-222	49717-49725	activity	_	
307-223	49726-49727	A	_	
307-224	49728-49734	global	_	
307-225	49735-49747	optimization	_	
307-226	49748-49754	method	_	
307-227	49755-49758	for	_	
307-228	49759-49765	robust	_	
307-229	49766-49772	affine	_	
307-230	49773-49785	registration	_	
307-231	49786-49788	of	_	
307-232	49789-49794	brain	_	
307-233	49795-49801	images	_	
307-234	49802-49810	Improved	_	
307-235	49811-49823	optimisation	_	
307-236	49824-49827	for	_	
307-237	49828-49831	the	_	
307-238	49832-49838	robust	_	
307-239	49839-49842	and	_	
307-240	49843-49851	accurate	_	
307-241	49852-49858	linear	_	
307-242	49859-49871	registration	_	
307-243	49872-49875	and	_	
307-244	49876-49882	motion	_	
307-245	49883-49893	correction	_	
307-246	49894-49896	of	_	
307-247	49897-49902	brain	_	
307-248	49903-49909	images	_	
307-249	49910-49920	Functional	_	
307-250	49921-49924	and	_	
307-251	49925-49935	anatomical	_	
307-252	49936-49944	cortical	_	
307-253	49945-49962	underconnectivity	_	
307-254	49963-49965	in	_	
307-255	49966-49972	autism	_	
307-256	49972-49973	:	_	
307-257	49974-49982	evidence	_	
307-258	49983-49987	from	_	
307-259	49988-49990	an	_	
307-260	49991-49995	fMRI	_	
307-261	49996-50001	study	_	
307-262	50002-50004	of	_	
307-263	50005-50007	an	_	
307-264	50008-50017	executive	_	
307-265	50018-50026	function	_	
307-266	50027-50031	task	_	
307-267	50032-50035	and	_	
307-268	50036-50042	corpus	_	
307-269	50043-50051	callosum	_	
307-270	50052-50063	morphometry	_	
307-271	50064-50073	Detecting	_	
307-272	50074-50086	neuroimaging	_	
307-273	50087-50096	biomarker	_	
307-274	50097-50100	for	_	
307-275	50101-50114	schizophrenia	_	
307-276	50114-50115	:	_	
307-277	50116-50117	a	_	
307-278	50118-50131	meta-analysis	_	
307-279	50132-50134	of	_	
307-280	50135-50147	multivariate	_	
307-281	50148-50155	pattern	_	
307-282	50156-50167	recognition	_	
307-283	50168-50175	studies	_	
307-284	50176-50189	Understanding	_	
307-285	50190-50199	executive	_	
307-286	50200-50207	control	_	
307-287	50208-50210	in	_	
307-288	50211-50217	autism	_	
307-289	50218-50226	spectrum	_	
307-290	50227-50236	disorders	_	
307-291	50237-50239	in	_	
307-292	50240-50243	the	_	
307-293	50244-50247	lab	_	
307-294	50248-50251	and	_	
307-295	50252-50254	in	_	
307-296	50255-50258	the	_	
307-297	50259-50263	real	_	
307-298	50264-50269	world	_	
307-299	50270-50277	Studies	_	
307-300	50278-50280	in	_	
307-301	50281-50284	the	_	
307-302	50285-50294	childhood	_	
307-303	50295-50304	psychoses	_	
307-304	50304-50305	.	_	

#Text=I.
308-1	50306-50307	I	_	
308-2	50307-50308	.	_	

#Text=Diagnostic criteria and classification
#Text=Autistic disorder and schizophrenia: diagnostic overlaps
#Text=
#Text=Topologically reorganized connectivity architecture of default-mode, executive-control, and salience networks across working memory task loads
#Text=The autism diagnostic observation schedule–generic: a standard measure of social and communication deficits associated with the spectrum of autism
#Text=Altered semantic but not phonological verbal fluency in young help-seeking individuals with ultra high risk of psychosis
#Text=A probabilistic atlas of the human brain: theory and rationale for its development
#Text=De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability
#Text=Reduced mirror neuron activity in schizophrenia and its association with theory of mind deficits: evidence from a transcranial magnetic stimulation study
#Text=Saliency, switching, attention and control: a network model of insula function
#Text=Mirror neuron deficit in schizophrenia: evidence from repetition suppression
#Text=Deficits in facial-affect recognition and schizophrenia
#Text=Multisite functional connectivity MRI classification of autism: ABIDE results
#Text=Topographic hub maps of the human structural neocortical network
#Text=EEG evidence for mirror neuron dysfunction in autism spectrum disorders
#Text=The human mirror neuron system: a link between action observation and social skills
#Text=Executive functioning in schizophrenia
#Text=Does the salience network play a cardinal role in psychosis?
309-1	50309-50319	Diagnostic	_	
309-2	50320-50328	criteria	_	
309-3	50329-50332	and	_	
309-4	50333-50347	classification	_	
309-5	50348-50356	Autistic	_	
309-6	50357-50365	disorder	_	
309-7	50366-50369	and	_	
309-8	50370-50383	schizophrenia	_	
309-9	50383-50384	:	_	
309-10	50385-50395	diagnostic	_	
309-11	50396-50404	overlaps	_	
309-12	50406-50419	Topologically	_	
309-13	50420-50431	reorganized	_	
309-14	50432-50444	connectivity	_	
309-15	50445-50457	architecture	_	
309-16	50458-50460	of	_	
309-17	50461-50473	default-mode	_	
309-18	50473-50474	,	_	
309-19	50475-50492	executive-control	_	
309-20	50492-50493	,	_	
309-21	50494-50497	and	_	
309-22	50498-50506	salience	_	
309-23	50507-50515	networks	_	
309-24	50516-50522	across	_	
309-25	50523-50530	working	_	
309-26	50531-50537	memory	_	
309-27	50538-50542	task	_	
309-28	50543-50548	loads	_	
309-29	50549-50552	The	_	
309-30	50553-50559	autism	_	
309-31	50560-50570	diagnostic	_	
309-32	50571-50582	observation	_	
309-33	50583-50599	schedule–generic	_	
309-34	50599-50600	:	_	
309-35	50601-50602	a	_	
309-36	50603-50611	standard	_	
309-37	50612-50619	measure	_	
309-38	50620-50622	of	_	
309-39	50623-50629	social	_	
309-40	50630-50633	and	_	
309-41	50634-50647	communication	_	
309-42	50648-50656	deficits	_	
309-43	50657-50667	associated	_	
309-44	50668-50672	with	_	
309-45	50673-50676	the	_	
309-46	50677-50685	spectrum	_	
309-47	50686-50688	of	_	
309-48	50689-50695	autism	_	
309-49	50696-50703	Altered	_	
309-50	50704-50712	semantic	_	
309-51	50713-50716	but	_	
309-52	50717-50720	not	_	
309-53	50721-50733	phonological	_	
309-54	50734-50740	verbal	_	
309-55	50741-50748	fluency	_	
309-56	50749-50751	in	_	
309-57	50752-50757	young	_	
309-58	50758-50770	help-seeking	_	
309-59	50771-50782	individuals	_	
309-60	50783-50787	with	_	
309-61	50788-50793	ultra	_	
309-62	50794-50798	high	_	
309-63	50799-50803	risk	_	
309-64	50804-50806	of	_	
309-65	50807-50816	psychosis	_	
309-66	50817-50818	A	_	
309-67	50819-50832	probabilistic	_	
309-68	50833-50838	atlas	_	
309-69	50839-50841	of	_	
309-70	50842-50845	the	_	
309-71	50846-50851	human	_	
309-72	50852-50857	brain	_	
309-73	50857-50858	:	_	
309-74	50859-50865	theory	_	
309-75	50866-50869	and	_	
309-76	50870-50879	rationale	_	
309-77	50880-50883	for	_	
309-78	50884-50887	its	_	
309-79	50888-50899	development	_	
309-80	50900-50902	De	_	
309-81	50903-50907	novo	_	
309-82	50908-50917	mutations	_	
309-83	50918-50920	in	_	
309-84	50921-50934	schizophrenia	_	
309-85	50935-50944	implicate	_	
309-86	50945-50954	chromatin	_	
309-87	50955-50965	remodeling	_	
309-88	50966-50969	and	_	
309-89	50970-50977	support	_	
309-90	50978-50979	a	_	
309-91	50980-50987	genetic	_	
309-92	50988-50995	overlap	_	
309-93	50996-51000	with	_	
309-94	51001-51007	autism	_	
309-95	51008-51011	and	_	
309-96	51012-51024	intellectual	_	
309-97	51025-51035	disability	_	
309-98	51036-51043	Reduced	_	
309-99	51044-51050	mirror	_	
309-100	51051-51057	neuron	_	
309-101	51058-51066	activity	_	
309-102	51067-51069	in	_	
309-103	51070-51083	schizophrenia	_	
309-104	51084-51087	and	_	
309-105	51088-51091	its	_	
309-106	51092-51103	association	_	
309-107	51104-51108	with	_	
309-108	51109-51115	theory	_	
309-109	51116-51118	of	_	
309-110	51119-51123	mind	_	
309-111	51124-51132	deficits	_	
309-112	51132-51133	:	_	
309-113	51134-51142	evidence	_	
309-114	51143-51147	from	_	
309-115	51148-51149	a	_	
309-116	51150-51162	transcranial	_	
309-117	51163-51171	magnetic	_	
309-118	51172-51183	stimulation	_	
309-119	51184-51189	study	_	
309-120	51190-51198	Saliency	_	
309-121	51198-51199	,	_	
309-122	51200-51209	switching	_	
309-123	51209-51210	,	_	
309-124	51211-51220	attention	_	
309-125	51221-51224	and	_	
309-126	51225-51232	control	_	
309-127	51232-51233	:	_	
309-128	51234-51235	a	_	
309-129	51236-51243	network	_	
309-130	51244-51249	model	_	
309-131	51250-51252	of	_	
309-132	51253-51259	insula	_	
309-133	51260-51268	function	_	
309-134	51269-51275	Mirror	_	
309-135	51276-51282	neuron	_	
309-136	51283-51290	deficit	_	
309-137	51291-51293	in	_	
309-138	51294-51307	schizophrenia	_	
309-139	51307-51308	:	_	
309-140	51309-51317	evidence	_	
309-141	51318-51322	from	_	
309-142	51323-51333	repetition	_	
309-143	51334-51345	suppression	_	
309-144	51346-51354	Deficits	_	
309-145	51355-51357	in	_	
309-146	51358-51371	facial-affect	_	
309-147	51372-51383	recognition	_	
309-148	51384-51387	and	_	
309-149	51388-51401	schizophrenia	_	
309-150	51402-51411	Multisite	_	
309-151	51412-51422	functional	_	
309-152	51423-51435	connectivity	_	
309-153	51436-51439	MRI	_	
309-154	51440-51454	classification	_	
309-155	51455-51457	of	_	
309-156	51458-51464	autism	_	
309-157	51464-51465	:	_	
309-158	51466-51471	ABIDE	_	
309-159	51472-51479	results	_	
309-160	51480-51491	Topographic	_	
309-161	51492-51495	hub	_	
309-162	51496-51500	maps	_	
309-163	51501-51503	of	_	
309-164	51504-51507	the	_	
309-165	51508-51513	human	_	
309-166	51514-51524	structural	_	
309-167	51525-51536	neocortical	_	
309-168	51537-51544	network	_	
309-169	51545-51548	EEG	_	
309-170	51549-51557	evidence	_	
309-171	51558-51561	for	_	
309-172	51562-51568	mirror	_	
309-173	51569-51575	neuron	_	
309-174	51576-51587	dysfunction	_	
309-175	51588-51590	in	_	
309-176	51591-51597	autism	_	
309-177	51598-51606	spectrum	_	
309-178	51607-51616	disorders	_	
309-179	51617-51620	The	_	
309-180	51621-51626	human	_	
309-181	51627-51633	mirror	_	
309-182	51634-51640	neuron	_	
309-183	51641-51647	system	_	
309-184	51647-51648	:	_	
309-185	51649-51650	a	_	
309-186	51651-51655	link	_	
309-187	51656-51663	between	_	
309-188	51664-51670	action	_	
309-189	51671-51682	observation	_	
309-190	51683-51686	and	_	
309-191	51687-51693	social	_	
309-192	51694-51700	skills	_	
309-193	51701-51710	Executive	_	
309-194	51711-51722	functioning	_	
309-195	51723-51725	in	_	
309-196	51726-51739	schizophrenia	_	
309-197	51740-51744	Does	_	
309-198	51745-51748	the	_	
309-199	51749-51757	salience	_	
309-200	51758-51765	network	_	
309-201	51766-51770	play	_	
309-202	51771-51772	a	_	
309-203	51773-51781	cardinal	_	
309-204	51782-51786	role	_	
309-205	51787-51789	in	_	
309-206	51790-51799	psychosis	_	
309-207	51799-51800	?	_	

#Text=An emerging hypothesis of insular dysfunction
#Text=Schizophrenia and the brain's control network: aberrant within-and between-network connectivity of the frontoparietal network in schizophrenia
#Text=Searching for ways out of the autism maze: genetic, epigenetic and environmental clues
#Text=Theory of mind abilities of children with schizophrenia, children with autism, and normally developing children
#Text=Functional connectivity classification of autism identifies highly predictive brain features but falls short of biomarker standards
#Text=Functional network organization of the human brain
#Text=Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion
#Text=Multi-subject search correctly identifies causal connections and most causal directions in the DCM models of the Smith et al. simulation study
#Text=Correlated gene expression supports synchronous activity in brain networks
#Text=Premotor cortex and the recognition of motor actions
#Text=Epigenetic mechanisms in schizophrenia
#Text=Childhood schizophrenia reconsidered
#Text=The benefit of directly comparing autism and schizophrenia for revealing mechanisms of social cognitive impairment
#Text=Developmental deficits in social perception in autism: the role of the amygdala and fusiform face area
#Text=Discriminative analysis of resting-state functional connectivity patterns of schizophrenia using low dimensional embedding of fMRI
#Text=Fast robust automated brain extraction
#Text=From lumping to splitting and back again: atypical social and language development in individuals with clinical-high-risk for psychosis, first episode schizophrenia, and autism spectrum disorders
#Text=Can magnetic resonance imaging aid diagnosis of the autism spectrum?
310-1	51801-51803	An	_	
310-2	51804-51812	emerging	_	
310-3	51813-51823	hypothesis	_	
310-4	51824-51826	of	_	
310-5	51827-51834	insular	_	
310-6	51835-51846	dysfunction	_	
310-7	51847-51860	Schizophrenia	_	
310-8	51861-51864	and	_	
310-9	51865-51868	the	_	
310-10	51869-51876	brain's	_	
310-11	51877-51884	control	_	
310-12	51885-51892	network	_	
310-13	51892-51893	:	_	
310-14	51894-51902	aberrant	_	
310-15	51903-51913	within-and	_	
310-16	51914-51929	between-network	_	
310-17	51930-51942	connectivity	_	
310-18	51943-51945	of	_	
310-19	51946-51949	the	_	
310-20	51950-51964	frontoparietal	_	
310-21	51965-51972	network	_	
310-22	51973-51975	in	_	
310-23	51976-51989	schizophrenia	_	
310-24	51990-51999	Searching	_	
310-25	52000-52003	for	_	
310-26	52004-52008	ways	_	
310-27	52009-52012	out	_	
310-28	52013-52015	of	_	
310-29	52016-52019	the	_	
310-30	52020-52026	autism	_	
310-31	52027-52031	maze	_	
310-32	52031-52032	:	_	
310-33	52033-52040	genetic	_	
310-34	52040-52041	,	_	
310-35	52042-52052	epigenetic	_	
310-36	52053-52056	and	_	
310-37	52057-52070	environmental	_	
310-38	52071-52076	clues	_	
310-39	52077-52083	Theory	_	
310-40	52084-52086	of	_	
310-41	52087-52091	mind	_	
310-42	52092-52101	abilities	_	
310-43	52102-52104	of	_	
310-44	52105-52113	children	_	
310-45	52114-52118	with	_	
310-46	52119-52132	schizophrenia	_	
310-47	52132-52133	,	_	
310-48	52134-52142	children	_	
310-49	52143-52147	with	_	
310-50	52148-52154	autism	_	
310-51	52154-52155	,	_	
310-52	52156-52159	and	_	
310-53	52160-52168	normally	_	
310-54	52169-52179	developing	_	
310-55	52180-52188	children	_	
310-56	52189-52199	Functional	_	
310-57	52200-52212	connectivity	_	
310-58	52213-52227	classification	_	
310-59	52228-52230	of	_	
310-60	52231-52237	autism	_	
310-61	52238-52248	identifies	_	
310-62	52249-52255	highly	_	
310-63	52256-52266	predictive	_	
310-64	52267-52272	brain	_	
310-65	52273-52281	features	_	
310-66	52282-52285	but	_	
310-67	52286-52291	falls	_	
310-68	52292-52297	short	_	
310-69	52298-52300	of	_	
310-70	52301-52310	biomarker	_	
310-71	52311-52320	standards	_	
310-72	52321-52331	Functional	_	
310-73	52332-52339	network	_	
310-74	52340-52352	organization	_	
310-75	52353-52355	of	_	
310-76	52356-52359	the	_	
310-77	52360-52365	human	_	
310-78	52366-52371	brain	_	
310-79	52372-52380	Spurious	_	
310-80	52381-52384	but	_	
310-81	52385-52395	systematic	_	
310-82	52396-52408	correlations	_	
310-83	52409-52411	in	_	
310-84	52412-52422	functional	_	
310-85	52423-52435	connectivity	_	
310-86	52436-52439	MRI	_	
310-87	52440-52448	networks	_	
310-88	52449-52454	arise	_	
310-89	52455-52459	from	_	
310-90	52460-52467	subject	_	
310-91	52468-52474	motion	_	
310-92	52475-52488	Multi-subject	_	
310-93	52489-52495	search	_	
310-94	52496-52505	correctly	_	
310-95	52506-52516	identifies	_	
310-96	52517-52523	causal	_	
310-97	52524-52535	connections	_	
310-98	52536-52539	and	_	
310-99	52540-52544	most	_	
310-100	52545-52551	causal	_	
310-101	52552-52562	directions	_	
310-102	52563-52565	in	_	
310-103	52566-52569	the	_	
310-104	52570-52573	DCM	_	
310-105	52574-52580	models	_	
310-106	52581-52583	of	_	
310-107	52584-52587	the	_	
310-108	52588-52593	Smith	_	
310-109	52594-52596	et	_	
310-110	52597-52599	al	_	
310-111	52599-52600	.	_	
310-112	52601-52611	simulation	_	
310-113	52612-52617	study	_	
310-114	52618-52628	Correlated	_	
310-115	52629-52633	gene	_	
310-116	52634-52644	expression	_	
310-117	52645-52653	supports	_	
310-118	52654-52665	synchronous	_	
310-119	52666-52674	activity	_	
310-120	52675-52677	in	_	
310-121	52678-52683	brain	_	
310-122	52684-52692	networks	_	
310-123	52693-52701	Premotor	_	
310-124	52702-52708	cortex	_	
310-125	52709-52712	and	_	
310-126	52713-52716	the	_	
310-127	52717-52728	recognition	_	
310-128	52729-52731	of	_	
310-129	52732-52737	motor	_	
310-130	52738-52745	actions	_	
310-131	52746-52756	Epigenetic	_	
310-132	52757-52767	mechanisms	_	
310-133	52768-52770	in	_	
310-134	52771-52784	schizophrenia	_	
310-135	52785-52794	Childhood	_	
310-136	52795-52808	schizophrenia	_	
310-137	52809-52821	reconsidered	_	
310-138	52822-52825	The	_	
310-139	52826-52833	benefit	_	
310-140	52834-52836	of	_	
310-141	52837-52845	directly	_	
310-142	52846-52855	comparing	_	
310-143	52856-52862	autism	_	
310-144	52863-52866	and	_	
310-145	52867-52880	schizophrenia	_	
310-146	52881-52884	for	_	
310-147	52885-52894	revealing	_	
310-148	52895-52905	mechanisms	_	
310-149	52906-52908	of	_	
310-150	52909-52915	social	_	
310-151	52916-52925	cognitive	_	
310-152	52926-52936	impairment	_	
310-153	52937-52950	Developmental	_	
310-154	52951-52959	deficits	_	
310-155	52960-52962	in	_	
310-156	52963-52969	social	_	
310-157	52970-52980	perception	_	
310-158	52981-52983	in	_	
310-159	52984-52990	autism	_	
310-160	52990-52991	:	_	
310-161	52992-52995	the	_	
310-162	52996-53000	role	_	
310-163	53001-53003	of	_	
310-164	53004-53007	the	_	
310-165	53008-53016	amygdala	_	
310-166	53017-53020	and	_	
310-167	53021-53029	fusiform	_	
310-168	53030-53034	face	_	
310-169	53035-53039	area	_	
310-170	53040-53054	Discriminative	_	
310-171	53055-53063	analysis	_	
310-172	53064-53066	of	_	
310-173	53067-53080	resting-state	_	
310-174	53081-53091	functional	_	
310-175	53092-53104	connectivity	_	
310-176	53105-53113	patterns	_	
310-177	53114-53116	of	_	
310-178	53117-53130	schizophrenia	_	
310-179	53131-53136	using	_	
310-180	53137-53140	low	_	
310-181	53141-53152	dimensional	_	
310-182	53153-53162	embedding	_	
310-183	53163-53165	of	_	
310-184	53166-53170	fMRI	_	
310-185	53171-53175	Fast	_	
310-186	53176-53182	robust	_	
310-187	53183-53192	automated	_	
310-188	53193-53198	brain	_	
310-189	53199-53209	extraction	_	
310-190	53210-53214	From	_	
310-191	53215-53222	lumping	_	
310-192	53223-53225	to	_	
310-193	53226-53235	splitting	_	
310-194	53236-53239	and	_	
310-195	53240-53244	back	_	
310-196	53245-53250	again	_	
310-197	53250-53251	:	_	
310-198	53252-53260	atypical	_	
310-199	53261-53267	social	_	
310-200	53268-53271	and	_	
310-201	53272-53280	language	_	
310-202	53281-53292	development	_	
310-203	53293-53295	in	_	
310-204	53296-53307	individuals	_	
310-205	53308-53312	with	_	
310-206	53313-53331	clinical-high-risk	_	
310-207	53332-53335	for	_	
310-208	53336-53345	psychosis	_	
310-209	53345-53346	,	_	
310-210	53347-53352	first	_	
310-211	53353-53360	episode	_	
310-212	53361-53374	schizophrenia	_	
310-213	53374-53375	,	_	
310-214	53376-53379	and	_	
310-215	53380-53386	autism	_	
310-216	53387-53395	spectrum	_	
310-217	53396-53405	disorders	_	
310-218	53406-53409	Can	_	
310-219	53410-53418	magnetic	_	
310-220	53419-53428	resonance	_	
310-221	53429-53436	imaging	_	
310-222	53437-53440	aid	_	
310-223	53441-53450	diagnosis	_	
310-224	53451-53453	of	_	
310-225	53454-53457	the	_	
310-226	53458-53464	autism	_	
310-227	53465-53473	spectrum	_	
310-228	53473-53474	?	_	

#Text=Transitive inference in schizophrenia: impairments in relational memory organization
#Text=Network hubs in the human brain
#Text=Whole brain resting state functional connectivity abnormalities in schizophrenia
#Text=
#Text=Diminished sensitivity to sad facial expressions in high functioning autism spectrum disorders is associated with symptomatology and adaptive functioning
#Text=BrainNet Viewer: a network visualization tool for human brain connectomics
#Text=A small number of abnormal brain connections predicts adult autism spectrum disorder
311-1	53475-53485	Transitive	_	
311-2	53486-53495	inference	_	
311-3	53496-53498	in	_	
311-4	53499-53512	schizophrenia	_	
311-5	53512-53513	:	_	
311-6	53514-53525	impairments	_	
311-7	53526-53528	in	_	
311-8	53529-53539	relational	_	
311-9	53540-53546	memory	_	
311-10	53547-53559	organization	_	
311-11	53560-53567	Network	_	
311-12	53568-53572	hubs	_	
311-13	53573-53575	in	_	
311-14	53576-53579	the	_	
311-15	53580-53585	human	_	
311-16	53586-53591	brain	_	
311-17	53592-53597	Whole	_	
311-18	53598-53603	brain	_	
311-19	53604-53611	resting	_	
311-20	53612-53617	state	_	
311-21	53618-53628	functional	_	
311-22	53629-53641	connectivity	_	
311-23	53642-53655	abnormalities	_	
311-24	53656-53658	in	_	
311-25	53659-53672	schizophrenia	_	
311-26	53674-53684	Diminished	_	
311-27	53685-53696	sensitivity	_	
311-28	53697-53699	to	_	
311-29	53700-53703	sad	_	
311-30	53704-53710	facial	_	
311-31	53711-53722	expressions	_	
311-32	53723-53725	in	_	
311-33	53726-53730	high	_	
311-34	53731-53742	functioning	_	
311-35	53743-53749	autism	_	
311-36	53750-53758	spectrum	_	
311-37	53759-53768	disorders	_	
311-38	53769-53771	is	_	
311-39	53772-53782	associated	_	
311-40	53783-53787	with	_	
311-41	53788-53802	symptomatology	_	
311-42	53803-53806	and	_	
311-43	53807-53815	adaptive	_	
311-44	53816-53827	functioning	_	
311-45	53828-53836	BrainNet	_	
311-46	53837-53843	Viewer	_	
311-47	53843-53844	:	_	
311-48	53845-53846	a	_	
311-49	53847-53854	network	_	
311-50	53855-53868	visualization	_	
311-51	53869-53873	tool	_	
311-52	53874-53877	for	_	
311-53	53878-53883	human	_	
311-54	53884-53889	brain	_	
311-55	53890-53902	connectomics	_	
311-56	53903-53904	A	_	
311-57	53905-53910	small	_	
311-58	53911-53917	number	_	
311-59	53918-53920	of	_	
311-60	53921-53929	abnormal	_	
311-61	53930-53935	brain	_	
311-62	53936-53947	connections	_	
311-63	53948-53956	predicts	_	
311-64	53957-53962	adult	_	
311-65	53963-53969	autism	_	
311-66	53970-53978	spectrum	_	
311-67	53979-53987	disorder	_	
